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ABSTRACT 
Formation of 2-halomethylene-4-cyclopentene-1,3-diones and/or 2-halo-1,4-benzoquinones, 
total synthesis of methyl linderone and Wacker-type oxidation of aryl-substituted alkenes 
Hong Yin 
 
We have discovered a practical general method for the preparation of diverse 
2-halomethylene-4-cyclopentene-1,3-diones and/or 2-halo-1,4-benzoquinones. An in-depth 
study of the reactions of 4-(ethynyl)-4-hydroxy-2,3-substituted-2-cyclobuten-1-ones with 
N-bromo- or N-iodosuccinimide is described. This reaction was used in a short total synthesis 
of methyl linderone. Also, a series of facile, palladium catalyzed, direct, and regiospecific 
Wacker-type oxidations has been developed to yield various α-arylated ketones from 
aryl-substituted internal alkenes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Acknowledgments 
This work is dedicated to my parents, Lingxiang Yin and Yuying Hong. I am glad that 
they are here today to witness my accomplishments. 
I would like to thank my advisor, Dr. Björn C. G. Söderberg, for his constant advising, 
patience, and encouragement during my graduate studies. I would also like to thank all 
faculty members in the C. Eugene Bennett Department of Chemistry for their assistance over 
the years, especially my doctoral defense committee members.  
Finally, thanks to all my research group members, past and present, for all of their 
help and friendship. 
iv 
 
Table of Contents 
Title Page                                                                  i            
Abstract                                                                   ii            
Acknowledgment                                                           iii            
Table of Contents                                                           iv            
Appendix                                                                 vii 
List of Figures                                                            viii           
List of Schemes                                                           xvi 
List of Tables                                                             xix 
 
Chapter 1 
Formation of 2-halomethylene-4-cyclopentene-1,3-diones and/or 
2-halo-1,4-benzoquinones via ring-expansion of 
4-ethynyl-4-hydroxy-2,3-substituted-2-cyclobuten-1-ones 
1.1 Rearrangement of 4-alkynylcyclobutenones                                    2 
1.1.1 Thermally induced ring expansions of 4-alkynylcyclobutenones               3 
1.1.2 Electrophilic reagents induced ring expansions of 4-alkynylcyclobutenones     15 
1.2 Ring expansion of 4-alkynyl-4-hydroxycyclo-2-buten-1-ones in the presence of an 
N-halosuccinimide                                                     20 
1.3 Results and discussion                                                   23 
1.4 Conclusions                                                            31 
 
v 
 
Chapter 2 
Total synthesis of methyl linderone 
2.1 Introduction to linderone and methyl linderone                               33 
2.2 Previous synthesis of linderone and methyl linderone                          38 
2.3 Methyl linderone via ring expansion of 4-ene-yne-substituted cyclo-2-buten-1- 
one and N-iodosuccinimide                                               45 
2.3.1 Retrosynthetic analysis                                             45 
2.3.2 Results and discussion                                              46 
2.3.3 Conclusions                                                      47 
 
Chapter 3 
Synthesis of α-arylated ketone via Wacker-type oxidation of 
aryl-substituted alkenes 
3.1 α-Arylated ketone background                                             49 
3.2 Wacker-type oxidation                                                   58 
3.3 Wacker-type oxidation of aryl-substituted alkenes                             73 
3.4 Results and discussion                                                   77 
3.5 Conclusions                                                            84 
 
 
 
 
vi 
 
Chapter 4 
Supporting information: experimental procedures 
 
4.1 Supporting information Chapter 1: Ring-expansion of 4-ethynyl-4-hydroxy-2,3- 
substituted-2-cyclobuten-1-ones                                           86 
4.2 Supporting information Chapter 2: Total synthesis of methyl linderone            103 
4.3 Supporting information Chapter 3: Wacker-type oxidation of aryl-substituted alkenes 107 
                                                                                                                                                               
vii 
 
Appendix 
1H and 13C NMR Spectra 
 1H and 13C NMR for Chapter 1: Ring-expansion of 4-ethynyl-4-hydroxy-2,3- 
substituted-2-cyclobuten-1-ones                                          149 
 1H and 13C NMR for Chapter 2: Total synthesis of methyl linderone              201 
 1H and 13C NMR for Chapter 3: Wacker-type oxidation of aryl-substituted alkenes  208 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
List of Figures 
Figure1: Structures of arnebifuranone, isoarnebifuranone, nanaomycin D, and 
deoxyfrenolicin 
 
6 
Figure 2: Structures of (±)-terreic acid and (±)-isoperezone 12 
Figure 3: Eicosanoid core and naturally occurring eicosanoids 16 
Figure 4: Postulated reaction path for palladium catalyzed ring expansion reaction 17 
Figure 5: Hydrolysis products 85 and 86 27 
Figure 6: Structures of linderone, methyl linderone, lucidone, methyl lucidone isolated 
from Lindera species 
 
34 
Figure 7: Structures of Stigmahamones I-II 34 
Figure 8: Structure of kanakugiol 36 
Figure 9: Structure of calythrone 38 
Figure 10: Structures of coumestan, phenylbenzofurans, and isoflavones 49 
Figure 11: Chemical structures of various palladium-complex catalysts 52 
Figure 12: Typical apparatus for Wacker-type oxidation 60 
Figure 13: Palladium complex accounts for the deactivation 62 
Figure 14: Structures of substrates 238, 240, 241, and 242 74 
Figure 15: Wacker-type oxidation of 1-aryl-1-propene 75 
Figure 16: Products 276 and 277 82 
Figure 17: 1H NMR of 2,3-bis(1-methylethoxy)-5-trimethylsilyl-2,5-cyclohexadiene- 
1,4-dione (70) 
 
149 
ix 
 
Figure 18: 13C NMR of 2,3-bis(1-methylethoxy)-5-trimethylsilyl-2,5-cyclohexadiene- 
1,4-dione (70) 
 
150 
Figure 19: 1H NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)- 
4-cyclopentene-1,3-dione (71) 
 
151 
Figure 20: 13C NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)- 
4-cyclopentene-1,3-dione (71) 
 
152 
Figure 21: 1H NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)- 
4-cyclopentene-1,3-dione (72) 
 
153 
Figure 22: 13C NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)-
4-cyclopentene-1,3-dione (72) 
 
154 
Figure 23: 1H NMR of 2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (74) 155 
Figure 24: 13C NMR of 2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (74)  156 
Figure 25: 1H NMR of 2-(iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (75) 
 
157 
Figure 26: 13C NMR of 2-(iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (75) 
 
158 
Figure 27: 1H NMR of 2-(bromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (76) 
 
159 
Figure 28: 13C NMR of 2-(bromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (76) 
 
160 
Figure 29: 1H NMR of 5-chloro-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione 
(77) 
 
161 
x 
 
Figure 30: 13C NMR of 5-chloro-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione 
(77) 
 
162 
Figure 31: 1H NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-iodoethynyl)-2- 
cyclobutene-1-one (78) 
 
163 
Figure 32: 13C NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-iodoethynyl)-2- 
cyclobutene-1-one (78) 
 
164 
Figure 33: 1H NMR of 5-iodo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione 
(79) 
 
165 
Figure 34: 13C NMR of 5-iodo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione 
(79) 
 
166 
Figure 35: 1H NMR of 2-(diiodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (80) 
 
167 
Figure 36: 13C NMR of 2-(diiodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (80) 
 
168 
Figure 37: 1H NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-bromoethynyl)-2- 
cyclobutene-1-one (81) 
 
169 
Figure 38: 13C NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-bromoethynyl)-2- 
cyclobutene-1-one (81) 
 
170 
Figure 39: 1H NMR of 5-bromo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione   
(82) 
 
171 
Figure 40: 13C NMR of 5-bromo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione 
(82) 
 
172 
xi 
 
Figure 41: 1H NMR of 2-(1-bromo-1-iodomethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (83) 
 
173 
Figure 42: 13C NMR of 2-(1-bromo-1-iodomethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (83) 
 
174 
Figure 43: 1H NMR of 2-(dibromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (84) 
 
175 
Figure 44: 13C NMR of 2-(dibromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-
1,3-dione (84) 
 
176 
Figure 45: 1H NMR of 4-hydroxy-2-methyl-3-(1-methylethoxy)-4- 
(2-trimethylsilylethynyl)-2-cyclobutene-1-one (89) 
 
177 
Figure 46: 13C NMR of 4-hydroxy-2-methyl-3-(1-methylethoxy)-4- 
(2-trimethylsilylethynyl)-2-cyclobutene-1-one (89) 
 
178 
Figure 47: 1H NMR of 2-trimethylsilylmethylene-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (90) and 5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (91) 
 
 
179 
Figure 48: 13C NMR of 2-trimethylsilylmethylene-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (90) and 5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (91) 
 
 
180 
Figure 49: 1H NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4-(1-methylethoxy)- 
5-methyl-4-cyclopentene-1,3-dione (92) 
 
181 
Figure 50: 13C NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4-(1-methylethoxy)- 
5-methyl-4-cyclopentene-1,3-dione (92) 
 
182 
xii 
 
Figure 51: 1H NMR of 6-iodo-5-trimethylsilyl-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (93) 
 
183 
Figure 52: 13C NMR of 6-iodo-5-trimethylsilyl-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (93) 
 
184 
Figure 53: 1H NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5- 
methyl-4-cyclopentene-1,3-dione (94) 
 
185 
Figure 54: 13C NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5- 
methyl-4-cyclopentene-1,3-dione (94) 
 
186 
Figure 55: 1H NMR of 6-bromo-5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (95) 
 
187 
Figure 56: 13C NMR of 6-bromo-5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (95) 
 
188 
Figure 57: 1H NMR of 3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (97) 189 
Figure 58: 13C NMR of 3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (97) 190 
Figure 59: 1H NMR of 2-(1-iodomethylene)-4-methyl-5-(1-methylethoxy)-4- 
cyclopentene-1,3-dione (98) 
 
191 
Figure 60: 13C NMR of 2-(1-iodomethylene)-4-methyl-5-(1-methylethoxy)-4- 
cyclopentene-1,3-dione (98) 
 
192 
Figure 61: 1H NMR of 2-(1-bromomethylene)-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (99) 
 
193 
Figure 62: 13C NMR of 2-(1-bromomethylene)-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (99) 
 
194 
xiii 
 
Figure 63: 1H NMR of 2-(diiodomethylene)-4-(1-methylethoxy)-5-methyl- 
4-cyclopentene-1,3-dione (101) 
 
195 
Figure 64: 13C NMR of 2-(diiodomethylene)-4-(1-methylethoxy)-5-methyl- 
4-cyclopentene-1,3-dione (101) 
 
196 
Figure 65: 1H NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
iodoethanoate (104) 
 
197 
Figure 66: 13C NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
iodoethanoate (104) 
 
198 
Figure 67: 1H NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
bromoethanoate (105) 
 
199 
Figure 68: 13C NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
bromoethanoate (105) 
 
200 
Figure 69: 1H NMR of 2,3-dimethoxy-4-hydroxy-4-[(E)-4-phenyl-3-buten-1-yn-1-yl]-2- 
cyclobuten-1-one (137) 
 
201 
Figure 70: 13C NMR of 2,3-dimethoxy-4-hydroxy-4-[(E)-4-phenyl-3-buten-1-yn-1-yl]- 
2-cyclobuten-1-one (137) 
 
202 
Figure 71: 1H NMR of 4,5-dimethoxy-[(E)-2-(1-iodo-3-phenyl-2-propen-1-ylidene)]-4- 
cyclopentene-1,3-dione (138) 
 
203 
Figure 72: 13C NMR of 4,5-dimethoxy-[(E)-2-(1-iodo-3-phenyl-2-propen-1-ylidene)]-4- 
cyclopentene-1,3-dione (138) 
 
204 
Figure 73: 1H NMR of 4,5-dimethoxy-2-[(E)-3-phenyl-2-propen-1-ylidene]-4- 
cyclopente-1,3-dione (139) 
 
205 
xiv 
 
Figure 74: 13C NMR of 4,5-dimethoxy-2-[(E)-3-phenyl-2-propen-1-ylidene]-4- 
cyclopente-1,3-dione (139) 
 
206 
Figure 75: 1H NMR of 4,5-dimethoxy-2-[(E)-1-(N,N-dimethylamino)-3-phenyl-2- 
propen-1-ylidene]-4-cyclopente-1,3-dione (140) 
 
207 
Figure 76: 1H NMR of 4-fluoro-2-nitro-1-(1-propen-1-yl)benzene (233) 208 
Figure 77: 13C NMR of 4-fluoro-2-nitro-1-(1-propen-1-yl)benzene (233) 209 
Figure 78: 1H NMR of 2,4-dinitro-1-(1-propen-1-yl)benzene (234) 210 
Figure 79: 1H NMR of 4-carbomethoxy-2-nitro-1-(1-propen-1-yl)benzene (235) 211 
Figure 80: 1H NMR of 4-methoxy-2-nitro-1-(1-propen-1-yl)benzene (236) 212 
Figure 81: 13C NMR of 4-methoxy-2-nitro-1-(1-propen-1-yl)benzene (236) 213 
Figure 82: 1H NMR of 5-methoxy-2-nitro-1-(1-propen-1-yl)-benzene (237) 214 
Figure 83: 1H NMR of 3-nitrobenzaldehyde (250) and 1-(3-nitrophenyl)-1,2- 
propanedione (251) 
 
215 
Figure 84:13C NMR of 3-nitrobenzaldehyde (250) and 1-(3-nitrophenyl)-1,2- 
propanedione (251) 
 
216 
Figure 85: 1H NMR of 1-(4-fluoro-2-nitrophenyl)-2-propanone (257) 217 
Figure 86: 13C NMR of 1-(4-fluoro-2-nitrophenyl)-2-propanone (257) 218 
Figure 87: 1H NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-nitrobenzene (258) 219 
Figure 88: 13C NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-nitrobenzene (258) 220 
Figure 89: 1H NMR of 4-fluoro-2-nitrobenzaldehyde (259) and 1-(4-fluoro-2- 
nitrophenyl)-1,2-propanedione (260) 
 
221 
xv 
 
Figure 90: 13C NMR of 4-fluoro-2-nitrobenzaldehyde (259) and 1-(4-fluoro-2- 
nitrophenyl)-1,2-propanedione (260) 
 
222 
Figure 91: 1H NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-nitrobenzene (263) 223 
Figure 92: 13C NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-nitrobenzene (263) 224 
Figure 93: 1H NMR of 4-carbomethoxy-2-nitrobenzaldehyde (266) and 
1-(4-carbomethoxy-2-nitrophenyl)-1,2-propanedione (267) 
 
225 
Figure 94: 1H NMR of 1-(5-methoxy-2-nitrophenyl)-2-propanone (269) 226 
Figure 95: 13C NMR of 1-(5-methoxy-2-nitrophenyl)-2-propanone (269) 227 
Figure 96: 1H NMR of 5-methoxy-2-nitro-benzaldehyde (270) and 1-(5-methoxy-2- 
nitrophenyl)-1,2-propanedione (271) 
 
228 
Figure 97: 13C NMR of 5-methoxy-2-nitro-benzaldehyde (270) and 1-(5-methoxy-2- 
nitrophenyl)-1,2-propanedione (271) 
 
229 
Figure 98: 1H NMR of 4-(2-nitrophenyl)-3-methoxy-2-methyl-1-butene (277) 230 
Figure 99: 13C NMR of 4-(2-nitrophenyl)-3-methoxy-2-methyl-1-butene (277) 231 
Figure 100: 1H NMR of 1-(2-bromophenyl)-1,2-propanedione (282) 232 
Figure 101: 13C NMR of 1-(2-bromophenyl)-1,2-propanedione (282)  233 
 
 
 
 
 
 
xvi 
 
List of Schemes 
Scheme 1: Rearrangement of 4-alkynylcyclobutenones 2 
Scheme 2: Preparation of 4-alkynyl-4-hydroxycyclobutenones from squaric acid 2 
Scheme 3: Thermally ring expansion to form substituted 1,4-benzoquinones 3 
Scheme 4: Thermally ring expansion to form substituted 1,4-benzoquinones and 
2-alkylidene-1,3-cyclopentenediones 
 
4 
Scheme 5: Plausible mechanisms for thermal ring expansion of 4-hydroxy-2- 
cyclobuteneones 
 
5 
Scheme 6: Thermally ring expansion to form 2-alkylidene-1,3-cyclopentenediones 5 
Scheme 7. Synthesis of isoarnebifuranone 8 
Scheme 8. Synthesis of nanaomycin D 10
Scheme 9: Synthesis of deoxyfrenolicin 10
Scheme 10: Thermal ring expansion of 4-alkynyl-tert-butoxycyclobutenones 11 
Scheme 11: Synthesis of the natural product, (±)-terreic acid 13
Scheme 12: Synthesis of the natural product, (±)-isoperezone 14
Scheme 13: Palladium(II) catalyzed ring expansion of 4-alkynyl-4-hydroxy- 
cyclobutenones 
 
15
Scheme 14: Palladium catalyzed ring expansion-coupling reaction 14
Scheme 15: Iodine mediated ring expansion of 4-alkynyl-4-hydroxycyclobutenones 18
Scheme 16: Conversion of iodomethylenecyclopentene-l,3-dione to 
aminomethylenecyclopentene-l,3-dione 
 
20
xvii 
 
Scheme 17: Synthesis of ring expansion substrates 73, 78, and 81 21
Scheme 18: Synthesis of ring expansion substrates 89 and 96 22
Scheme 19: Attempted synthesis of 100 22
Scheme 20: Thermal ring expansion of tert-butoxy analog 30
Scheme 21: Ring expansion of an electron deficient substrate 30
Scheme 22: Proposed mechanism for inhibition of human chymase by compound 112 35
Scheme 23: Lee’s synthesis route of methyl linderone in 1967 39
Scheme 24: Lee’s synthesis route of methyl linderone in 1986 41
Scheme 25: Aoyama’s synthesis route of methyl linderone 42
Scheme 26: Langer’s synthesis route of linderone 43
Scheme 27: Retrosynthetic analysis of methyl linderone 46
Scheme 28: Synthesis of methyl linderone 47
Scheme 29: Transition metal-catalyzed arylation reactions of ketone enolates 50
Scheme 30: Synthesis of 2,3-diarylbenzofurans by means of a palladium catalyst system 50
Scheme 31: Plausible reaction mechanism for the synthesis of 2,3-diarylbenzofurans 51
Scheme 32: Synthesis of the benzomorphan derivatives 53
Scheme 33: Asymmetric α-arylation of 2-methyl-α-tetralones 53
Scheme 34: Nickel-catalyzed enantioselective α-arylation of cycloalkanones 54
Scheme 35: α-Arylation of N-tosyl-2’-aminoacetophenone with o-dibromobenzene 54
Scheme 36: Pd-catalyzed synthesis of 1,2,2-triarylethanones from aryl benzyl ketones 55
xviii 
 
Scheme 37: Pd-catalyzed synthesis of 1,2,2-triarylethanones from acetophenones 55
Scheme 38: Pd-catalyzed synthesis of the acetonylpurine 56
Scheme 39: Pd-catalyzed synthesis of benzyl methyl ketone 56
Scheme 40: Individual reactions of the Wacker process 58
Scheme 41: Wacker process of terminal alkenes 59
Scheme 42: Overall catalytic cycle of the Wacker process 60
Scheme 43. Modified Wacker oxidation using H2O2 as the terminal oxidant 62
Scheme 44: Mimoun et al.’s mechanism for peroxide-mediated Wacker oxidation 63
Scheme 45: Formation of biogenetic intermediate 190 and 191 64
Scheme 46: Synthesis of (+)-dihydropinidine and (-)-epidihydropinidine 65
Scheme 47: Synthesis of (-)-pinidinone 65
Scheme 48: Synthesis of tetracycle (+)-203 66
Scheme 49: Synthesis towards key hexahydronaphthalene 206 67
Scheme 50: The synthesis of 1,2,5-trisubstituted pyrrole 68
Scheme 51: C3 Symmetric tripyrrolyl benzene synthesis 68
Scheme 52: Synthesis of 1,3-cyclooctanedione 219 from cyclooctanone 217 69
Scheme 53: TBHP-mediated Wacker-type oxidation 70
Scheme 54: TBHP-mediated Wacker-type oxidation to form β-hydroxy ketone 71
Scheme 55: TBHP-mediated Wacker-type oxidation to form methyl ketone 71
Scheme 56: Benzoquinone-reoxidant Wacker-type oxidation to acetophenone 72
 
xix 
 
List of Tables 
Table 1: Ring-expansion of 68, 73, 78, and 81 in the absence or presence of NXS 23
Table 2: Ring-expansion of 89 and 96 in the absence or presence of NIS or NBS 28
Table 3: Synthesis of 1-aryl-1-propenes 73
Table 4: Ratios of products for crude reaction mixtures from oxidation of 
2-ethenyl-1-nitrobenzene 
 
76
Table 5: Wacker-type oxidation of aryl-substituted alkenes 77
 
1 
 
Chapter 1 
Formation of 2-halomethylene-4-cyclopentene-1,3-diones and/or 2-
halo-1,4-benzoquinones via ring-expansion of 4-ethynyl-4-hydroxy-
2,3-substituted-2-cyclobuten-1-ones 
1.1 Rearrangement of 4-alkynylcyclobutenones 
1.1.1  Thermally induced ring expansions of 4-alkynylcyclobutenones 
1.1.2  Electrophilic reagents induced ring expansions of 4-alkynylcyclobutenones  
1.2 Ring expansion of 4-alkynyl-4-hydroxycyclo-2-buten-1-ones in the presence of an  
N-halosuccinimide  
1.3 Results and discussion 
1.4 Conclusions 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1 Rearrangement of 4-alkynylcyclobutenones 
The rearrangement of 4-alkynylcyclobutenones 1 is an extremely useful method for 
the synthesis of substituted 1,4-benzoquinones 3 and 2-alkylidene-1,3-cyclopentenediones 2 
(Scheme 1).1,2 Substituted 1,4-benzoquinones constitute members of compounds which are 
reasonable precursors to electrophilic alkylating agents3,4 while 2-alkylidene-4-cyclopentene-
1,3-diones are attractive building blocks for synthesis of cyclopentanoids.5-7 
Scheme 1: Rearrangement of 4-alkynylcyclobutenones 
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Moore et al. provided a simple method for the transformation of 4-
alkynylcyclobutenones into benzoquinones and/or 2-alkylidene-4-cyclopentenediones, 
starting with cyclobutenediones 5, a class of compounds which are easily prepared in a 
variety of substitution patterns from commercially available squaric acid (4).8 Alkynyl anions 
add in high yield to cyclobutenediones 59 to give 4-alkynyl-4-hydroxycyclobutenones 6 
(Scheme 2), and the reaction occurs with good regioselectivity with a number of 
unsymmetrically substituted substrates.10,11 
Scheme 2: Preparation of 4-alkynyl-4-hydroxycyclobutenones from squaric acid 
 
 
3 
 
1.1.1 Thermally induced ring expansions of 4-alkynylcyclobutenones 
In 1989, Moore and co-workers developed a limited thermal rearrangement route 
involving a (2-alkynylethenyl)ketene12 for the synthesis of benzoquinones and/or 2-
alkylidene-4-cyclopentenediones. The synthetic scope and specific examples illustrating the 
synthetic utility of this method are given in Schemes 3. The syntheses in Scheme 3 began 
with the conversion of dimethyl squarate (7) to the 4-alkynyl-2,3-dimethoxy-4-hydroxyl 
cyclobutenones 8 in 50-90% yield using the corresponding lithium acetylides (THF, -78 oC) 
followed by quenching of the reaction mixture with ammonium chloride. Thermolyses of the 
realized cyclobutenones (p-xylene, 138 oC) provided the 1,4-benzoquinones 9 as the only 
isolable products. 
Scheme 3: Thermally ring expansion to form substituted 1,4-benzoquinones 
 
The thermal ring expansion of 4-alkynyl-2,3-dimethoxy-4-hydroxyl cyclobutenones 8 
is an extremely useful method for the synthesis of benzoquinones, which have a variety of 
substitution patterns for further study.13,14  It is also important to note that this reaction is 
apparent an ideal and  highly regioselective generality for the synthesis of trimethylsilyl-
substituted 1,4-benzoquinones, which are particularly regarded as potential bioreductive 
alkylating agents or reasonable precursors to electrophilic quinone methides subsequent to an 
in vivo reduction.  
 Recognizing that only the corresponding benzoquinones were detected as products of 
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the thermolyses of all of the above examples, in which the alkyne moiety is substituted with 
an alkyl group or a proton, Moore et al. decided to implement the same condition in cases 
when the substituent R of 10 (Scheme 4) is an alkoxy, phenyl, or trimethylsilyl group. 
Interestingly, a mixture of the benzoquinones 11 and 2-alkylidene-1,3-cyclopentenediones 12 
resulted. 
Scheme 4: Thermally ring expansion to form substituted 1,4-benzoquinones and 2-
alkylidene-1,3-cyclopentenediones 
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In order to explain the observed results, Moore et al. proposed the mechanisms of 
thermal ring expansion of 4-hydroxy-2-cyclobutenones 13 as shown in Scheme 5,  beginning 
with a remarkably selective electrocyclic ring opening upon mild thermolysis to form    (2-
a1kynylethenyl)ketenes 14. Next, a ring closure of ketene 14 occurs to give the unique 
diradicals (or zwitterions) 15 and 17. Finally, an intramolecular transfer of the proton 
substituent from oxygen to carbon of diradicals gives products 16 and 18.12 
With knowledge that this rearrangement selectivity to give either benzoquinones or 
cyclopentenediones is significantly influenced by the R substituent of the alkyne moiety, an 
effort was made by Moore et al. to drive the rearrangement completely to the 
cyclopentenediones 20 when the cyclobutenones 19 are employed (Scheme 6). This came to 
fruition. 
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Scheme 5: Plausible mechanisms for thermal ring expansion of 4-hydroxy-2-
cyclobuteneones 
 
 
Scheme 6: Thermally ring expansion to form 2-alkylidene-1,3-cyclopentenediones 
 
Stabilization of the carbon centered radical in 17 by the adjacent R group has been 
used as an argument for the formation of 2-alkylidene-4-cyclopentene-1,3-diones.12 The 
intermediate 17 becomes favored over 15 when the substituent R becomes more and more 
capable of stabilizing an adjacent radical site (Scheme 5). In contrast, the presumed aromatic 
stabilization associated with six-membered ring formation 15 is overcome by direct 
stabilization of one of the radical centers by the adjacent R substituent when five-membered 
ring formation 17 takes place. 
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In general, alkynes having an ester or a carbon-carbon double bond in conjugation 
give only 2-alkylidene-4-cyclopentene-1,3-diones while terminal alkynes, alkyl, and 
trimethylsilyl substituted alkynes produce predominantly or only 1,4-benzoquinones. 
Mixtures of both products are usually encountered from substrates having an aryl or an 
alkoxy group attached to the alkyne.  
Later, in the same year, Moore et al.15 utilized their methodology described in the 
preceding paper, the rearrangement of 4-alkynylcyclobutenones to 1,4-benzoquinones, in the 
preparation of selected naturally occurring  products arnebifuranone (21), isoarnebifuranone 
(22), nanaomycin D (23), and deoxyfrenolicin (24) to further illustrate its wide utility and 
synthetic scope. 
Figure1: Structures of arnebifuranone, isoarnebifuranone, nanaomycin D, and 
deoxyfrenolicin 
 
Arnebifuranone (21) is a naturally occurring 2,3-dimethoxy-l,4-benzoquinone16,17 
which possesses Z stereochemistry at the stereogenic alkene site.18 Arnebifuranone, along 
with des-O-methyllasiodiplodin, shikonofuran, arnebinol, and arnebinone have been isolated 
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from the roots of Arnebia euchroma (Royle) Johnst., which has been used as a pain killer in 
the Chinese culture.19 These compounds are of high interest because of their various 
pharmacological assay systems and they are able to function as inhibitors of prostaglandin 
biosynthesis.20,21 The attempted synthesis of arnebifuranone (21), was outlined in Scheme 7.  
The synthesis of 22 initiated from 3-(2-bromoethyl)furan (25), which was converted 
to the corresponding Grignard reagent using magnesium in ether, and was further transformed 
into 26 in 75% yield upon the treatment with 2-methylpropenal. When SOCl2 was added in 
hexane to 26, the allylic chloride 27 was obtained in 65% isolated yield and excellent 
regioselectivity. 27 was the major isomer of a 7:l mixture of regioisomers. Exposure of 27 to 
the Grignard reagent obtained from (trimethylsi1yl)ethyne under copper-catalyzed conditions 
and subsequently deprotection provided the previously unknown alkyne 28 in 76% yield as a 
colorless liquid. Alkyne 28 was then underwent deprotonation using butyl lithium and was 
reacted with dimethyl squarate (7) in THF at -78 oC to give the adduct 29 as a colorless oil. 
Finally, the developed methodology was applied as a key step in the construction of 
arnebifuranone (21).1,10 However, thermolysis of 29 in refluxing p-xylene (138 oC) for 2 h 
only gave isoarnebifuranone (22) as an orange oil in 86% isolated yield. Isoarnebifuranone is 
actually stereoisomeric with the natural product arnebifuranone (21) and is another 
benzoquinone with the thermodynamically more stable E configuration, which is consistent 
with the fact that the naturally occurring quinone is quite unstable. 
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Scheme 7: Synthesis of isoarnebifuranone 
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Another reported example that further illustrates the synthetic utility of the quinone-
cyclobutenone rearrangement is the regiospecific syntheses of the naphthoquinones 34 and 36, 
which are key synthetic precursors to the biologically important quinones nanaomycin D (23) 
and deoxyfrenolicin (24).  
Nanaomycin D (23) and deoxyfrenolicin (24) are members of an important family of 
naturally occurring isochroman-1,4-naphthoquinones (approximately 45) which are of great 
importance due to the significant biological activity that they have elicited in antibiotics, 
antimycotics and antineoplastic assays.22-24 The definite and concrete biological action 
mechanism of these compounds remains elusive. The proposed mode of their biological 
action involves bioreductive alkylation due to their structural features, which was regarded 
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necessary to allow them to be employed as precursors to electrophilic quinone methides 
subsequent to an in vivo reduction.3,4 
Starting from 30, treatment with the lithium salt of 3-(tetrahydropyrany1oxy) propyne 
(2:l mixture of diastereomers) at -78 oC in THF gave 31 and its regioisomer in a respective 
ratio of 3:l as a yellow oil in 58% yield (Scheme 8). Moreover, each regioisomer was 
obtained as a 2:l mixture of diastereomers. Further experimentation with 30 and other lithium 
acetylides revealed that the reaction regioselectivities could be improved to approximately 
95:5 at -100 oC in a mixed solvent of THF/diethyl ether (l:l) while yields might be lowered as 
a result.25 Reaction of 31 with an excess of allyl iodide followed by the addition of Ag2CO3 in 
dioxane gave the allyl ether 32 in >95% yield as a yellow oil.19 Allyl ether 32 was then 
converted to naphthoquinone 33 as a yellow oil in 71% yield upon thermolysis in refluxing p-
xylene (138 oC). The reaction proceeded by removal of THP protecting group using 4:2:1 
CH3COOH/THF/H2O, resulted in the synthetic precursor naphthoquinone 34 in 73% yield. 
Finally, nanaomycin D (23) was prepared from 34 according to the published methods.27 
The last example to demonstrate the synthetic utility of the quinone-cyclobutenone 
rearrangement is the synthesis of 36, the precursor of deoxyfrenolicin, which was 
accomplished by performing a procedure analogous to that described above (Scheme 9). That 
is, once the major regioisomer product of the alkynylation of 30 with the lithium salt of 3-
(tetrahydropyrany1oxy)hexyne in hand, which is actually a mixture of two diastereomeric 
benzocyclobutenones with only 2% of the corresponding regioisomers. The major product 
was conveniently purified by flash chromatography and the allylation of the major product 
was carried out to give 35, which was further converted to synthetic precursor 
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naphthoquinone 36 by the method reported above. Finally, deoxyfrenolicin (24) was prepared 
from 36 according to the published methods.27 
Scheme 8: Synthesis of nanaomycin D 
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Scheme 9: Synthesis of deoxyfrenolicin 
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The methodology provided successful syntheses of naphthoquinones 34 and 36, 
constituting a formal synthesis of the natural isochroman-1,4-naphthoquinones nanaomycin D 
(23), and deoxyfrenolicin (24).29,30 Quinones 34 and 36 were obtained in 28% and 22% yield 
from 30 respectively. Therefore, the quinone-cyclobutenone rearrangement methodology is 
not only efficient, brief, and simple, but also is a potentially general route to naphthoquinones 
of specific substitution patterns. 
In 1990, Moore et al. further developed their methodology where 2,3-di-tert-
butoxycyclobutenedione (37) (Scheme 10) was a useful synthon for hydroxyquinones. 
Besides the synthetic scope of this methodology, they also described its specific utilization in 
successful preparation of natural products, (±)-terreic acid (43), and (±)-isoperezone (44) 
based on the thermal ring expansion of 4-alkynyl-tert-butoxycyclobutenones.31 
Scheme 10: Thermal ring expansion of 4-alkynyl-tert-butoxycyclobutenones 
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Moore et al. reported the synthesis of tert-butoxyquinones 41 from the thermal ring 
expansion of 4-alkynyl-butoxycyclobutenones 40 in p-xylene at 138 oC and subsequently 
transformed to hydroxyquinones 42 upon treatment with trifluoroacetic acid at low 
temperature (Scheme 10).  
In a typical procedure, squaric acid (4) was first converted to 2,3-di-tert-
butoxycyclobutenedione (37) without any difficulty.12 Next, cyclobutenedione 37 was treated 
with an alkynyl organolithium reagent to give the cyclobutenones 38 which were then readily 
hydrolyzed to the cyclobutenediones 39 upon treatment with trifluoroacetic anhydride 
(TFAA).32 After regiospecific addition of an alkynyllithium reagent to the more electrophilic 
(nonvinylogous ester) carbonyl group in 39, cyclobutenones 40 were furnished. As mentioned 
above, thermolysis of 40 gave the tert-butoxyquinones 41, which are members of a rare class 
of quinones. Finally, a variety of hydroxyquinones 42 were provided via deprotection of 41 
upon treatment with trifluoroacetic acid at 0 oC.33 
Two real complex examples of the specific synthetic utility of this methodology are 
given below. The first example is the total synthesis of the natural antibiotic (±)-terreic acid  
(43), and the second one is total synthesis of naturally occurring (±)-isoperezone (44). 
Figure 2: Structures of (±)-terreic acid and (±)-isoperezone 
 
The efficient synthesis of (±)-terreic acid (43), a naturally occurring antibiotic34,35 
was outlined in  Scheme 11.  
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Preparation of (±)-terreic acid (43) via thermal ring expansion of 4-alkynyl-tert-
butoxycyclobutenones began with the alkynylation of 3-tert-butoxy-4-
methylcyclobutenedione (45) with lithium acetylides followed by ammonium chloride, 
yielding the cyclobutenones 46 in good yield. These transformations were carried out at -78 
oC in THF and the reactions were efficient. Cyclobutenones 46 were then converted to 
benzoquinones 47 in respective yields of 79% and 69% in refluxing acetonitrile or benzene. 
Reactions of these quinones 47 with tert-butyl hydroperoxide or Triton B36 gave epoxide 48 
in yields 59% and 68%. De-tert-butylation of 48 under previous used condition (0 oC, 
trifluoroacetic acid ) gave (±)-terreic acid (43) in 84% yield. The syntheses had an overall 
yields of 22% and 26%, starting with the cyclobutenedione 45 which was readily available 
from squaric acid (4). Compared with the previously reported work, these syntheses are 
superior to the other two routes to (±)-terreic acid.37,38 
Scheme 11: Synthesis of the natural product, (±)-terreic acid 
 
Final illustration of the specific synthetic utility of the thermal rearrangement of 4-
alkynyl-tert-butoxycyclobutenones methodology was described as follows, that is, total 
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synthesis of the naturally occurring (±)-isoperezone (44) (Scheme 12). The synthesis began 
via an alkylation of squarate 37 with 2-lithio-6-methyl-hept-5-ene, resulting in cyclobutenone 
49,39 which was then dissolved in pyridine in the presence of trifluoroacetic anhydride to give 
the cyclobutenedione 50 in 52% yield. Cyclobutenone 51 was then obtained by the 
regiospecific addition of 1-lithiopropyne to the more electrophilic carbonyl group of 50 and 
thermolysis of 51 in refluxing benzene furnished quinone 52 in 70% yield. The last step to 
complete this total synthesis of (±)-isoperezone was deprotection of 52 with 4 N HCl in 
refluxing dioxane, which directly provided 44 in 72% yield. The overall yield is 26% while 
the previous synthesis, reported in 1987, proceeded in 38% overall yield from parvifolene, a 
natural product isolated from Pereziae spp.40 
Scheme 12: Synthesis of the natural product, (±)-isoperezone 
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1.1.2 Electrophilic reagents induced ring expansions of 4-alkynylcyclobutenones 
In addition to thermally induced ring expansion, some electrophilic reagents have also 
been shown to induce ring expansions of 4-alkynyl-4-hydroxy-2-cyclobuten-1-ones. For 
example, Liebeskind et al. proposed that the 4-alkynyl-4-hydroxy-cyclobutenone ring system 
6, was transformed to an alkylidenecyclopentenedione 53 possessing a vinyl-palladium bond 
via ring expansion reaction with an electrophilic source of Pd(II).41,42 53 could be 
subsequently activated toward protonation by using the HX generated in the ring expansion 
step to provide access to synthetically useful alkylidenecyclopentenediones 54. Meanwhile, 
the electrophilic Pd(II) reagent source rendering the reaction catalytic in Pd was regenerated 
(Scheme 13). 
Scheme 13: Palladium(II) catalyzed ring expansion of 4-alkynyl-4-hydroxy-
cyclobutenones 
 
In 1987, Liebeskind et al.43 successfully demonstrated a new, highly stereoselective 
and practical synthesis of highly functionalized 4-oxygenated 5-alkylidenecyclopentenones 
and 3-oxygenated 2-alkylideneindanones based on the palladium-catalyzed reactions. As 
shown in Scheme 14, Palladium(II) catalyzed reactions afford exclusively 2-alkylidene-4-
cyclopentene-1,3-diones. Exposing 4-(l-hexynyl)-4-hydroxy-3-methoxy-2-methyl-cyclobut-
2-enone (55a) to the condition (10 mol % Pd(OCOCF3)2 in THF at 60 oC for 1 h,) afforded 
(E)-alkylidene cyclopentenedione 56a, which was isolated together with the Z-stereoisomer 
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in a 12:1 ratio in 45% yield. Two other 4-alkynyl-4-hydroxycyclobutenones 55b, 55c were 
exposed to the similar conditions discussed above (10 mol % Pd(OCOCF3)2 in THF at 40 oC 
for 5 h) and resulted in the formation of 56b in 49% yield (11 : 1 ratio) and 56c in 40% yield 
(15: 1 ratio).  
Scheme 14: Palladium catalyzed ring expansion-coupling reaction 
 
The reaction is of interest because of its potential application in the synthetic field of 
the naturally occurring eicosanoids as well as simpler analogues of the natural products. 
Figure 3: Eicosanoid core and naturally occurring eicosanoids  
 
Marine organisms produce an unprecedented molecular diversity by the incorporation 
of elements like halogen that are not readily available to terrestrial species.44 Naturally 
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occurring marine eicosanoids, such as the clavulone 5845 (claviridenones45,46), chloro,6,48 
bromo, and iodovulones (59),49 and the punaglandin 60,50 containing a 4-oxygenated 5-
alkylidenecyclopentenone core 57 (Figure 3), are often produced and of great importance due 
to their remarkable bioactivity that they possess in both vitro and vivo cytotoxicity studies.51 
There has been numerous reported syntheses for the 4-oxygenated 5-
alkylidenecyclopentenone core 57,52-54 however, the remarkable stereoselectivity challenges 
associated with the construction of these complex alkylidene systems are reflected in the 
many distinct approaches that have been reported for their racemic and enantioselective total 
syntheses.55-58  
The observed exceptional stereoselectivity in the palladium-induced ring expansions 
of 4-alkynyl-4-hydroxycyclobutenones was rationalized by the author.43 It was postulated that 
non-vinyl bond “a” in 61 (Figure 4) was migrating to the adjacent sp hybridized carbon, 
resulting in a cationic intermediate with the ability to best stabilize the positive charge. The 
reaction proceeded through the most stable cationic intermediate and the ability of the 
migrating group to stabilize positive charge might play an important role in controlling the 
selectivity of the reaction. Therefore, a plausible reaction pathway might be the trans addition 
of bond “a” across the alkyne bond to furnish the desired alkylidene cyclopentenedione in a 
stereospecific fashion.  
Figure 4: Postulated reaction path for palladium catalyzed ring expansion reaction 
 
In 1995, Eguchi et al.59 demonstrated the ring expansion in Scheme 15 was probably 
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cationic in nature, and the result of coordination of an electron deficient species [Pd(II) and 
H+] to the alkyne followed by acyl migration.60,61 Those transformations in Scheme 15 
employed diethyl squarate (62) as a starting material, which was easily converted to the 4-
alkynyl-4-hydroxycyclobutenone ring system 63 upon treatment with the corresponding 
lithium acetylides (THF, -78 oC) followed by quenching of the reaction mixture with 
ammonium chloride.9,32 The realized cyclobutenones 63 were converted to the corresponding 
cyclopentene-l,3-diones 64 via the ring expansion employing reagents which were believed to 
form hypoiodite. Specifically, conversion of cyclobutenones 63a, 63b, 63c to the 
corresponding cationic intermediate using I2/PhI(OAc)2 at -15 oC, followed by deprotonation 
afforded cyclopentene-l,3-diones 64a, 64b, 64c in 68%, 63%, 57% yields respectively.  
The mechanism of the reaction was thought to begin with the transfer of positive 
iodine atom from a hypoiodite moiety to alkyne the terminus and concomitantly, 1,2-acyl 
migration happened to form cyclopentene-l,3-diones 64. One of the driving force for this 
reaction was the ring strain relief which would facilitate the 1,2-acyl migration, and hence 
ring expansion. 
Scheme 15: Iodine mediated ring expansion of 4-alkynyl-4-hydroxycyclobutenones 
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Electrophilic reagent induced ring expansions of 4-alkynylcyclobutenones provide an 
alternative practical route to cyclopentene-l,3-diones from squaric acid, switching the 
rearrangement of 4-alkynyl-4-hydroxycyclobutenones from radical to ionic via electron 
deficient species. Overall, both thermally induced ring expansions and electrophilic reagent 
induced ring expansions of 4-alkynylcyclobutenones have significant synthetic utility in 
preparing substituted 1,4-benzoquinones and 2-alkylidene-1,3-cyclopentenediones. 
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1.2 Ring expansion of 4-alkynyl-4-hydroxycyclo-2-buten-1-ones in the presence of an N-
halosuccinimide 
Although the ring expansion of 4-alkynylcyclobutenones has been well investigated, 
very little research has been examined the thermal ring expansion of 4-alkynyl-4-
hydroxycyclo-2-buten-1-ones in the presence of an N-halosuccinimide or thermal ring 
expansion of haloalkynylcyclobutenones. Herein, we paid an effort to prepare chloro-, 
bromo- or iodo-substituted methylenecyclopentene-l,3-diones and benzoquinones from 
squaric acid, which also may be useful for further conversion or employed in palladium 
catalyzed cross coupling reactions and ultimately in the synthesis of functionalized 
carbazoles. A simple case is demonstrated below (Scheme 16).59 
Scheme 16: Conversion of iodomethylenecyclopentene-l,3-dione to aminomethylene 
cyclopentene-l,3-dione 
 
We examined the thermal ring expansion of 4-alkynyl-4-hydroxycyclo-2-buten-1-ones 
in the presence of an N-halosuccinimide. If the cationic pathway is sufficiently slow, at the 
elevated temperatures required for a thermal rearrangement, it may be possible to halogenate 
the diradical 15 (Scheme 5)62 in the presence of an N-halosuccinimide. The results of 
reactions of 4-alkynyl-4-hydroxycyclo-2-buten-1-ones with or without an N-halosuccinimide 
will be presented in this chapter. 
Four 2,3-di(1-methylethoxy)-4-alkynyl-4-hydroxy-2-cyclobuten-1-ones having 
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different alkynyl groups including ethynyl (73), 2-trimethylsilylethynyl (68), 2-iodoethynyl 
(78), and 2-bromoethynyl (81) groups were initially examined. Compound 68 and 73 were 
prepared according to literature procedures63 and compound 78 and 81 were prepared from 
68 using NIS or NBS, respectively, in the presence of a catalytic amount of AgNO3 (Scheme 
17). Compound 68 was prepared from diisopropyl squarate (67).  
Scheme 17: Synthesis of ring expansion substrates 73, 78, and 81 
 
In addition to the reactions discussed above, cyclobutenones 89, readily available 
from diisopropyl squarate (67) as well, was converted to 2-methyl-3-(1-methylethoxy)-4-
ethynyl-2-cyclobuten-1-one (96) as outlined in Scheme 18. This was accomplished by its 
initial treatment with an alkynyl organolithium reagent to give cyclobutenone 87, which are 
readily hydrolyzed to 88 upon treatment with hydrochloric acid in dichloromethane (CH2Cl2). 
Cyclobutenedione 88 was then converted to 89 by the regiospecific addition of an 
alkynyllithium reagent to the more electrophilic carbonyl group. Subsequently, 
cyclobutenone 89 was transformed to 96 using potassium fluoride in methanol and water. 
Cyclobutenone 96 was then subjected to reactions with or without NIS or NBS.  
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Scheme 18: Synthesis of ring expansion substrates 89 and 96 
 
It is noteworthy that in an attempt to prepare iodoalkynyl derivative 100 by reaction 
of 89 with NIS, only diiodomethylene cyclopentenedione 101 was obtained in a low isolated 
yield (Scheme 19). It is plausible that 100 was formed in the reaction but immediately 
underwent NIS induced ring expansion under the reaction conditions. 
Scheme 19: Attempted synthesis of 100 
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1.3 Result and discussion 
As described above, we first attempted to examine four 2,3-di(1-methylethoxy)-4-
alkynyl-4-hydroxy-2-cyclobuten-1-ones having different alkynyl groups including ethynyl 
(73), 2-trimethylsilylethynyl (68), 2-iodoethynyl (78), and 2-bromoethynyl (81). 
Each compound was subjected to thermolysis either in the absence or in the presence 
of an N-halosuccinimide at selected temperatures. The results of these reactions are 
summarized in Table 1. 
Table 1: Ring-expansion of 68, 73, 78, and 81 in the absence or presence of NXS 
Entrya Solvent (temp./time) Cyclobutenone NXS Cyclopentenedioneb Quinoneb
  
 
 
 
 
1 Benzene (140 oC/3 h) 68 No NXS 69+70 (77%, 1:18) 
2 Toluene (150 oC/3 h) 68 No NXS 69+70 (70%, 1:14) 
  
 
 
 
 
3 Benzene (rt/3 h) 68 NIS 71 (65%)  
4 MeCN (rt/15h) 68 NIS 71 (51%)  
5 Toluene (rt/20 h) 68 NIS 71 (65%)  
  
 
 
 
 
6 Toluene (rt/120 h) 68 NBS No reaction  
7 Benzene (80 oC/3 h) 68 NBS 72 (25%)c  
8 Benzene (80 oC/6 h) 68 NBS 72 (40%) 
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Table 1 (continued) 
Entrya Solvent (temp./time) Cyclobutenone NXS Cyclopentenedioneb Quinoneb
  
 
  
 
9 Benzene (80 oC/3 h) 68 NCS  No reaction 
10 Toluene (150 oC/3 h) 68 NCS  69+70 (55%, 1:20) 
  
 
  
 
11 Benzene (140 oC/3 h) 73 No NXS  74 (58%) 
  
 
 
 
 
12 Benzene (rt/3 h) 73 NIS 75 (34%)  
13 Benzene (80 oC/3 h) 73 NIS 75 (36%)  
  
 
 
 
 
14 Benzene (80 oC/3 h) 73 NBS 76 (35%)d  
15 Benzene (80 oC/17 h) 73 NBS 76 (47%)e  
16 Benzene (80 oC/24 h) 73 NBS 76 (55%)  
  
 
  
 
17 Toluene (150 oC/3 h) 73 NCS  77 (24%)+74 (55%)
18 Toluene (150 oC/3 h) 73 NCSf  77 (40%)+74 (35%)
19 Toluene (150 oC/3 h) 73 NCSg  77 (45%)+74 (20%)
  
Oi-PrO
i-PrO OH
I
 
 
  
20 Benzene (140 oC/3 h) 78 No NXS 75 (42%) 79 (25%)
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Table 1 (continued) 
Entrya Solvent (temp./time) Cyclobutenone NXS Cyclopentenedioneb Quinoneb
  
Oi-PrO
i-PrO OH
I
 
 
 
 
21 Benzene (rt/3 h) 78 NIS 80 (41%)h  
22 Benzene (80 oC/3 h) 78 NIS 80 (43%)  
  
 
 
  
23 Benzene (140 oC/3 h) 81 No NXS 76 (31%) 82 (34%)
  
Oi-PrO
i-PrO OH
Br
 
 
 
 
24 Benzene (80 oC/3 h) 81 NIS 83 (68%)  
  
Oi-PrO
i-PrO OH
Br
 
 
 
 
25 Benzene (80 oC/3 h) 81 NBS 84 (46%)  
a See Experimental section for detailed reaction conditions. 
b Yield of product after chromatographic separation on silica gel. 
c Hydrolysis product 85 (8%) and starting material (68, 24%) were also obtained. 
d Hydrolysis product 86 (12%) and starting material (32%) were also obtained. 
e Hydrolysis product 86 (11%) and starting material (73, 10%) were also obtained. 
f Three equivalents of NCS were used. 
g Six equivalents of NCS were used. 
h Starting material (78, 29%) was obtained. 
All thermolysis reactions were performed in an ACE-Glass pressure tube capped with 
a Teflon screw cap. Thermolysis of 68 at 140 oC in benzene gave an inseparable mixture of 
1,4-benzoquinone 70 and the corresponding cyclopentene-1,3-dione 69 in an 18:1 ratio in 77% 
yield as evidenced by 1H NMR (entry 1). The reaction of 68 is somewhat more selective and 
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higher yielding compared to the previously reported rearrangement of the analogous 2,3-
dimethoxy-substituted compound wherein an 8:1 ratio was observed in a 46% yield.12 
Toluene was also used as the solvent with a slightly lower ratio of products in a comparable 
yield (entry 2). 
The benzoquinone and cyclopentenedione products reported herein are easily 
differentiated by 1H NMR analysis. For example, the methine protons of the two methylethyl 
groups of 4-cyclopentene-1,3-dione 69 resonate at 5.59 and 5.54 ppm, respectively. In 
contrast, the corresponding 1,4-benzoquinone methine protons of compound 70 resonate 
upfield at 4.81 and 4.80 ppm. A similar difference in chemical shifts for methoxy groups of 
related 4-cyclopentene-1,3-diones and 1,4-benzoquinones has previously been reported by 
Moore et al.1,12 In addition, the color of the pure products are different, the 1,4-
benzoquinones are red while the 4-cyclopentene-1,3-diones are orange. 
Reaction of 68 with N-iodosuccinimide (NIS) proceeded much faster and gave even at 
ambient temperature in benzene only 2-iodomethylene-4-cyclopentene-1,3-dione 71 (entry 3). 
The same product was observed using acetonitrile or toluene as the solvent, the former gave a 
somewhat lower yield of product 71 (entries 4 and 5). Reaction of 68 with N-
bromosuccinimide (NBS) did not afford any appreciable amount of product at ambient 
temperature even after prolonged reaction time (entry 6). However, 2-bromomethylene-4-
cyclopentene-1,3-dione 72 was isolated as the only ring expansion product after heating for 6 
h at 80 oC (entry 8). A small amount of the hydrolysis product cyclobutenedione 85 was also 
isolated (Figure 5). Although the solvents were carefully dried before use, adventitious water 
present may still be present in the solution.  
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Figure 5: Hydrolysis products 85 and 861 
 
The reaction of 68 in the presence of N-chlorosuccinimide (NCS) was even slower 
and did not proceed at all at 80 oC. Increasing the temperature of the reaction to 150 oC did 
not furnish any chlorinated product but gave instead 1,4-benzoquinone 70 as the only product 
(entries 9 and 10). The results obtained from the reactions of 68 are interpreted as a change 
from a rapid cationic process seen for NIS to a slower cationic process using NBS to a radical 
process not involving NCS. It should be noted that no reaction was observed at temperatures 
below 100 oC for 68 in the absence of NBS or NIS.  
Thermal reactions of 73 were examined next. Heating 73 in benzene at 140 oC gave 
1,4-benzoquinone 74 as the sole product (entry 11). As was observed for 68, reactions using 
either NIS or NBS produced 2-iodo- and 2-bromo-methylene-4-cyclopentene-1,3-diones, 
respectively (entries 12-16). Substrate 73 appeared to react somewhat slower with NBS 
compared to 68 since a longer reaction time was required for complete consumption of the 
starting material. A small amount of the hydrolysis product 86 (Figure 5) was isolated in 
some cases (entries 14 and 15). Thermolysis of 73 in the presence of NCS gave the 
chlorinated 1,4-benzoquinone 77 and 1,4-benzoquinone 74 in a 1:2 ratio (entry 17). The yield 
of 77 was improved by addition of an excess of NCS however, a significant amount of 1,4-
benzoquinone 74 was isolated even using 6 equiv of NCS (entries 18 and 19). The latter three 
reactions indicate that it is possible to obtain chlorinated 1,4-benzoquinones via this 
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methodology although, in low to moderate yields using a large excess of NCS. Due to the 
absence of chlorinated product using 68 and the mediocre yield isolated from 73, NCS was 
not further examined. 
Thermal ring expansions of haloalkynylcyclobutenones have not previously been 
reported. Heating 78 at 140 oC in benzene in the absence of NXS gave a mixture of the five- 
and six-membered products 75 and 79 (entry 20). A similar reactivity was observed using 81 
affording 76 and 82 (entry 23). Reaction of 78 with NIS proved to be somewhat slower 
compared to 68 and 73. A significant amount of starting material was isolated after 3 h at 
ambient temperature but a complete conversion to 80 was observed at 80 oC (entries 21 and 
22). Finally, 81 was transformed to the iodobromomethylene and dibromomethylene 
derivatives 83 and 84 in moderate yields using NIS and NBS, respectively (entries 24 and 25). 
In addition to the reactions discussed above, two 2-methyl-3-(1-methylethoxy)-4-
alkynyl-2-cyclobuten-1-ones (89 and 96) were prepared and subjected to reactions with or 
without NIS or NBS. The results are summarized in Table 2.  
Table 2: Ring-expansion of 89 and 96 in the absence or presence of NIS or NBS 
Entrya Solvent (temp./time) Cyclobutenone NXS Cyclopentenedioneb Quinoneb
   
  
1 Benzene (140 oC/3 h) 89 No NXS 90c (22%, 1.2:1) 91c (32%) 
   
  
2 Benzene (80 oC /3 h) 89 NIS 92 (61%, 1.5:1) 93 (5%) 
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Table 2 (continued) 
Entrya Solvent (temp./time) Cyclobutenone NXS Cyclopentenedioneb Quinoneb
   
  
3 Benzene (80 oC/3 h) 89 NBS 94 (65%, 2.8:1) 95 (15%) 
  
 
  
 
4 Benzene (140 oC/3 h) 96 No NXS  97 (85%) 
  
 
 
 
 
5 Toluene (150 oC/3 h) 96 NIS 98 (66%, 13:1)  
  
 
 
 
 
6 Benzene (80 oC/3 h) 96 NBS 99 (59%, 2.8:1)  
a  For detailed reaction conditions, see Chapter 4 experimental procedures. 
b Yield of product after chromatography. 
c The products could not be separated by chromatorgraphy. 
Thermal ring expansion of 89 gave an inseparable 2:3 mixture of five- and six-
membered cyclic products (entry 1). The cyclopentenedione 90 was obtained as a 1.2:1 
mixture of double bond isomers.12 A mixture of products was obtained from reactions of 89 
with either NIS or NBS at elevated temperatures (entries 2 and 3). The result is surprising 
since we have not observed the formation of a quinone in any previous reaction using NIS or 
NBS. It is also interesting to note that Moore et al. did not report the formation of a five-
membered cyclic product upon thermolysis of the tert-butoxy analog of 46 (Scheme 20).2  
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Scheme 20: Thermal ring expansion of tert-butoxy analog 
 
Heating a solution of 96 either in the absence or presence of NIS or NBS gave the 
more predictable result. That is, quinone 97 was formed upon thermolysis of 96 in the 
absence of an NXS, while reactions with NIS or NBS gave cyclopentenediones 98 and 99, 
respectively (entries 4-6). 
As the final example, the electron deficient alkyne 102 was examined. This substrate 
has previously been shown by Moore et al. to exclusively afford 2-alkylidene-4-
cyclopentene-1,3-dione 103 upon thermolysis in xylenes (Scheme 21).12 This selectivity for 
five-membered cyclic products was also observed upon reaction with either NIS or NBS 
where 104 and 105 were formed, respectively. 
Scheme 21: Ring expansion of an electron deficient substrate 
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1.4 Conclusions 
An in-depth study of the reactions of 4-(ethynyl)-4-hydroxy-2,3-substituted-2- 
cyclobuten-1-ones with N-bromo- or N-iodosuccinimide, affording in most cases 2-
halomethylene-4-cyclopentene-1,3-dione, is described. In addition, the ring expansion of 
haloalkynylcyclobutenones with or without the presence N-halosuccinimide has been 
developed as well. The thermal ring expansion of 4-alkynyl-4-hydroxy cyclobutenones in the 
presence of N-halosuccinimide to form 2-halogenated methylene-4-cyclopentene-1,3-diones 
and/or 2-halo-1,4-benzoquinones selectively is a transformation of synthetic importance since 
no reliable general route to them has previously been reported. 
The synthetic scope of this methodology has been investigated in this chapter and its 
specific utilization in the synthesis of a natural product, methyl linderone, will be described in 
next chapter. 
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Chapter 2 
Total synthesis of methyl linderone 
2.1 Introduction to linderone and methyl linderone 
2.2 Previous synthesis of linderone and methyl linderone 
2.3 Methyl linderone via ring expansion of 4-ene-yne-substituted cyclo-2-buten-1-one and 
N-iodosuccinimide 
2.3.1 Retrosynthetic analysis 
2.3.2 Results and discussion 
2.3.3 Conclusions 
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2.1 Introduction to linderone and methyl linderone 
A handful of 2-alkylidene-4-cyclopentene-1,3-diones have been isolated from natural 
sources (Figure 6). For example, linderone (106) and/or methyl linderone (107) were isolated 
from the root of Lindera pipericarpa64 and Lindera erythrocarpa.65 Lindera erythrocarpa 
Makino is one of the Lauraceae woody plants, which are distributed widely in Asia, including 
the People’s Republic of China, Korea, Japan. Lindera species, the large family Lauraceae that 
consists of mostly trees or shrub widely spread throughout the world, from the warmer regions of 
the earth, in both lowland and montane forests of Malaysia and Singapore66 and in the base of 
mountain forests of the Far East. They are found to be important medicinal plants including the 
Shiny Laurel, Lindera lucida (B1.) Boerl., L. strychnifolia, L. aggregate, and L. chunii. L. 
erythrocarpa (Lauraceae). Their fruits are used as a traditional medicine because of their 
analgesic, digestive, diuretic, antidote, and antibacterial properties.65,67 
Plant secondary metabolites have provided an important source of drugs since ancient 
times and now around half of the practical drugs used are derived from natural sources. Many 
plants of Lauraceae have been applied in folk medicine for their interesting bioactivities. 
Previous studies of this species have afforded in addition to the cyclopentenedione derivatives 
linderone (106) and methyl lucidone (107), lucidone (108) and methyl lucidone (109) as 
lignans65 which were isolated from the bark of L. erythrocarpa.68 Methyl linderone (107), 
lucidone (108) and methyl lucidone (109) were also isolated from the fruits of Lindera 
lucida,69,70 and methyl linderone has been reported from both L. erythrocarpa67 and L. 
pipericarpa.71 
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Figure 6: Structures of linderone, methyl linderone, lucidone, methyl lucidone isolated 
from Lindera species 
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In 2000, Wu et al.72 reported two novel, closely related cyclopentenones, stigmahamone I 
(110) and stigmahamone II (111), had been isolated from the seeds of Fissistigma oldhamii. 
Fissistigma oldhamii (Hemsl.) Merr. (Annonaceae) is a perennial shrub, which is distributed 
mainly in southern China. As a folklore medicine, this plant is used for liver protection, 
anti-inflammatory and anti-arthritic effects, and anti-tumor action.73 These compounds are of 
high interest because of their significant activity in preliminary bioassay, such as in antiplatelet 
aggregation and so on. 
Figure 7: Structures of Stigmahamones I-II 
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Nowadays, more and more scientific study has been reported on the bioactivities of the 
cyclopentenedione derivatives, linderone (106), methyl lucidone (107), lucidone (108) and 
methyl lucidone (109). Methyl linderone is not only a human chymase inhibitor,74 but also 
exhibits cytotoxicity against a number of cell lines75 and the linderones are chitin synthase 
inhibitors.76  
Human chymase is a chymotrypsin-like serine protease that is stored in the secretory 
granules of mast cells.77 Although the precise physiological and pathological functions of human 
chymase have not been elucidated, several studies have suggested its involvement in 
cardiovascular diseases78 and chronic inflammation following fibrosis.79 In 2001, Aoyama et al.74 
first reported the biological activity of methyl linderone as a human chymase inhibitor, which are 
thought to be potentially useful tools for elucidating the physiological function of chymase and 
therapeutic agents.  
The postulated inhibition mechanism of the core struture 112 existing in methyl linderone 
against human chymase was as presented in Scheme 22. Mechanistically, the formation of serine 
hydroxy O-alkenyl enzyme occured through a process involving nucleophilic substitution of the 
active site serine residue (serine 195) in the enzyme at the β-olefinic carbon atom activated by 
two carbonyl groups, meanwhile, the phenyl group in 112 docks into the S1 pocket. 
Scheme 22: Proposed mechanism for inhibition of human chymase by compound 112 
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In 2002, Kho et al.75 suggested the important cytotoxic compound in lindera 
erythrocarpa was methyl linderone (107) based on evidence from the evaluating of three lignans, 
linderone (106), methyl linderone (107), and kanakugiol (113) in vitro cytotoxicity using three 
cancer cell line assay. Amongst the compounds, methyl linderone exhibited significant 
cytotoxicity against mouse melanoma (B16-F10), human acetabulum fibrosarcoma (HT 1080), 
and choronic myelogenous leukemia (K562) cancer cell lines, while linderone 106, and 
kanakugiol 113 showed weak inhibitory activity. 
Figure 8: Structure of kanakugiol 
 
All four linderones and lucidones are inhibitors of farnesyl transferase,80 having 
anti-inflammatory activity,81 and they are PPAR-g agonists.82 In 2005, Kwon et al.80 described 
the activity-guided isolation from the fruits of L. erythrocarpa and their inhibitory activities on 
FPTase. The results proved all four cyclopentenediones mentioned above were farnesyl protein 
transferase (FPTase) inhibitors and anti-tumor compounds by examining their inhibitory activity 
against H-ras-transformed rat-2 cells and a variety of human cancer cell lines. Especially, 
compounds methyl linderone and methyl lucidone showed strong inhibition for the growth of 
human cancer cells and colon tumor xenografted. From their bioassay results, a conclusion was 
drawn that methyl lucidone can be a potential anti-cancer agent against H-ras-transformed tumor 
and the cyclopentenediones will also be a good lead molecule for the development of a new class 
of anti-tumor drug and agents. 
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After Kwon and his coworkers demonstrated that four cyclopentenediones from the 
methanol extract of the fruits of L. erythrocarpa exhibited farnesyl protein inhibitory activity, in 
2007, Chang et al.81 reported their study of a bioactive investigation of the extract from L. 
erythrocarpa fruits presented a significant in vitro and in vivo anti-inflammatory activity in 
inhibiting significantly nitric oxide (NO) production in lipopolysaccharide induced NO in the 
murine macrophage cell line. Among the evaluated compounds, lucidone (108), cis/trans-methyl 
ludicone (109), methyl linderone (107) and linderone (106), lucidone possessed the strongest NO 
inhibitory activity. Furthermore, lucidone also provided anti-inflammatory activity in the croton 
oil-induced ear edema assay. It was indicated that lucidone has a good potential to be developed 
as an anti-inflammation agent. 
In summary, L. erythrocarpa fruits possess potent anti-inflammatory activity, and 
according to the results obtained from large investigation, the cyclopentenedione skeleton 
compounds, are good candidates for development as anti-tumor and anti-inflammatory agent. 
This class of compounds is of great importance in further nutraceutical applications, 
pharmaceutical industries and epidemiological studies. 
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2.2 Previous synthesis of linderone and methyl linderone 
Linderone (106) and methyl linderone (107) are natural acylcyclopentenediones 
structurally similar to calythrone (114)83 (Figure 9) and methyl linderone belongs to a unique 
class of natural acylcyclopentenedione pigments.70,84  To our best knowlege, linderone and 
methyl linderone have been synthesized four times since first isolated.74,85-87 
Figure 9: Structure of calythrone 
 
In 1967, Lee group described the first total synthesis of linderone and methyl linderone.85 
It has been proposed these compounds might be derived from the appropriate precursor 
demethyldihydrolinderone (118), which could be readily generated through the alkaline 
rearrangement of the 1,4-quinone 117.  
Preparation of linderone and methyl linderone from a six-membered ring precursor 
(Scheme 23) via well known reactions involving ring-contraction88 began with the oxidation of 
the chalcone 115 with nitric acid in acetic acid, indeed yielding the required quinochalcone 
precursor 116. Quinochalcone precursor 116 was then readily debenzylated via catalytic 
hydrogenation in methanol, with simultaneous saturation of the cinnamoyl side-chain. 
Subsequently, the hydroquinone intermediate was transformed to the 2,6-dihydroxy-quinone 117 
by aerial oxidation in alkaline solution. A yellow product identified as demethyldihydrolinderone 
(118) was obtained after the quinone stood at room temperature in aqueous sodium hydroxide for 
2-2.5 h either in the presence or absence of air. With the demethyldihydrolinderone (118) in hand, 
there remained only the introduction of unsaturation into the acyl side chain to complete the total 
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synthesis of the natural product. Methylation of compound 118, followed by dehydrogenation 
gave methyl linderone (107) and hence linderone (106). This was accomplished by first 
converting demethyldihydrolinderone (118) with diazomethane into methyldihydrolinderone 
(119) and then dehydrogenating the latter with 2,3-dichloro-5,6-dicyanoquinone, thus giving 
methyl linderone (107) in 60% yield. Finally, the partial hydrolysis of methyl linderone to 
linderone (106) completed the total synthesis of the desired naturally occruing compound.84 
Scheme 23: Lee’s synthesis route of methyl linderone in 1967 
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In 1986, Lee et al.86 reported they have utilized another direct approach89 to synthesize 
linderone (106). That is converting methyl pedicinin (125) to 126 through the oxidative 
rearrangement by acetic anhydride-DMSO, which would be expected to undergo an 
acid-catalyzed conversion into linderone (106). The total synthesis employing this methodology 
is outlined in Scheme 24. 
Methyl pedicinin (125), which could be isolated from the leaves of Didymocarpus 
pedicellata, was first synthesized in four steps from 2-hydroxy-3,4,6-trimethoxyacetophenone 
(121).90 The synthesis started with a Friedel-Crafts acetylation of 1,2,3,5-tetramethoxy benzene 
(120) with acetyl chloride and aluminum chloride in dichloromethane at 30 oC, resulting in 
2-hydroxy-3,4,6-trimethoxyacetophenone (121) in 66% yield. Treatment of 121 with 
benzaldehyde and potassium carbonate in alcohol for 3 days provided 
2-hydroxy-3,4,6-trimethoxy-chalkone (122). The reaction of 122 with potassium carbonate and 
persulphate in pyridine at 10-15 oC, followed by refluxing in benzene in the presence of sodium 
sulfite and chloric acid furnished pedicin (123), which was then subjected to oxidation using 
bromine in chloroform to give pedicinin (124). Exposing pedicinin (124) to the methylation 
condition (diazomethane prepared from nitrosomethyl urea, ice-chest, 48 h) afforded methyl 
pedicinin (125). Subsequent rearrangement of 125 by using acetic anhydride-DMSO at 75 oC for 
1 h gave compound 126 as a yellow solid identified as linderone acetate in 42% yield. Mild acid 
hydrolysis of compound 126 upon refluxing in 10% methanolic hydrochloric acid completed the 
synthesis of linderone (106). 
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Scheme 24: Lee’s synthesis route of methyl linderone in 1986 
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In 2001, Aoyama et al.74 performed a new and practical synthesis of methyl linderone 
(107). Methyl linderone was prepared using a palladium catalyzed rearrangement of 128 to 129 
as the key step (Scheme 25). A DDQ mediated oxidation and a Michael-addition elimination 
sequence completed the synthesis. 
42 
 
This synthesis of 107 initiated from alkyne 127 prepared from hydrocinnamaldehyde by 
the Corey–Fuchs method.91 127 was then converted to its lithium salt and added to dimethyl 
squarate (7) to give cyclobutenone 128. The palladium-catalyzed ring expansion of 128 with 5% 
Pd(OCOCF3)2 in the presence of N-bromosuccinimide (NBS) provided compound 129 in 77% 
yield.43 Dehydrogenation of 129 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)85,86 
followed by nucleophilic substitution with NaOMe gave methyl linderone (107). Using this 
protocol, total synthesis of methyl linderone (107) was achieved in only four steps and the 
overall yield from dimethyl squarate was 21%. 
Scheme 25: Aoyama’s synthesis route of methyl linderone 
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In 2004, Langer et al.87 developed an approach to linderone using synthetic precursor 135 
prepared from 130 in 5 steps in 41% overall yield (Scheme 26). When 2,4-bis-silyl enol ether 
130 was treated with oxalyl chloride and trimethylsilyl triflate in dichloromethane at low 
temperature (-78-20 oC), compound 131 was obtained in 82% yield. 
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Scheme 26: Langer’s synthesis route of linderone 
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Furanone 132 was formed in excellent yield by treating 131 with dimethyl sulfate and 
potassium carbonate in acetone. Exposure of 132 to trimethylsilyl triflate in diethyl ether in the 
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presence of triethyl amine generated the corresponding silyl enol ether 133 in 93% yield. 
Subsequent reaction of 133 with benzaldehyde provided compound 134, which was then 
converted to 135 via dehydration. Finally, 135 was transformed to linderone (106), employing 
previously reported condition.92 
The total syntheses of linderone (106) and methyl linderone (107) were achieved by Lee 
group via ring-contraction reaction and oxidative rearrangement. However, their total syntheses 
consist of many steps. Aoyama group successfully performed a much shorter total synthesis 
compared to Lee’s method. With the inspiration of their research and our study in the reactions 
of 4-(ethynyl)-4-hydroxy-2,3-substituted-2-cyclobuten-1-ones with N-halosuccinimide, herein 
we report another synthetic route for the naturally occurring product methyl linderone (107). 
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2.3 Methyl linderone via ring expansion of 4-ene-yne-substituted cyclo-2-buten-1-one and 
N-iodosuccinimide 
As discussed in Chapter 1, a new convenient methodology to form the 
2-halomethylene-4-cyclopentene-1,3-diones was developed. It is of interest to extend this type of 
ring expansion reactions and utilize it as a convenient method for the preparation of other natural 
cyclopentenediones, such as methyl linderone (107). The specific utilization of this methodology 
in the synthesis of methyl linderone is described in this chapter. 
 
2.3.1 Retrosynthetic analysis 
The proposed retrosynthetic route and a retrosynthetic analysis of methyl linderone (107), 
which takes advantage of the above rearrangement, is outlined in Scheme 27. It diagrams 
linderone and methyl linderone can be prepared from a general precursor cyclopentenedione 138. 
138 can be seen as the product of the ring expansion of 4-ene-yne substituted 
cyclo-2-buten-1-one 137 in the presence of NIS. Compound 137 can be formed from 
deprotonation of 4-phenyl-3-butene-1-yne (136) 93 followed by addition of dimethyl squarate (7). 
This came to fruition. 
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Scheme 27: Retrosynthetic analysis of methyl linderone 
 
2.3.2 Results and discussion 
The synthesis was performed using the 4-ene-yne substituted cyclo-2-buten-1-one 137 
and NIS (Scheme 28). Deprotonation of 4-phenyl-3-butene-1-yne (136) with butyllithium 
followed by addition of dimethyl squarate (7) gave 2,3-dimethoxy-4-(5-phenyl-3-penten-1-ynyl)- 
4-hydroxy-3-cyclobutene-1-one (137) in 47% yield. To our knowledge, only three cases of 
thermal ring expansions of 4-ene-yne-substrates have previously been reported affording 
five-membered cyclic products.12 An intermolecular Diels-Alder dimerization of the diene 
system of the product has been reported and was initially a concern. Fortunately, thermolysis of 
137 in the absence of NIS gave only 139 without a trace of Diels-Alder product. Reaction of 137 
with N-iodosuccinimide gave the expected cyclopentenedione 138. The iodide in 138 was 
smoothly replaced with a methoxy group to give the natural product methyl linderone (107) in a 
comparable 15% overall yield to the synthesis seen in Scheme 28. While the substitution of an 
iodide for a methoxy group was facile, we were unable to introduce a hydroxy group under basic 
or acidic conditions. Even the small amount of dimethylamine formed or present in 
dimethylformamide (DMF) reacted preferentially to give the dimethylamino derivative 140. 
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Treatment of 138 using a number of other solvent systems including tetrahydrofuran-H2O, 
1,4-dioxane-H2O, and N-methylpyrroli-dinone-H2O under both basic and acidic conditions only 
resulted in no reaction or decomposition of the starting material. 
Scheme 28: Synthesis of methyl linderone 
 
 
2.3.3 Conclusions 
We have achieved an efficient short-step total synthesis of methyl linderone in only three 
steps with an overall yield of 15% from dimethyl squarate. The rearrangement of 
4-ene-yne-substituted cyclo-2-buten-1-ones to halo-substituted cyclopentenediones in the 
presence of N-halosuccinimide can be utilized as key steps in the construction of 
cyclopentenedione derivatives having a variety of substitution patterns, which constitute 
members of a rare class of compounds with potential to be further developed to anti-cancer 
reagents and anti-tumor drugs in the future. 
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Chapter 3 
Synthesis of α-arylated ketones via Wacker-type oxidation of aryl-
substituted alkenes 
3.1 α-Arylated ketone background 
3.2 Wacker-type oxidation 
3.3 Wacker-type oxidation of aryl-substituted alkenes 
3.4 Results and discussion 
3.5 Conclusions 
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3.1 α-arylated ketone background 
The α-arylated ketone structural skeleton can be seen in a variety of biologically 
active natural products and they are very useful synthetic intermediates of active 
pharmaceutical ingredients such as coumestan (141),94 phenylbenzofurans 142,95 and 
isoflavones 143 (Figure 10).96 In organic synthesis, α-arylated carbonyl compounds could be 
used as synthetic building blocks in constructing more complicated substituted heterocycles 
such as indoles, furans, imidazoles, oxazoles, and pyrazoles.97  
Figure 10: Structures of coumestan, phenylbenzofurans, and isoflavones 
 
The selective installation of an aryl group in the α-position of a carbonyl group has 
been an intense research subject over the past 40 years98 and many synthetic methods have 
been reported99-102 to construct these scaffolds, such as reaction of an enolate with a 
derivative of benzyne,99 aryl reagents,102 Grignard reaction of benzamides with 
benzylmagnesium halides,103 Friedel–Crafts reaction of phenols with various phenylacetic 
acids in BF3-Et2O,104 and so on. 
However, due to their own limitation, the transition metal-catalyzed direct coupling of 
aryl halides 144 or pseudohalides with enolates 145 obtained in situ from the corresponding 
ketones under basic conditions to synthesize of α-aryl substituted ketones 146 has emerged 
over the last three decades as a highly versatile method for the inter- and intramolecular 
construction of α-arylated ketones (Scheme 29).105-107 The most commonly employed 
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catalysts in the field of α-arylation of ketones with aryl halides are the palladium catalysts. 
Scheme 29: Transition metal-catalyzed arylation reactions of ketone enolates 
 
The earliest examples of transitional metal-catalyzed α-arylation of ketone enolates with aryl 
halides and pseudohalides was by Kuwajima,108 Buchwald,109 and Hartwig,110 in 1980s and 
1990s. The reactions were usually carried out with a base and a combination of Pd(OAc)2 or 
a Pd(0) compound such as Pd2(dba)3 or Pd(dba)2 and a suitable phosphine ligand. One 
example of the synthetic utility of this methodology is Miura et al.111 in 1999 prepared a 
variety of 2,3-diarylbenzofurans 149 via reaction of aryl benzyl ketones 147 with o-
dibromobenzenes 148 (Scheme 30).  
Scheme 30: Synthesis of 2,3-diarylbenzofurans by means of a palladium catalyst system 
 
A plausible reaction sequence and key steps for these palladium-catalyzed reactions 
involves (i) the oxidative addition of the aryl halide to a Pd(0) species; (ii) arylation at the 
benzylic position of the aryl benzyl ketone in the presence of a base, (iii) C-O bond formation, 
as shown in Scheme 31, (iv) a reductive elimination reaction of Pd species resulting observed 
diarylbenzofurans 149. 
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Scheme 31: Plausible reaction mechanism for the synthesis of 2,3-diarylbenzofurans 
 
In addition to tertiary phosphines, many excellent supporting ligands have been 
investigated in numerous palladium-catalyzed reactions and alternatives to the tertiary 
phosphines have been developed.112-114 A number of Pd-complexes catalysts show excellent 
activity in the α-arylation of various ketone substrates with aryl halides, such as  
allylchloro[1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium 
[(SIPr)Pd(allyl)Cl] 150112,113, complex (IPr)Pd(OAc)2 151114 [IPr=1,3-bis(2,6-di-i-
propylphenyl)imidazol-2-ylidene], (IPr)Pd(acac)Cl 152115, aminopalladacycle 153,78 complex 
154,79 155，80 156,81 and 157.116-120 
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Figure 11: Chemical structures of various palladium-complex catalysts 
 
Khartulyari and Maier in 2007 highlighted the synthetic utility of the palladium-
catalyzed intramolecular α-arylations of ketones in an attempt to prepare benzomorphan 
analogues 159.121 Specifically, the cyclization of bromoketoesters 158a and 159b was carried 
out in refluxing toluene in the presence of K3PO4 as the base and a Pd(dba)2 and P(t-Bu)3 as 
the catalyst system to give tricyclic compounds 159a and 159b in 35% and 36% yield, 
respectively (Scheme 32).  
 
53 
 
Scheme 32: Synthesis of the benzomorphan derivatives 
 
From 1998 until now, several asymmetric syntheses using the transition metal-
catalyzed α-arylation of ketone with aryl halides have been developed.95-98 For instance, in 
1998, Buchwald et al. performed the intermolecular asymmetric arylation of 2-methyl-α-
tetralones 160 with 5 equiv of aryl halide at 70 oC, in the presence of 5 equiv of NaOt-Bu and 
Pd2(dba)3/(S)- or (R)-BINAP catalyst system.122 The enantio-enriched products 161 were 
obtained with good levels of the yield and enantiomeric excess (ee) (Scheme 33). 
Scheme 33: Asymmetric α-arylation of 2-methyl-α-tetralones 
O
Me
R1
+ ArBr
Pd2(dba)3 / (S)-BINAP (10-20 mol %)
NaOt-Bu (2.0 equiv)
PhMe, 100 oC
O
R1
Me
Ar
160 161
yield(%) ee(%)
R1= H, Ar=Ph 66 73
R1= H, Ar=4-t-BuC6H4 73 88
R1=MeO, Ar= 4-t-BuC6H4 56 77  
In addition to palladium catalyzed α-arylation, nickel catalyzed asymmetric synthesis 
of ketones from organic halides and cycloalkanones was reported as well. In 2006, Kwong, 
Chan et al. used the atropoisomeric dipyridylphosphine (R)-P-Phos123 to help pioneer 163 
formation utilizing nickel-catalyzed α-arylation of cycloalkanone 162 with aryl halides 144. 
Product 163 was enantio-selectively synthesized in excellent yields and ee (Scheme 34). 
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Scheme 34: Nickel-catalyzed enantioselective α-arylation of cycloalkanones 
O
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(R)-P-Phos (2.4 mol %)
NaOt-Bu (2.0 equiv)
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n
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*
(n= 0-2), X=Cl, Br, I
N N
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OMe
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162 163144
(ee up to 98%)
 
It is important to note that the synthesis of α-aryl substituted ketones by α-arylation of 
ketones with aryl halides or pseudohalides has been used extensively for the construction of 
key intermediates in pharmaceutically important compounds. 
For example, N-tosyl-2′-aminoacetophenone (164) reacted with orthodibromobenzene 
(165) in toluene and water at 120 °C in the presence of Cs2CO3 and a combination of 
Pd(OAc)2 and XantPhos (Scheme 35) to provide intermediate 166 was a key step in a route to 
oxcarbazepine (167) (Trileptal).124 Trileptal is the most widely prescribed drug for the 
treatment of epilepsy both in children and adults.  
Scheme 35: α-Arylation of N-tosyl-2’-aminoacetophenone with o-dibromobenzene 
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Another example is the synthesis of a wide variety of tamoxifen-related 1,2,2-
triarylethanones 170, which function as active selective estrogen receptor modulator in the 
treatment of breast cancer.125 SanMartin, Dominguez et al. in 2002 demonstrated that 170 
were synthesized from the arylation reaction of aryl benzyl ketones 168 at the benzylic 
position with aryl bromides 169 (Scheme 36) with fair-to-good yield. 
Scheme 36: Pd-catalyzed synthesis of 1,2,2-triarylethanones from aryl benzyl ketones 
 
Later in 2004, 1,2,2-triarylethanones 170 were synthesized from acetophenones 171 
and aryl bromides 172 in a better yield (Scheme 37).126 Specifically, method A focused on the 
use of the system Pd(OAc)2/PPh3/Cs2CO3, while method B entailed the use of the 
commercially available polymerbound catalyst FiberCat1026.  
Scheme 37: Pd-catalyzed synthesis of 1,2,2-triarylethanones from acetophenones 
 
56 
 
Scheme 38: Pd-catalyzed synthesis of the acetonylpurine
       
In 2005, Gupta and Nair127 applied the methodology in the synthesis of 
acetonylpurine (174), which is a important precursor in the synthesis of potent antiviral 
compound 2-acetonylinosine (175) via Pd(PPh3)4-catalyzed reaction of 6-chloro-2-iodopurine 
ribonucleoside (173), Bu3SnOMe, and isopropenyl acetate (Scheme 38). Benzyl methyl 
ketone 177 was prepared using a similar protocol. Reaction of aryl bromide 176, isopropenyl 
acetate, and Bu3SnOMe in the presence of Pd2(dba)3 and 2-diphenylphosphino-2′-
dimethylaminobinaphthyl catalyst system resulted the desired product in a good yield.128 
Scheme 39: Pd-catalyzed synthesis of benzyl methyl ketone 
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Up to date, the transition metal-catalyzed synthesis of α-aryl substituted ketones by α-
arylation of ketones with aryl halides or pseudohalides appears to be the most widely used as 
a very useful and powerful methodology for the formation of Csp3-Csp2 bonds. However, 
these reactions suffer from some drawbacks. For instance, some necessary ligands, catalysts, 
additives for the reactions are very expensive; some substrates do not tolerate the strongly 
basic reaction conditions or required harsh conditions such as elevated temperatures; 
sometimes multiple arylation might happen and specific protecting group need to be 
introduced to block one α-position of the ketone. 
Therefore, there is a need for the further development of direct installation of 
C(sp3)−C(sp2) bonds. Recently, our research in Wacker-type oxidation of aryl-substituted 
alkenes to furnish diverse α-aryl substituted ketones seems to be a promising alternative 
method for this goal. 
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3.2 Wacker-type oxidation 
The Wacker oxidation, olefin oxidation with PdCl2 catalysts, and related processes, 
has been a topic of research interest for well over a century.129 Smidt and co-workers were the 
first researchers to describe the overall process, and the transition metal promoted oxidation 
of ethylene to give acetaldehyde was realized in the late 1950s by using palladium(II) 
chloride and copper(II) chloride as catalyst under an oxygen atmosphere (Scheme 40).130 This 
transformation was achieved by the oxidation of an olefin with an aerobic PdCl2-catalyzed, 
Cu-mediated aqueous medium containing hydrochloric acid to a carbonyl.  
The Wacker Process has remained one of the most important industrial process 
employing transition metal catalysts. Even though it was initially reported in 1962, it is still 
widely utilized for the industrial production of acetaldehyde from ethylene.  
Scheme 40: Individual reactions of the Wacker process 
+ PdCl2 + H2O H
O
+ Pd(0) + 2HCl
Pd(0) + 2CuCl2 + 2CuClPdCl2
2CuCl + 2HCl 2CuCl2 ++ 1/2 O2 H2O
+
H
O
Eq. (1)
Eq. (2)
Eq. (3)
1/2 O2
 
The Wacker oxidation reaction of ethylene involves three sequential stoichiometric 
oxidation and reduction reactions to constitute a catalytic cycle. Eq. (1) in Scheme 40 
represents an oxidation reaction involving a Pd(II) catalyst which has been known for more 
than a century;131 Eq. (2) indicates the formed Pd(0) in eq. (1) could be regenerated by cupric 
chloride in situ; the final step [Eq. (3)] is the re-oxidation of CuCl to CuCl2. The net reaction 
59 
 
of these three reactions leads to a simple air oxidation of ethene to ethanal. 
In addition to ethylene, several synthesis have been developed by Smidt and 
coworkers specifically to produce other carbonyl compounds.130 These studies involve a wide 
variety of starting materials and reaction conditions, including both an acidic aqueous 
solution of palladium(II) chloride and organic media.132,133 In general, terminal olefins are 
transformed to methyl ketones rather than aldehydes through Wacker process as shown in 
Scheme 41. 
Scheme 41: Wacker process of terminal alkenes 
 
Although a lot of efforts have focused on the mechanism study of Wacker reaction,134-
136 a textbook example of a homogeneous transition-metal-catalyzed reaction, no “true” 
pathway of the Wacker oxidation process was described so far due to its complicated kinetics. 
However an abbreviated scheme of the complete catalytic cycle of the Wacker process was 
proposed in Scheme 42,137 involving four key steps: the coordination of terminal alkene 179 
to a palladium(II) species 178; nucleophilic attack of water to the palladium-alkene complex 
180 results intermediate 181. Hydride shift in 181 followed by a reductive elimination furnish 
methyl ketone 182 and regenerate palladium(0) species, which could be reoxidized to 
palladium(II) catalyst. Extraordinary amount of research has provided strong evidence that 
subtle changes in experimental conditions, such as the structure of olefins, solvents and 
reoxidants, can result in substantially different reaction mechanisms,138,139 rates and yields. 
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Scheme 42: Overall catalytic cycle of the Wacker process 
               The oxidation on a laboratory scale can be carried out with palladium(II) catalyst and 
a copper salt under an oxygen atmosphere at room temperature using an apparatus as depicted 
in Figure 12. 
Figure 12: Typical apparatus for Wacker-type oxidation 
 
In order to apply this methodology to more complicated substrates, mixed-solvent 
systems have been developed and a lot of molecule-targeted syntheses were performed under 
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various conditions.130,134 ,139 The Wacker oxidations of higher terminal olefins are slow but 
this problem can be partly solved by the addition of suitable organic solvents which can mix 
olefins with water. However, it is worth noticing that oxidation and isomerization of the 
double bond are competitive reactions, and the extents of the reactions are influenced by 
solvents. For instance, dimethylformamide is good for the oxidation, whereas use of acetic 
acid facilitate the isomerization.139 The double bond migration is facilitated by high 
temperatures.140 
A typical synthetic Wacker procedure, a mixed-solvent system of N,N-
dimethylformamide and H2O with catalytic PdCl2 and stoichiometric CuCl under an aerobic 
atmosphere is referred to as Wacker-Tsuji oxidation. These classical conditions, using N,N-
dimethylformamide (DMF)/H2O mixture and stoichiometric CuCl,141 are developed by Tsuji 
based on modification and extension of the simple Wacker oxidation. Compared to other 
reported modified Wacker oxidation systems, these conditions are most common because of 
their convenience and simplicity.134 
Many modifications for Wacker oxidation have been made. Other than PdCl2, 
palladium(II) trifluoroacetate, palladium(II) acetate, disodium tetrachloropalladate, 
palladium(II) sulfate, palladium(II) chloride-cobalt complexes, bis[acetonitrile]chloro-
nitropalladium complex139 and so on were used as catalysts as well. Sometimes, palladium 
catalyst deactivation occurs during the reaction by the precipitation of black palladium metal, 
even when no precipitation is observed. The reason accounts for this issue is the formation of 
palladium(II) complex. For example, palladium(II) chloride bis-dimethylamine complex  
deactivates the catalyst when dimethylformamide is used as a solvent,133 and π-allyl 
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palladium complexes 183 may retard the reaction when some olefin substrates were used as a 
reactants.142 
Figure 13: Palladium complex accounts for the deactivation 
R
Pd-Cl
183  
Therefore, the activation of the palladium catalyst is a common issue in the Wacker 
oxidation as well as other Pd(II)-catalyzed oxidation reactions. Simple Wacker process adopts 
copper(II) chloride as a cocatalyst to efficiently regenerate the active Pd(II) catalyst. A 
number of other reoxidants have been introduced,139 such as copper(I) chloride, copper(II) 
nitrate, copper(II) acetate, benzoquinone, hydrogen peroxide and t-butyl hydroperoxide. 
Compared to copper(II) catalyst, copper(I) chloride, when pretreated with oxygen, is used no 
chlorination of ketones takes place and the rate of the reaction is high. Benzoquinone was 
another good reoxidant and was first used by Moiseev et al.,143 but a stoichiometric amount is 
necessary. The ability of hydrogen peroxide and t-butyl hydroperoxide to reoxidize 
palladium(0) as the terminal oxidant in the absence of Cu have been proved as well.144 In 
1980s, Mimoun and co-workers145 reported that high conversion and selectivity were 
obtained from terminal straight-chain olefins by using 0.067 mol % Pd(OAc)2 with 5 equiv of 
H2O2(aq) in acetic acid (Scheme 43). The isotopic labeling studies using 18OH2 indicated that 
the O atom incorporated into the ketone originated from hydrogen peroxide.  
Scheme 43: Modified Wacker oxidation using H2O2 as the terminal oxidant 
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On the basis of this finding, a mechanism was proposed wherein a palladacyclic 
intermediate 184 is formed from peroxide insertion into the olefin, followed by an α-hydride 
shift facilitated by O-O bond cleavage (Scheme 44).146 An exciting aspect of the proposed 
catalytic cycle is that Pd does not necessarily proceed through Pd(0) because catalyst 
regeneration can occur via a proton transfer from a peroxide to 185, regenerating active 
catalyst 186. This potentially alleviates the probability of Pd(0) aggregation and catalyst 
deactivation, which is a common problem in these oxidations. 
Scheme 44: Mimoun et al.’s mechanism for peroxide-mediated Wacker oxidation 
 
Methyl ketones are important functional groups and the palladium(II)-catalyzed 
oxidation of terminal olefins seems to be one of the best methods to methyl ketones because 
terminal olefins are easily available, stable under acidic, basic or nucleophilic conditions.139 
Thus, synthetic organic chemists have paid great attention to the widespread use of the 
reaction as a synthetic method for ketones147 and carried out a considerable amount of work 
on the applications to organic synthesis. The reaction is an extremely useful method for the 
synthesis of a variety of natural product precursors and biologically active compound 
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intermediates. Synthetic schemes from 45 to 52 are shown below as examples to demonstrate 
the usefulness of Wacker-type oxidation.   
In 2006, Cook et al.148 successfully converted stable (+)-macroline equivalent 188 to 
(-)-alstonerine (189) in 12.6% overall yield，starting from tryptophan methyl ester 187, via 
an intramolecular Tsuji-Wacker oxidation (Scheme 45). The alkaloid 189 could be further 
converted into biogenetic intermediate (-)-talcarpine (190) and (-)-
anhydromacrosalhinemethine (191). The transformations constituted an improved total 
synthesis of the (-)-anhydromacrosalhine-methine (191) as well as (-)-talcarpine (190). 
Scheme 45: Formation of biogenetic intermediate 190 and 191 
 
In 2011, Szolcsanyi et al.149 have reported up to date shortest routes with highest 
overall yields for three naturally occurring 2,6-disubstituted piperidine alkaloids, (+)-
dihydropinidine (196), (-)-epidihydropinidine (195) (as HCl salts), and (-)-pinidinone (199), 
which are naturally occurring defense chemicals, possessing antifeedant properties against 
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budworm and usually isolated from many spruce and pinus species and various insects. The 
total syntheses began with (S)-epichlorohydrin (192) as common starting material, and 
regioselective copper-free Wacker-Tsuji oxidation of alkenylazides 193 and 197 as key steps 
to exclusively generate methyl ketones 194 and 198 (Scheme 46). 194 subsequently 
converted to (-)-epidihydropinidine (195) and (+)-dihydropinidine (196) with 34% and 54% 
overall yield. The similar optimized Wacker-Tsuji transformation condition allowed the 
dialkenylazide 197 oxidized in good yield to the desired azidodiketone 198. The latter was 
finally converted to (-)-pinidinone (199) in high yield (Scheme 47) upon treatment with 
hydrogenation on Pearlman’s catalyst in 35% overall yield starting from 192. 
Scheme 46: Synthesis of (+)-dihydropinidine and (-)-epidihydropinidine 
N3
O2, cat. PdCl2
NMP/H2O, rt, 85% N3
O
O
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H2, Pd(OH)2/C,
MeOH, rt then HCl,
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(-)-epiDHP
195.HCl
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Scheme 47: Synthesis of (-)-pinidinone 
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In 2013, Yaragorla et al.150 have demonstrated a concise approach toward the 
tetracycle 203, whose structural skeleton is contained in a diverse range of shiartane-type 
nortriterpenoids. They display a wide ranging bioactivity profile that includes anti-oxidant, 
anti-HIV, anti-cancer activities and possess great potential in modern drug discovery as well 
as in traditional medicine. The synthesis began with the conversion of synthon (+)-200 to the 
epoxy-ketone 201 in six steps, followed by exposure of 201 to Wacker–Tsuji oxidation 
condition provided cleanly to the desired diketone 202 in 72% yield and set the stage for 
further four transformations to the tetracycle 203 (Scheme 48). The total synthesis was 
completed in 11 steps with 8% overall yield. 
Scheme 48: Synthesis of tetracycle (+)-203 
 
In 2013, Pipelier et al.151 utilized the Wacker–Tsuji oxidation in the stereoselective 
synthesis of a hexahydronaphthalene derivative 206, which was used as a building block or a 
suitable intermediate for the preparation of a variety of nardosinane-type compounds. 
Nardosinane sesquiterpene exhibits a wide biological activity spectrum and can be extracted 
from soft corals. They successful developed two synthetic strategies to realize this goal 
(Scheme 49). The first route was achieved by the Wacker-type oxidation of silyl ether 204 to 
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give expected ketone 205 in 89% yield, which could be further transformed to bicyclic diene 
206 in 60% yield (dr>95:5) under acidic condition, (para-toluenesulfonic acid in 
acetone/water). Then they described their improvement in the access to diene 206 by a shorter 
synthesis. Same to the condition used in the first strategy, allylic enol 207 was oxidized to 
methyl ketone 208 in 65% yield, the tertiary hydroxy group in which was subsequently 
undergo dehydration under acidic conditions to afford diene 206 still with high 
diastereoselectivity (dr>95:5) in 73% yield.  
Scheme 49: Synthesis towards key hexahydronaphthalene 206 
 
In 2004, Lubell et al.152 designed a convergent synthetic strategy from a series of 
structurally diverse aliphatic and aromatic esters 209 to give access to a range of pyrroles 212 
by the three-step Grignard/Tsuji-Wacker/Paal-Knorr sequence in good yield and purity. 
Pyrroles are abundant as constituents of natural products5-8 and 1,2,5-trisubstitution pattern 
68 
 
pyrroles display interesting biological properties, including antipsychotic,10-12 
antiinflammatory,13,14 radioprotective,15 and spasmolytic16,17 activity. The oxidation of the 
olefin terminus was applied to ketone 210, generating the 1,4-dione 211, which could be used 
for next steps without further purification (Scheme 50).  
Scheme 50: The synthesis of 1,2,5-trisubstituted pyrrole  
 
Scheme 51: C3 Symmetric tripyrrolyl benzene synthesis 
                10 Years later, Lubell group153 further extended the utilization of their synthetic 
methodology mention above in the preparation of conjugated C3 symmetric aryl tripyrroles, 
which may be promising materials for both electrochromic and fluorescence sensor 
applications. Three-step Grignard/Tsuji-Wacker/Paal-Knorr reaction sequence formed the 
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final tripyrroles 216 in 9% overall yields, starting from trimethyl 1,3,5-benzene tricarboxylate 
213.  Modified Wacker-Tsuji olefin oxidation of homoallylic ketone 214 gave tris(1,4-dione) 
215 in 49% yields, featuring ultrasound agitation of the substrate in the presence of PdCl2 
(0.6 equiv) and CuCl (3 equiv) in THF/H2O (4:1) under oxygen atmosphere (Schemes 51). 
Actually, a variety of terminal olefins can be oxidized to the corresponding methyl 
ketones via Wacker-type oxidation with functional groups remain intact, including aldehyde, 
carboxylic acid, ester, alcohol, ether, acetal, chloride, bromide, sulfonyl ester, sulfone and so 
on,139 since the Wacker-type oxidation proceeds under mild conditions. 
In 2011, Anseth et al.154 first reported the successful application of the Wacker-type 
oxidation to a cyclic substrate to synthesis large-scale 1,3-cyclooctanedione (219) in five 
steps with 29% yield. The preparation started from converting the commercially available 
inexpensive starting material cyclooctanone (217) to enone 218 through 4 steps followed by a 
modified Wacker-Tsuji oxidation to gave the desired dione in a single step in 37% yield 
(Scheme 52).29,30 This synthesis was proved to be a good alternative method for the standard 
preparation of 1,3-cyclooctanedione.17 Moreover, this modified Wacker-Tsuji oxidation 
condition, which employed inexpensive oxidant, tert-butyl hydroperoxide was efficient for 
the oxidation of internal double bonds conjugated to carbonyl groups.41 
Scheme 52: Synthesis of 1,3-cyclooctanedione 219 from cyclooctanone 217 
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A definite mechanism explaining various modified Wacker-type oxidations remains 
elusive because of the utilization of added ions and co-oxidants. Recent advancements have 
been made toward the elimination of Cu additives resulting in the development of peroxide-
mediated and ligand modulation Wacker oxidations. Sigman et al. are among the researchers 
who paid great efforts in this area.  
In 2009, Sigman et al.155 discovered a highly efficient Wacker-type oxidation system 
capable of converting classically challenging substrates to corresponding methyl ketones, for 
example, protected allylic alcohols 220 to acyloins 221, and homoallylic alcohol 222 to 223 
in excellent yield (Scheme 53). In a typical reaction condition, low-loadings palladium(II)-
Quinox (bidentate ligand, quinoline-2-oxazoline) complex, aqueous 70 wt% TBHP (tert-butyl 
hydroperoxide) and SbF6- was used as catalyst, terminal oxidant and counterion, respectively. 
Various terminal alkenes were selectively converted to methyl ketones under these mild 
conditions with high selectivity.  
Scheme 53: TBHP-mediated Wacker-type oxidation 
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Two years later, in 2009, Sigman and co-workers156 further proved the methodology 
they discovered before could be used as a general synthetic route to oxidize olefin substrates 
bearing homoallylic alcohols to their corresponding methyl ketone, regardless of substitution 
on the substrates. Various homoallylic alcohols, such as 224 was transformed to β-hydroxy 
ketone 225 using a TBHP-mediated Pd(Quinox)-catalyzed Wacker-type system in good 
yields with significantly reduced reaction times (Scheme 54). 
Scheme 54: TBHP-mediated Wacker-type oxidation to form β-hydroxy ketone 
 
A number of styrene derivatives are another challenging substrate class for the 
Wacker-Tsuji oxidation.157 Therefore, more modified Wacker-type oxidations have been 
created for the purpose of enlarging its synthetic utility.  
Exposing nitro-substituted styrene 226 to TBHP-mediated Wacker-type oxidation155 
mentioned above resulted in methyl ketone 227 in 60% yield because of the highly electron-
deficient system and a trace amount of m-nitro benzaldehyde was obtained (Scheme 55). 
Scheme 55: TBHP-mediated Wacker-type oxidation to form methyl ketone 
 
In 2012, Gröger, et al.158 converted styrene (228) to acetophenone (229) in excellent 
conversion and good selectivity of 99% and 90% respectively by using PdCl2 as a palladium 
catalyst, benzoquinone as oxidation and a mixture of methanol and water as solvent. However, 
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side products o-methylphenylethan-1-ol (3%), phenylacetaldehyde dimethyl acetal (2%), 
methyl phenylacetate (3%), and traces of racemic phenylethan-1-ol (1%) were observed. 
Scheme 56: Benzoquinone-reoxidant Wacker-type oxidation to acetophenone 
 
Compared with the facile oxidation of terminal olefins, the reaction of Wacker-type 
oxidation of internal alkenes is extremely slow and the selectivity for unsymmetrical alkenes 
is often poor unless substrates with some functional groups at suitable positions would be 
oxidized regioselectively by participation of the functional groups under proper conditions. 
For example, the selectivity can be substantially enhanced if the alkene substrate has a 
pendant group able to coordinate with palladium (PdCl2, H2O, O2 (3 atm), DMA, 80 oC).159 
Thus, more improvement is necessary for the Wacker-type oxidation of internal olefins. The 
regioselective oxidation of functionalized internal olefins will be surveyed in this chapter 
because it would be a powerful and flexible method in the synthesis of α-aryl substituted 
ketones, which are quite important synthons in pharmaceutical and biomedical chemistry.  
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3.3 Wacker-type oxidation of aryl-substituted alkenes 
Aryl-substituted alkenes are a substrate class that offers a unique set of challenges to 
Wacker-type oxidation. The 1-aryl-1-alkenes were prepared via a Kosugi-Migita-Stille cross 
coupling of an aryl-iodide or -bromide with tributyl 1-propen-1-yltin (Table 3) 160-162. Since 
the impetus of the present study was the palladium catalyzed oxidation, no attempts were 
made to optimize the yields of the cross coupling reactions. 
 
Table 3: Synthesis of 1-aryl-1-propenes 
Entry X R  Yield (%) 
1 I 2-NO2 --- 230 (49%) 
2 Br 3-NO2 --- 231 (49%) 
3 Br 4- NO2 --- 232 (57%) 
4 I 2-NO2 4-F 233 (73%) 
5 Br 2-NO2 4-NO2 234 (51%) 
6 I 2-NO2 4-CO2Me 235 (56%) 
7 I 2-NO2 4-OMe 236 (32%) 
8 I 2-NO2 5-OMe 237 (37%) 
9 Br 2-NO2 6-Me 239 (69%) 
10 I 2-Br --- 243 (40%) 
11 I --- --- 244 (13%) 
Three other alkene substrates, 1-nitro-2-(1-penten-1-yl)-benzene (240), 1-(3-methyl-
1-butenyl)-2-nitrobenzene (241), and 1-nitro-2-(2-phenylethenyl)-benzene (242) (Figure 14) 
were synthesized using literature procedures.163,164 Coumpound (238), α-asarone is 
commercially available. 
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Figure 14: Structures of substrates 238, 240, 241, and 242 
 
Our initial plan was to examine the possibility of generating α-arylated ketones 
directly under the typical Wacker-Tsuji oxidation condition (Figure 15), 10 mol % of PdCl2 as 
a palladium catalyst, 1 equiv of copper chloride as oxidation reagent, and DMF/H2O (10:1 
(v/v) under an O2 atmosphere at 50 oC for 20 h (Condition 1). The 1-aryl-1-propene 230 was 
expected to be oxidized to form α-arylated propanone 245. But this condition yielded even no 
trace amounts of the expected 245; the starting materials were recovered unchanged. A 
thorough study of the literature on Wacker process made us realize that the oxidation of 
internal olefins is extremely slow under the usual conditions and the reactions are not region-
selective. Rates and yields of the oxidation are heavily dependent on the structure of olefins. 
Also, the proper selection of solvents and reoxidants is crucial. Due to the traditional Wacker-
Tsuji oxidation condition seemed to be ineffective for this transformation, we chose first to 
change solvent by replacing DMF with MeOH (Condition 3). To our delight, a rapid reaction 
took place and α-arylated ketone 245 was isolated in a decent yield of 73% with dimethyl 
acetal 246 (4%) and an inseparable mixture of o-nitrobenzaldehyde 247 (7%) and dione 248 
(7%) as side products. Subsequently, we decided to conduct an oxidant reagent screen by 
utilizing H2O2 with radical inhibitor (2,6-di-t-butyl-4-methylphenol) or tert-butyl 
hydroperoxide (TBHP) with radical inhibitor (Condition 4 and 5). α-Arylated ketone 245 was 
isolated in 72% and 92% yields respectively. We were pleased to find that the oxidation of 
230 was very clean under Condition 5 (only a single product spot on the TLC) and the 
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desired methyl ketone was formed with a good 92% yield with no trace of any other by-
products. It is important to note that the yield of methyl ketone 245 dropped off from 72% to 
18% when changing the reaction condition from Condition 4 to 2. In fact, the addition of 
solvent (methanol and water) had a significant impact on the reaction yield (Conditions 2, 4).  
Figure 15: Wacker-type oxidation of 1-aryl-1-propene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction conditions: 
1. Substrate (0.2 mmol), PdCl2 (10 mol %), CuCl (1 equiv), 1.1 mL of DMF:H2O (10:1) at 50 oC, 20 h. 
2. Substrate (0.2 mmol), PdCl2 (10 mol %), H2O2 (10 equiv) with 50% con. in aqueous solution, 50 oC, 48h.  
3. Substrate (0.2 mmol), PdCl2 (10 mol %), CuCl (1 equiv), 1.1 mL of MeOH:H2O (10:1) at 50 oC, 20 h. 
4. Substrate (0.2 mmol), PdCl2 (10 mol %), H2O2 (10 equiv) with 50% con. in aqueous solution, 2,6-di-t-
butyl-4-methylphenol (10 mol %), 1.1 mL of MeOH:H2O (10:1), 50 oC, 48 h. 
5. Substrate (0.2 mmol), PdCl2(10 mol %), tert-butyl hydroperoxide (10 equiv) with 90% con. in aqueous 
solution, 2,6-di-t-butyl-4-methylphenol (10 mol %), 1.1 mL of  MeOH:H2O (10:1), 50 oC, 48 h.  
 
Inspired by these results, we next conducted a thorough solvent ratio screen using the 
oxidation of 2-nitro styrene (285) as the model (Table 4). MeOH/H2O (9:1) was found to be 
the best solvent system (entry 2), giving methyl ketone product in 29% yeild. The reaction in 
H2O was significantly slower (entry 6); only 61% of 2-nitro styrene was converted after 20 h 
Yield 
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and 22% yield of methyl ketone 286 was isolated. Reactions using MeOH/H2O (3/7) or 
DMF/H2O (10/1) did not complete either and large amount of starting material was recovered 
with low yield of desired ketone obtained (entries 5 and 7). Neither anhydrous methanol 
(entry 1) nor DMF/MeOH (1/1) (entry 8) led to any methyl ketone product. It seemed that the 
ratio of water to methanol had a significant impact on the product ratio under these reaction 
conditions (entries 1-6). Ratios of different products from oxidation of 2-nitro styrene (285) 
were summarized in Table 4. 
Table 4: Ratios of products for crude reaction mixtures from oxidation of 2-ethenyl-1-
nitrobenzene 
     
285  286 287 246 247 288 
Entry MeOH/H2O      
1 1/- (100%) 0 17 (73%) 0 0 1 
2 9/1 1 (29%) 2.3 0.15 0.25 0.16 
3 7/3 1 (26%) 1.11 0.29 0.48 0.14 
4 1/1 1 (16%) 0.60 0.73 1.28 0.26 
5 3/7a(21% sm) 1 (11%) 0.23 0 1.75 0.26 
6 -/1b(39% sm) 1 (22%) 0 0 1.31 0 
7 10/1c(8% sm) 1 (7%) 0 0 5.3 (37%) 0 
8 1/1d(36% sm) 0 1.4 (26%) 0 0.07 1 (19%) 
The starting material was completely consumed in cases (1-4).PdCl2 (10 mol %), CuCl (1 equiv), 50 oC, 20 h.
a MeOH/H2O (3/7) was used as the solvents and starting material (21%) was obtained after the reaction. 
b H2O was used as the solvent and starting material (39%) was obtained after the reaction. 
c DMF/H2O (10/1) was used as the solvents and starting material (8%) was obtained after the reaction. 
d DMF/MeOH (1/1) was used as the solvents and starting material (36%) was obtained after the reaction. 
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3.4 Results and Discussion 
To ascertain the wide applicability of this Wacker-type oxidation methodology to 
target syntheses, the oxidations of a number of aryl-substituted internal alkene variants were 
investigated in an attempt to prepare structurally diverse α-arylated ketones (Table 5). 
Table 5: Wacker-type oxidation of aryl-substituted alkenes 
Entry Alkene Ketone Acetal Aldehyde Dione 
 
  
   
1-A 230  245 (73%) 246 (4%) 247/248 (1:1, 14%) 
1-B 230 245 (18%)  247 (8%)  
1-C 230 245 (72%) 246 (2%) 247 (21%)  
1-D 230 245 (92%)    
 
  
   
2-A 231  249 (30%) 250/251 (1:1, 14%) 
2-D 231 252 (34%)    
 
    
3-A 232  253 (32%) 254/255 (1:1, 20%) 
3-C 232  253 (34%) 254/255 (1:1, 14%) 
3-D 232 256 (55%) 253 (2%)  
 
  
   
4-A 233 257 (55%) 258 (3%) 259/260 (1:1, 10%) 
4-C 233 257 (35%) 258 (17%)   
4-D 233 257 (54%)    
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Table 5 (continued) 
Entry Alkene Ketone Acetal Aldehyde Dione 
 
    
5-A 234  261 (13%) 262 (39%) 263 (29%)
5-C 234 264 (31%)    
5-D 234 264 (5%)    
  
 
6-A 235 265 (29%)  266/267 (1.1:1, 38%) 
6-C 235 265 (37%)  266/267 (1.1:1, 9%) 
6-D 235 265 (21%)  266/267 (1.3:1, 7%) 
 
 
   
7-A 236 268 (53%)    
7-D 236 268 (55%)    
 
 
 
 
8-A 237 269 (41%)  270/271 (1.3:1, 17%) 
8-C 237 269 (36%)  270/271 (1:1, 24%) 
 
 
  
9-A 238 272 (7%) 273 (20%)   
9-D 238 nothing    
 
 
    
10-A 239c 99% recovered    
10-C 239 88% recovered    
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Table 5 (continued) 
Entry Alkene Ketone Acetal Aldehyde Dione 
 
  
  
 
11-Aa 240 274 (58%) 246 (9%)   
11-B 240 274 (29%) 246 (13%) 247 (4%)  
11-C 240 274 (50%) 246 (12%)   
11-D 240 274 (64%)    
 
NO2   
   
12-Ab 241 275 (17%) (45% sm) 276 (11%) 277 (13%)  
12-Bb 241 275 (18%) (19% sm)  247 (8%)  
12-Cb 241 275 (25%) (36% sm) 246 (9%) 247 (6%)  
12-D 241 275 (17%)    
 
  
   
13-Ab 242 278 (14%) (64% sm)    
13-Cb 242 278 (51%) (20% sm)    
13-D 242 278 (74%)    
13-E 242 278 (27%)    
 
  
   
14-A 243 279 (45%) 280/281 (1:1, 9%) 282 (6%)
 
  
 
  
15-A 244 283 (34%) 284 (12%)  
a 97% Conversion after 72h. 
 b Starting material was not completely consumed.  
c No reaction was observed, 99% sm was recovered. 
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Table 5 (continued) 
Conditions A: 10 mol% PdCl2, 1 equiv. CuCl, O2 (1 atm), MeOH:H2O (10:1), 50 oC, 20 h. 
Conditions B: 10 mol% PdCl2, H2O2 (10 equiv) with 50% con. in aqueous solution, MeOH:H2O (10:1), 50 oC, 
48 h.  
Conditions C: 10 mol% PdCl2, H2O2 (10 equiv) with 50% con. in aqueous solution, 2,6-di-tert-butyl-p-cresol 
(10 mol %), MeOH:H2O (10:1), 50 oC, 48 h.  
Conditions D: 10 mol% PdCl2, t-BuOOH (10 equiv) with 90% con. in aqueous solution, 2,6-di-tert-butyl-p-
cresol (10 mol %), MeOH:H2O (10:1), 50 oC, 48 h.  
Conditions E: t-BuOOH (10 equiv) with 90% con. in aqueous solution was used in place of CuCl-O2, no radical 
inhibitor. 
These substrates, another challenging substrate class for the Tsuji-Wacker oxidation, 
were evaluated.157 Substituted alkenes with various functional groups were efficiently 
oxidized, although highly electron-deficient systems were suspected to lead to a lower yield 
in previous report.155 An underlying problem is the difficulty in predicting which pendant 
groups and which of the numerous possible variants of the Wacker-type oxidation will lead to 
the desired product for a given substrate. The selectivity in the Wacker-type oxidation of aryl-
substituted alkenes appears to be under inherent substrate control and dependent on numerous 
factors, including substitution on the substrate and the precise conditions used, which can 
lead to a mixture of aldehyde, ketone, acetal or dione products. Highlighting this disparity, 
substrate such as 230 yielded methyl ketone product 245 in 73% yield in the presence of 
CuCl2-O2 (entry 1-A), while the acetal products 249 and 253 were observed as the 
predominant ones from similar substrates 231 and 232 under the same reaction condition 
(entries 2-A and 3-A). Additionally, the selectivity of these reactions can be affected by the 
choice of oxidant. For example, the use of the H2O2 favors the exclusive formation of 1-aryl-
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propanone 264 in 31% yield (entry 5-C), and CuCl-O2 favors the formation of products 
including acetal 261 (13%), aldehyde 262 (39%), and dione 263 (29%) (entry 5-A).  
As described above, in our pursuit of the improvement of selectivity, we discovered a 
copper-free catalyst system for Wacker-type oxidations that utilizes palladium catalyst along 
with tert-butyl hydroperoxide (TBHP) as the oxidant and 2,6-di-tert-butyl-p-cresol as the 
radical inhibitor. This system successfully oxidized various functionalized aryl-substituted 
substrates with high selectivity (>98%) for the α-arylated ketone products (entries 1-4 D, 6-7 
D, 11-13 D). The scope of condition A to E was then thoroughly evaluated, and it was found 
that, for some alkenes, it was sufficient to achieve good yields of desired ketones in 20 h 
(entries 4-A, 7-A, 8-A, 14-A) in the presence of 10 mol% PdCl2, 1 equiv. CuCl, O2 (1 atm) 
and MeOH:H2O (10:1) at 50 oC. Steric hindered alkenes tended to react slower, where 
incomplete conversion was observed after reaction of 72 h (entries 10-13 A). No reaction was 
observed by 1H NMR of the crude reaction mixture from 1-methyl-3-nitro-2-(1-propen-1-yl)-
benzene (239) using either H2O2 or CuCl-O2. The starting material was recovered in high 
yields (entries 10-A and 10-C). It seems steric hindrance considerably affects the rate of 
olefin oxidation. Mixtures of inseparable aldehyde and dione were also isolated from several 
reaction mixtures, as determined by 1H NMR (entries 1-4 A, 6-A, 8-A, 3-C, 6-C, 8-C, and 6-
D). With no exception, the TBHP-mediated catalyst system demonstrates high selectivity for 
the desired ketones, regardless of substitution on the substrates evaluated. This result is 
particularly interesting when compared with other modified conditions, where analogous 
substrates also formed other side products with different ratios and yields in a condition-
dependent manner. 
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To investigate the effect of the position of the pendent nitro group relative to the 
internal olefin, nitro-1-propen-1-yl-benzne (231 and 232) were also evaluated. When these 
substrates were subjected to the Condition A [10 mol% PdCl2, 1 equiv. CuCl, O2 (1 atm), 
MeOH:H2O (10:1), 50 oC, 20 h] (entries 2-A, 3-A), the desired ketone products were not 
observed; instead, the products isolated were identified acetals  (249, 253) and mixtures of 
aldehydes and diones. When these substrates were subjected to the condition D, methyl 
ketones 245 and 252 were obtained as the only products (entries 2-D, 3-D).  
Halogens, such as F and Br (entries 4, 14) as well as methoxy and methyl ester groups 
(entries 6-9) are apparently well-tolerated in the meta-/ortho- position of the nitroarene 
substrates. Reaction of 1-(2,4-dinitrophenyl)-1-propene (234) gave methyl ester 261 in 
addition to the dione 263, methyl 2,4-dinitrophenylbenzoate (262) (entry 5-A). It should be 
noted that the reported formation of this compound from reaction of 2,4-dinitro-1-
fluorobenzene with dimethoxycarbene followed by hydrolysis is in error.165 Oxidation of 1-
(3-methyl-1-butenyl)-2-nitrobenzene (241) using condition A (entry 12) afforded isomers 276 
and 277 in 11% and 13% respectively in addition to the α-arylated ketone 275.  
Figure 16: Products 276 and 277 
 
 
Cornell and Sigman reported a high selectivity for acetophenone formation upon 
oxidation of p-/m- or o-substituted styrenes with t-BuOOH in the presence of catalytic 
amounts of both a palladium(II) carbene complex and AgOTf.166  However, oxidation of 1-
phenyl-1-propene (244) was non-selective and gave an approximately 1:1 mixture of 1-
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phenyl-2-propanone (283) and 1-phenyl-1-propanone (284). We observed a somewhat more 
selective oxidation of (244) affording roughly a 3:1 ratio of 1-phenyl-2-propanone and 1-
phenyl-1-propanone (entry 15-A). The same 3:1 ratio of 283/284 was reported using PdCl2, 
CuCl, in DMF-H2O (1:1) at 1 atm of oxygen and ambient temperature.160 A 95% yield was 
reported without any concurrent double bond cleavage to benzaldehyde. Cleavage of the 
alkene to form benzaldehyde was also observed in Sigman’s paper (2.3:1 ratio of oxidation: 
cleavage).  
Overall, the results point out that these modified Wacker processes of aryl-substituted 
alkenes are also quite sensitive to and dependent on reaction conditions, which are believed 
to associate with different mechanistic scenarios. However, t-butyl hydroperoxide and 
hydrogen peroxide have proved to be efficient reoxidants for the oxidation of internal double 
bonds.  
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3.5 Conclusions 
In conclusion, we demonstrate that Wacker-type oxidation of aryl-substituted alkenes is 
feasible under modified Wacker-type oxidation conditions to yield α-arylated ketones that are 
challenging or impossible to obtain using conventional reaction conditions. The selectivity in 
the modified Tsuji-Wacker oxidation of aryl-substituted alkenes appears to be dependent on 
numerous factors, including the substrate and the precise conditions used. The reaction 
conditions discussed above appear to work with a fairly wide range of substrates. 
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Chapter 4 
Supporting information: experimental procedures 
4.1 Supporting information Chapter 1: Ring-expansion of 4-ethynyl-4-hydroxy-2,3- 
substituted-2-cyclobuten-1-ones 
4.2 Supporting information Chapter 2: Total synthesis of methyl linderone 
4.3 Supporting information Chapter 3: Wacker-type oxidation of aryl-substituted alkenes 
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General procedures. All NMR spectra were recorded in CDCl3. The chemical shifts are 
expressed in δ values relative to Me4Si (0.0 ppm, 1H and 13C) or CDCl3 (77.0 ppm, 13C) 
internal standards. Tetrahydrofuran (THF) and diethyl ether were distilled from sodium 
benzophenone ketyl prior to use. Toluene, pyridine, hexanes, and ethyl acetate were distilled 
from calcium hydride. Chemicals prepared according to literature procedures have been 
footnoted the first time used; all other reagents were obtained from commercial sources and 
used as received. All reactions were performed under a nitrogen atmosphere in oven-dried 
glassware unless otherwise stated. The thermolysis reactions were performed in ACE-Glass 
pressure tubes capped with a Teflon screw cap. Solvents were removed from reaction 
mixtures and products on a rotary evaporator at water aspirator pressure. All alkanes, arenes, 
and etherial solvents are purified with activated alumina then Q5 (Q5 is an O2 scavenging 
Cu-zeolite catalyst made by BASF). All other solvents with heteroatoms are dried through 
two columns of activated alumina.  
Caution: 3,4-dialkoxy-3-cyclobutene-1,2-diones have been shown to cause contact dermatitis 
upon contact.25 
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4.1 Supporting information Chapter 1: Ring-expansion of 4-ethynyl-4-hydroxy-2,3- 
substituted-2-cyclobuten-1-ones 
 
 
68                                  69                70 
4,5-Bis(1-methylethoxy)-2-(1-trimethylsilylmethylene)-4-cyclopentene-1,3-dione (69) and 
2,3-bis(1-methylethoxy)-5-trimethylsilyl-2,5-cyclohexadiene-1,4-dione (70).  
A solution of 689 (296 mg, 1.00 mmol) in benzene (3 mL) was heated at 140 oC for 3 h in an 
ACE-Glass pressure tube capped with a Teflon screw cap. The resulting dark mixture was 
cooled to ambient temperature and the solvent was removed at reduced pressure. The 
resulting crude product was purified by chromatography (hexanes/EtOAc, 98:2) to give an 
inseparable mixture of 69 and 70 (1:18 ratio, 229 mg, 0.773 mmol, 77%) as a red solid. 
Spectral data for 70: mp 34-37 oC; 1H NMR (270 MHz) δ 6.71 (s, 1H), 4.81 (sept, J=6.3 Hz, 
1H), 4.80 (sept, J=6.1 Hz, 1H),1.31 (d, J=6.1 Hz, 6H), 1.28 (d, J=6.1 Hz, 6H), 0.23 (s, 9H); 
13C NMR (150 MHz) δ 188.1, 184.7, 150.4, 146.4, 145.3, 142.0, 75.9, 75.7, 22.6, -1.6; IR 
(ATR) 2978, 1657, 1583, 1251, 1197, 1108, 910, 885, 841 cm-1; HRMS (ESI) calcd for 
C15H25O4Si (M+H+) 297.1522; found 297.1517. Partial spectral data for 69: 1H NMR (270 
MHz) δ 6.89 (s, 1H), 5.59 (sept, J=6.0 Hz, 1H), 5.54 (sept, J=6.1 Hz, 1H), 1.37 (d, J=6.1 Hz, 
6H), 1.35 (d, J=6.1 Hz, 6H). 
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68                                   71 
2-(1-Iodo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione 
(71). To a solution of 68 (148mg, 0.500mmol) in benzene (1.5 mL) was added NIS (124 mg, 
0.550 mmol). The tube was capped with a Teflon screw cap and stirred for 3 h at ambient 
temperature. Removal of solvent under reduced pressure followed by chromatography 
(hexanes/EtOAc, 9:1) gave 71 (137 mg, 0.324 mmol, 65%) as a yellow oil. 1H NMR 
(270MHz) δ 5.62 (sept, J=6.1 Hz, 1H), 5.40 (sept, J=6.1 Hz,1H), 1.35 (d, J=6.1 Hz, 6H), 1.34 
(d, J=6.1 Hz, 6H), 0.33 (s, 9H); 13C NMR (150 MHz) δ 183.9, 183.9, 151.2, 148.6, 140.8, 
127.3, 75.2, 75.0, 23.1, 22.9, 1.7; IR (ATR) 2987, 1678, 1613, 1304, 1246, 1065, 841 cm-1; 
HRMS (ESI) calcd for C15H24IO4Si (M+H+) 423.0489; found 423.0486. 
 
 
68                                   72 
2-(1-Bromo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione 
(72). Treatment of 68 (75 mg, 0.25 mmol) with NBS (59 mg, 0.33 mmol) in benzene (0.75 
mL) as described for 71 (80 oC, 6 h), gave after chromatography (hexanes/EtOAc, 99:1) 72 
(38 mg, 0.10 mmol, 40%) as a brown oil. 1H NMR (270 MHz) δ 5.57 (sept, J=6.1 Hz, 1H), 
5.41 (sept, J=6.1 Hz, 1H), 1.36 (d, J=6.1 Hz, 6H), 1.36 (d, J=6.1 Hz, 6H), 0.34 (s, 9H); 13C 
NMR (150 MHz) δ 184.3, 183.4, 151.4, 149.5, 148.0, 136.9, 75.2, 74.9, 23.1, 22.9, 0.3; IR 
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(ATR) 2993, 1682, 1622, 1385, 1306, 1098, 1068, 850 cm-1; HRMS calcd for C15H24BrO4Si 
(M+H+) 375.0627; found 375.0619. 
 
 
73                             74 
2,3-Bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (74). Treatment of 739 (56 mg, 0.25 
mmol) in benzene (0.75 mL) as described for 69 (140 oC, 3 h) gave after chromatography 
(hexanes/EtOAc, 98:2) 74 (33 mg, 0.14 mmol, 58%) as an orange-red oil. 1H NMR (270 
MHz) δ 6.60 (s, 2H), 4.82 (sept, J=6.1 Hz, 2H), 1.30 (d, J=6.1 Hz, 12H); 13C NMR (67.5 
MHz) δ 184.8, 145.8, 134.7, 76.1, 22.6; IR (ATR) 2983, 1662, 1588, 1375, 1291, 1187, 1098, 
1063 cm-1; HRMS (ESI) calcd for C12H17O4 (M+H+) 225.1127; found 225.1122. 
 
 
73                               75 
2-(Iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (75). Treatment of 73 
(112 mg, 0.500 mmol) with NIS (124 mg, 0.550 mmol) in benzene (1.5 mL) as described for 
71 (ambient temperature, 3 h), gave after chromatography (hexanes/EtOAc, 19:1 then 8:2) 75 
(59.7 mg, 0.170 mmol, 34%) as a pale orange oil. 1H NMR (270 MHz) δ 7.87 (s, 1H), 5.62 
(sept, J=6.1 Hz, 1H), 5.51 (sept, J=6.1 Hz, 1H), 1.38 (d, J=6.1 Hz, 6H), 1.36 (d, J=6.1 Hz, 
6H); 13C NMR (150 MHz) δ 183.5, 182.6, 153.4, 149.0, 136.3, 88.1, 75.4, 75.2, 23.1, 23.0; 
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IR (ATR) 2983, 1682, 1627, 1583, 1390, 1306, 1098, 1043, 910, 781 cm-1; HRMS (ESI) 
calcd for C12H16IO4 (M+H+) 351.0093; found 351.0090. 
 
 
73                              76 
2-(Bromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (76). Treatment of 
73 (57 mg, 0.25 mmol) with NBS (55.0 mg, 0.309 mmol) in benzene (1.5 mL) as described 
for 70 (80 oC, 17 h) gave after chromatography (hexanes/EtOAc, 95:5), 76 (36 mg, 0.12 
mmol, 47%) as a yellow oil. 1H NMR (270 MHz) δ 7.12 (s, 1H), 5.42 (sept, J=6.2 Hz, 1H), 
5.36 (sept, J=6.1 Hz, 1H), 1.23 (d, J=6.1 Hz, 6H), 1.21 (d, J=6.2 Hz, 6H); 13C NMR (150 
MHz) δ 182.7, 182.6, 153.2, 149.7, 131.8, 116.4, 75.5, 75.2, 23.1, 23.0; IR (ATR) 2993, 1682, 
1637, 1390, 1316, 1103, 910, 796 cm-1; HRMS (ESI) calcd for C12H16BrO4 (M+H+) 303.0232; 
found 303.0227. 
 
 
73                             77                74 
5-Chloro-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (77) and 2,3-bis(1-methyl 
ethoxy)-2,5-cyclohexadiene-1,4-dione (74). Treatment of 73 (110 mg, 0.491 mmol) with 
NCS (72 mg, 0.539 mmol) in toluene (3 mL) as described for 71 (150 oC, 3 h) gave after 
chromatography (hexanes then hexanes/EtOAc, 98:2), in order of elution, 77 (30 mg, 0.116 
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mmol, 24%) and 74 (60 mg, 0.27 mmol, 55%) both as orange oils. Analytical data for 77: 1H 
NMR (270 MHz) δ 6.82 (s, 1H), 4.87 (sept, J=6.1 Hz, 1H), 4.76 (sept, J=6.1 Hz, 1H), 1.32 (d, 
J=6.1 Hz, 6H), 1.31 (d, J=6.3 Hz, 6H); 13C NMR (150 MHz) δ 182.3, 177.1, 146.1, 145.6, 
142.0, 131.5, 76.7, 22.6; IR (ATR) 2987, 1659, 1590, 1389, 1254, 1096, 872, 779 cm-1; 
HRMS (ESI) calcd for C12H16ClO4 (M+H+) 259.0737; found 259.0732. 
 
 
68                                  78 
4-Hydroxy-2,3-bis(1-methylethoxy)-4-(2-iodoethynyl)-2-cyclobutene-1-one (78). A solution 
of 68 (914 mg, 3.08 mmol) under N2 in DMF (30 mL) was cooled to 0 oC and AgNO3 (38mg, 
0.22 mmol) was added in one portion. After stirring for 5 min, NIS (764mg, 3.40 mmol) was 
added and the reaction was slowly warmed to room temperature overnight. The mixture was 
cooled to 0 oC and ice-water (20mL) was added. The mixture was extracted with Et2O (6 x 50 
mL). The organic layers were washed with water followed by brine and dried (MgSO4). The 
solvent was removed under reduced pressure. Chromatography (hexanes/EtOAc, 7:3) gave 78 
(777 mg, 2.22 mmol, 72%) as a pale yellow solid. Mp 108-110 oC; 1H NMR (270 MHz) δ 
4.96 (sept, J=6.1 Hz, 1H), 4.84 (sept, J=6.1 Hz, 1H), 3.75 (s, 1H), 1.42 (d, J=6.3 Hz, 6H), 
1.28 (d, J=6.1 Hz, 3H), 1.27 (d, J=6.1 Hz, 3H); 13C NMR (150MHz) δ 180.0, 164.1, 134.3, 
88.9, 79.7, 78.2, 74.3, 22.7, 22.6, 22.5, 7.9; IR (ATR) 2988,1771,1617,1390,1325,1098, 999, 
954, 910, 737 cm-1; HRMS (ESI) calcd for C12H16IO4 (M+H+) 351.0093; found 351.0088. 
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           78                                75                 79 
2-(Iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (75) and 5-iodo-2,3- 
bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (79). Treatment of 78 (84 mg, 0.24 mmol) 
in benzene (0.75 mL) as described for 69 (140 oC, 3 h) gave after chromatography 
(hexanes/EtOAc, 98:2), in order of elution 79 (21 mg, 0.060 mmol, 25%) and 75 (35.0 mg, 
0.100 mmol, 42%) both as orange oils. Analytical data for 79: 1H NMR (270 MHz) δ 7.50 (s, 
1H), 4.83 (sept, J=6.1 Hz, 1H), 4.69 (sept, J=6.1 Hz, 1H), 1.27 (d, J=6.1 Hz, 6H), 1.26 (d, 
J=6.1 Hz, 6H); 13C NMR (150 MHz) δ 182.4, 178.2, 146.4, 144.3, 144.0, 117.0, 76.9, 76.5, 
22.7; IR (ATR) 2983, 1667, 1578, 1390, 1251, 1182, 1103, 910 cm-1; HRMS (ESI) calcd for 
C12H16IO4 (M+H+) 351.0093; found 351.0088. 
 
 
                    78                                 80 
2-(Diiodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (80). Treatment of 
78 (76 mg, 0.20 mmol) with NIS (66.6 mg, 0.296 mmol) in benzene (0.75 mL) as described 
for 70 (80 oC, 3 h) gave after chromatography (hexanes/EtOAc, 95:5) 80 (45 mg, 0.094 mmol, 
43%) as a pale yellow solid and 78 (23.4 mg, 0.0668, 30%). Data for 80: mp 89-94 oC; 1H 
NMR (270 MHz) δ 5.51 (sept, J=6.1 Hz, 2H), 1.37 (d, J=6.2 Hz, 12H); 13C NMR (150 MHz) 
δ 182.7, 149.8, 133.2, 75.5, 23.0, 17.8; IR (ATR) 2983, 1672, 1617, 1385, 1311, 1103, 1078, 
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910, 796 cm-1; HRMS (ESI) calcd for C12H15I2O4 (M+H+) 476.9060; found 476.9055. 
 
 
68                                  81 
4-Hydroxy-2,3-bis(1-methylethoxy)-4-(2-bromoethynyl)-2-cyclobutene-1-one (81). 
A solution of 68 (1.00 g, 3.38 mmol) under a nitrogen atmosphere in DMF (30 mL) was 
cooled to 0 oC and AgNO3 (40 mg, 0.24 mmol) was added. After stirring for 5 min, NBS (696 
mg, 3.91 mmol) was added and the reaction was slowly warmed to room temperature 
overnight. The mixture was cooled to 0 oC and quenched with ice-water (20 mL). The 
mixture was extracted with ether (3 x 75 mL). The combined organic layers were dried 
(MgSO4), filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by chromatography (hexanes/EtOAc, 95:5) to afford 81 (485 mg, 1.60 mmol, 
47%) as a pale yellow solid. Mp 109-110 oC; 1H NMR (600 MHz) δ 4.95 (sept, J=6.0 Hz, 
1H), 4.88 (sept, J=6.0 Hz, 1H), 2.76 (s, 1H), 1.44 (d, J=6.0 Hz, 3H), 1.44 (d, J=6.0 Hz, 3H), 
1.31 (d, J=6.6 Hz, 3H), 1.30 (d, J=6.6 Hz, 3H); 13C NMR (150 MHz) δ 180.1, 164.2, 134.0, 
79.1, 78.1, 75.0, 74.2, 49.8, 22.6, 22.6, 22.5, 22.4; IR (ATR) 3303, 1775, 1621, 1378, 1331, 
1096, 1007, 953, 907, 783 cm-1; HRMS (ESI) calcd for C12H15BrNaO4 (M+Na+) 325.0051; 
found: 325.0045. 
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81                                76                 82 
5-Bromo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (82) and 2-(bromo 
methylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (76). A solution of 81 (58 mg, 
0.19 mmol) in benzene (1.5 mL) was treated as described for 69 (140 oC, 3 h) gave after 
chromatography (hexanes/EtOAc, 98:2), in order of elution, 82 (20 mg, 0.066 mmol, 34%) as 
a red-orange oil and 76 (18.0 mg, 0.0594 mmol, 31%) as a yellowsolid. Analytical data for 82: 
1H NMR (600 MHz) δ 7.10 (s, 1H), 4.87 (sept, J=6.0 Hz, 1H), 4.75 (sept, J=6.0 Hz, 1H), 
1.32 (d, J=6.0 Hz, 6H), 1.31 (d, J=6.0 Hz, 6H); 13C NMR (150 MHz) δ 182.3, 177.1, 146.2, 
145.5, 135.9, 135.3, 76.8, 76.6, 22.6; IR (ATR) 2987, 1652, 1582, 1254, 1181, 1096, 907, 802, 
725 cm-1; HRMS (ESI) calcd for C12H16BrO4 (M+H+) 303.0232; found: 303.0224. 
 
 
81                                 83 
2-(1-Bromo-1-iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (83).  
Treatment of 81 (78 mg, 0.26 mmol) with NIS (62.4 mg, 0.276 mmol) in benzene (0.75 mL) 
as described for 71 (80 oC, 3 h) gave after chromatography (hexanes/EtOAc, 95:5) 83 (75 mg, 
0.18 mmol, 68%) as a pale yellow solid. Mp 109-113 oC; 1H NMR (600 MHz) δ 5.49 (sept, 
J=6.0 Hz, 1H), 5.49 (sept, J=6.0 Hz, 1H), 1.35 (d, J=6.0 Hz, 6H), 1.35 (d, J=6.0 Hz, 6H); 13C 
NMR (150 MHz) δ 182.1, 181.6, 150.2, 149.6, 131.4, 75.5, 75.4, 61.5, 23.0; IR (ATR) 2983, 
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1679, 1617, 1304, 1084, 903, 791, 745, 718 cm-1; HRMS (ESI) calcd for C12H15BrIO4 (M+H+) 
428.9198; found: 428.9195. 
 
 
81                                 84 
2-(Dibromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene-1,3-dione (84). Treatment 
of 81 (75 mg, 0.25 mmol) with NBS (50.2 mg, 0.282 mmol) in benzene (0.75 mL) as 
described for 71 (80 oC, 3 h) gave after chromatography (hexanes/EtOAc, 98:2) 84 (43 mg, 
0.11 mmol, 46%) as an orange solid. Mp 103-106 oC; 1H NMR (600 MHz) δ 5.49 (sept, 
J=6.0 Hz, 2H), 1.36 (d, J=6.0 Hz, 12H); 13C NMR (150 MHz) δ 181.3, 150.4, 128.8, 101.2, 
75.5, 23.0; IR (ATR) 2987, 1682, 1613, 1378, 1304, 1084, 899, 802, 748, 671 cm-1; HRMS 
(ESI) calcd for C12H14Br2NaO4 (M+Na+) 402.9157; found: 402.9152. 
 
 
88                           89 
4-Hydroxy-2-methyl-3-(1-methylethoxy)-4-(2-trimethylsilylethynyl)-2-cyclobutene-1-one 
(89). Butyllithium (8.29 mL, 1.6 M in hexane, 13.3 mmol) was added drop wise to a -78 oC 
cold solution of trimethylsilylethyne (2.7 mL, 13.9 mmol) in THF (16 mL) under a nitrogen 
atmosphere. The solution was stirred (2 h, -78 oC) where after it was transferred via a cannula 
to a -78 oC cold solution of 3-(1-methylethoxy)-4-methylcyclobut-3-ene-1,2-dione 88 (1.24 g, 
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7.95 mmol) in THF (40 mL). After stirring for 2 h, NH4Cl (70 mL) was added and the 
mixture was extracted with Et2O (5 x 50mL). The combined organic layerswere dried 
(MgSO4) and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 8:2) affording 89 (1.26 g, 4.99 mmol, 63%) as 
a pale yellow solid. Mp 84-88 oC; 1H NMR (270 MHz) δ 5.04 (sept, J=6.1 Hz, 1H), 2.88 (s, 
1H), 1.67 (s, 3H), 1.48 (d, J=6.1 Hz, 3H), 1.45 (d, J=6.3 Hz, 3H), 0.18 (s, 9H); 13C NMR 
(150 MHz) δ 186.7, 179.8, 125.0, 99.1, 95.3, 83.4, 78.3, 22.9, 22.6, 6.5, 0.4; IR (ATR) 2963, 
1766, 1622, 1395, 1340, 1098, 850, 766 cm-1; HRMS (ESI) calcd for C13H21O3Si (M+H+) 
253.1260; found 253.1254. 
 
 
89                                 90                91 
2-Trimethylsilylmethylene-4-(1-methylethoxy)-5-methyl-4-cyclopentene-1,3-dione (90) and 
5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (91). Treatment 
of 89 (65 mg, 0.26 mmol) in benzene (0.75 mL) as described for 69 (140 oC, 3 h) gave after 
chromatography (hexanes/EtOAc, 98:2) an inseparable mixture of 90 (14 mg, 0.056 mmol, 
22%, 1.2:1 ratio of isomers) and 91 (21 mg, 0.083 mmol, 32%) as a pale yellow oil. 
Analytical data for 90 (both isomers) from the mixture: 1H NMR (600 MHz) δ 7.04 (s, 1H), 
6.95 (s, 1H), 5.70 (sept, J=6.1 Hz, 1H), 5.68 (sept, J=6.2 Hz, 1H), 1.97 (s, 3H), 1.96 (s, 3H), 
1.37 (d, J=6.2 Hz, 6H), 1.36 (d, J=6.2 Hz, 6H), 0.25 (s, 9H), 0.24 (s, 9H); Analytical data for 
91 from the mixture: 1H NMR (600 MHz) δ 6.70 (s, 1H), 4.83 (sept, J=6.2 Hz, 1H), 1.93 (s, 
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3H), 1.29 (d, J=6.2 Hz, 6H), 0.23 (s, 9H). Analytical data for 90 and 91:13C NMR (150 MHz) 
δ 191.7, 190.7, 189.4, 188.5, 186.9, 183.1, 167.3, 166.2, 154.6, 152.2, 143.2, 142.9, 142.6, 
142.5, 142.0, 75.7, 74.7, 23.2, 22.9, 9.2, 7.0, 7.0, -0.8, -1.0, -1.6; IR (ATR) 2963, 1687, 1632, 
1603, 1390, 1330, 1251, 1187, 1108, 845, 766 cm-1; HRMS (ESI) calcd for C13H21O3Si 
(M+H+) 253.1260; found 253.1255. 
 
 
89                                  92               93 
2-(1-Iodo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene-1,3- 
dione (92) and 6-iodo-5-trimethylsilyl-3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene- 
1,4-dione (93). Treatment of 89 (64 mg, 0.25 mmol) with NIS (67 mg, 0.30 mmol) in 
benzene (0.75 mL) as described for 71 (80 oC, 3 h) gave after chromatography 
(hexanes/EtOAc, 95:5) in order of elution 92 (58.8 mg, 0.155 mmol, 61%,1.5:1 ratio of 
isomers) as a yellowoil and 93 (5 mg, 0.013 mmol, 5%) as a light yellow oil. Analytical data 
for 92: 1H NMR (270 MHz) δ (600 MHz) 5.72 (sept, J=6.1 Hz, 1H), 5.54 (sept, J=6.1 Hz, 
1H), 1.96 (s, 3H), 1.89 (s, 3H), 1.37 (d, J=6.2 Hz, 6H), 1.35 (d, J=6.1 Hz, 6H), 0.37 (s, 9H), 
0.36 (s, 9H); 13C NMR (150 MHz) δ 189.1, 188.2, 185.7, 185.6, 167.6, 163.2, 142.1, 142.0, 
136.6, 132.6, 131.4, 130.9, 75.1, 74.7, 23.3, 23.1, 7.7, 6.5, 1.7, 1.4; IR (ATR) 2988, 1682, 
1622, 1385, 1330, 1123, 1019, 771 cm-1; HRMS (ESI) calcd for C13H20IO3Si (M+H+) 
379.0226; found 379.0222. Analytical data for 93: 1H NMR (270 MHz) δ 4.90 (sept, J=6.2 
Hz, 1H), 1.91 (s, 3H), 1.41 (d, J=6.1 Hz, 3H), 1.32 (d, J=6.1 Hz, 3H), 0.23 (s, 9H); 13C NMR 
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(150 MHz) δ 173.3, 168.5, 151.2, 107.7, 97.1, 89.0, 74.2, 22.9, 22.7, 8.9, 0.5; IR (ATR) 2988, 
1781, 1662, 1306, 1251, 1108, 1053, 841 cm-1; HRMS (ESI) calcd for C13H19INaO3Si 
(M+Na+) 401.0046; found 401.0039. 
 
 
89                                 94                95 
2-(1-Bromo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene-1,3-di
one (94) and 6-bromo-5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4- 
dione (95). Treatment of 89 (64 mg, 0.26 mmol) with NBS (65 mg, 0.37 mmol) in benzene 
(0.75 mL) as described for 71 (80 oC, 3 h) gave after chromatography (hexanes/EtOAc, 95:5), 
in order of elution, 94 (55 mg, 0.17 mmol, 65%, 2:1 ratio of isomers) as a pale yellow oil and 
95 (13 mg, 0.039 mmol, 15%) as a colorless oil. Analytical data for 94: 1H NMR (270 MHz, 
major isomer) δ 5.69 (sept, J=6.1 Hz, 1H), 1.90 (s, 3H), 1.37 (d, J=5.9 Hz, 6H), 0.36 (s, 9H); 
1H NMR (270 MHz, minor isomer) δ 5.54 (sept, J=6.1 Hz, 1H), 1.96 (s, 3H), 1.35 (d, J=5.9 
Hz, 6H), 0.35 (s, 9H); 13C NMR (150 MHz) δ 189.1, 187.8, 186.5, 185.1, 167.3, 164.0, 151.0, 
137.9, 137.7, 136.9, 133.5, 75.0, 74.6, 23.3, 23.1, 7.4, 6.7, 0.28, 0.023; IR (ATR) 2988, 1687, 
1627, 1390, 1330, 1133, 1103, 870 cm-1; HRMS (ESI) calcd for C13H20BrO3Si (M+H+) 
331.0365; found 331.0362. Analytical data for 95: 1H NMR (270 MHz) δ 4.94 (sept, J=6.1 
Hz, 1H), 2.01 (s, 3H), 1.45 (d, J=6.1 Hz, 6H), 0.55 (s, 9H); 13C NMR (150 MHz) δ 171.1, 
166.5, 160.9, 136.5, 114.4, 104.0, 75.7, 22.8, 21.0, 9.6, 2.0; IR (ATR) 2993, 1786, 1632, 1316, 
1256, 1029, 855, 742 cm-1; HRMS (ESI) calcd for C13H19BrNaO3Si (M+Na+) 353.0185; 
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found 353.0176. 
 
96                              97 
3-Methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (97). Treatment of 9662 (64 mg, 
0.35 mmol) in benzene (0.75 mL) as described for 69 (140 oC, 3 h) gave after 
chromatography (hexanes/EtOAc, 98:2) 97 (38 mg, 0.21 mmol, 85%) as a yellowish-brown 
oil. 1H NMR (270 MHz) δ 6.68 (d, J=10.1 Hz, 1H), 6.59 (d, J=10.1 Hz, 1H), 4.83 (sept, 
J=6.1 Hz, 1H), 1.95 (s, 3H), 1.30 (d, J=6.1 Hz, 6H); 13C NMR (150 MHz) δ 188.4, 183.5, 
154.7, 136.4, 134.8, 130.9, 76.1, 22.9, 22.5, 9.0; IR (ATR) 
2983,1652,1593,1385,1306,1192,1098,1019, 850, 801 cm-1; HRMS (ESI) calcd for C10H13O3 
(M+H+) 181.0865; found 181.0859. 
 
 
                     96                               98 
2-(1-Iodomethylene)-4-methyl-5-(1-methylethoxy)-4-cyclopentene-1,3-dione (98).  
Treatment of 96 (120 mg, 0.66 mmol) and NIS (164 mg, 0.729 mmol) in toluene (5 mL) as 
described for 71 (150 oC, 3 h) gave after chromatography (hexanes/EtOAc, 19:1) 98 (130 mg, 
0.426 mmol, 64%, 13:1 ratio of double bond isomers) as an orange solid. Mp 47-52 oC; 
Major isomer: 1H NMR (270 MHz) δ 8.08 (s, 1H), 5.75 (sept, J=6.1 Hz, 1H), 1.91 (s, 3H), 
1.38 (d, J=6.1 Hz, 6H); 13C NMR (67.5 MHz) δ 187.3,185.8,168.2,137.1,133.2, 92.1, 75.2, 
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23.2, 6.7; Minor isomer: 1H NMR (270 MHz) δ 8.01 (s, 1H), 5.67 (pent, J=6.1 Hz, 1H), 1.95 
(s, 3H), 1.35 (d, J=6.5 Hz, 6H); partial data 13C NMR (67.5 MHz) δ 91.4, 75.0, 23.1, 7.35; IR 
(ATR) 1734, 1680, 1618, 1326, 1106 cm-1; HRMS (ESI) calcd for C10H12IO3 (M+H+) 
306.9826; found 306.9822. 
 
 
96                               99 
2-(1-Bromomethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene-1,3-dione (99). 
Treatment of 96 (50 mg, 0.28 mmol) with NBS (51 mg, 0.28 mmol) in benzene (3 mL) as 
described for 71 (80 oC, 3 h) gave after chromatography (hexanes) 99 (42 mg, 0.16 mmol, 59% 
as a 2.8:1 ratio of double bond isomers) as a yellow oil. 1H NMR (270 MHz, major isomer) δ 
7.58 (s, 1H), 5.74 (sept, J=6.1 Hz, 1H), 1.93 (s, 3H),1.39 (d, J=6.1 Hz, 6H); 1H NMR (270 
MHz, minor isomer) δ 7.51 (s,1H), 5.66 (sept, J=6.2 Hz, 1H), 1.97 (s, 3H),1.36 (d, J=6.1 Hz, 
6H); 13C NMR (67.5 MHz) δ 187.2, 187.2, 183.9, 184.9, 184.7, 167.9, 164.5, 139.1, 134.3, 
132.4, 132.3, 119.3, 119.0, 75.3, 75.1, 23.2, 23.1, 7.3, 6.9; IR (ATR) 2986, 1689, 1636, 1393, 
1327, 1269, 1015, 764 cm-1; HRMS (ESI) calcd for C10H12BrO3 (M+H+) 258.9971; found 
258.9964. 
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89                                 101 
2-(Diiodomethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene-1,3-dione (101). 
Treatment of a 0 oC cold solution of 89 (549 mg, 3.05 mmol) in DMF (30 mL) under N2 with 
AgNO3 (48 mg, 0.28 mmol) and NIS (762 mg, 3.39 mmol) was added and the reaction was 
slowly warmed to room temperature overnight. The mixture was cooled to 0 oC and ice-water 
(20 mL) was added and the resulting mixture was allowed to warm to ambient temperature. 
The mixture was extracted with ether (6 x 50 mL). The combined organic layers were washed 
with water and brine, dried (MgSO4), filtered, and the solvent was removed under reduced 
pressure. The crude product was purified by chromatography (hexanes/EtOAc, 9:1) to afford 
101 (209 mg, 0.483 mmol, 28%) as a yellow solid. Mp 75-80 oC; 1H NMR (270 MHz) δ 5.65 
(sept, J=6.1 Hz, 1H), 1.90 (s, 3H),1.37 (d, J=6.1 Hz, 6H); 13C NMR (150 MHz) δ 187.6, 
184.3, 165.0, 134.6, 134.3, 75.4, 23.2, 22.7, 7.1; IR (ATR) 2988, 1687, 1622, 1558, 1390, 
1321, 1118, 1098, 900, 677 cm-1; HRMS (ESI) calcd for C10H11I2O3 (M+H+) 432.8798; found 
432.8791. 
 
 
102                               104 
Ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2-iodoethanoate (104). 
Treatment of 10212 (60 mg, 0.25 mmol) with NBS (63.2 mg, 0.281 mmol) in benzene (0.75 
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mL) as described for 71 (80 oC, 3 h), gave after chromatography (hexanes/EtOAc, 9:1) 104 
(65 mg, 0.18 mmol, 71%) as a yellow solid. Mp 103-107 oC; 1H NMR (270 MHz) δ 4.38 (q, 
J=7.1 Hz, 2H), 4.29 (s, 3H), 4.24 (s, 3H), 1.35 (t, J=7.1 Hz, 3H); 13C NMR (150 MHz) δ 
181.5, 180.3, 166.1, 153.8, 149.9, 131.7, 93.7, 62.9, 60.2, 60.2, 13.7; IR (ATR) 1726, 1675, 
1629, 1589, 1465, 1431, 1329, 1236, 1146, 1093, 1017, 953, 852, 787 cm-1; HRMS calcd for 
C11H12IO6 (M+H+) 366.9679; found: 366.9676. 
 
 
102                               105 
Ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2-bromoethanoate (105).  
Treatment of 102 (60 mg, 0.25 mmol) with NBS (50 mg, 0.28 mmol) in benzene (0.75 mL) 
as described for 71 (80 oC, 3 h), gave after chromatography (hexanes/EtOAc, 9:1) 105 (30 mg, 
0.095 mmol, 38%) as a yellow oil; 1H NMR (270 MHz) δ 4.40 (q, J=7.1 Hz, 2H), 4.30 (s, 
3H), 4.26 (s, 3H), 1.37 (t, J=7.1 Hz, 3H); 13C NMR (150 MHz) δ 181.5, 180.3, 166.1, 153.8, 
149.9, 131.7, 93.7, 62.9, 60.24, 60.17, 13.7; IR (ATR) 1734, 1686, 1642, 1594, 1467, 1339, 
1255, 1155, 1103, 1027 cm-1; HRMS calcd for C11H11BrNaO6 (M+Na+) 340.9637; found 
340.9634. 
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7                          137 
2,3-Dimethoxy-4-hydroxy-4-[(E)-4-phenyl-3-buten-1-yn-1-yl]-2-cyclobuten-1-one (137). 
Butyllithium (0.82 mL, 1.30 mmol, 1.60 M in hexane) was added drop wise to a -78 oC cold 
solution of E-4-phenyl-but-3-en-1-yne (175 mg, 1.37 mmol) in THF (8 mL). The reaction 
mixture was stirred (-78 oC, 2 h) followed by transfer via a cannula to a -78 oC cold solution 
of 3,4-dimethoxy-3-cyclobutene-1,2-dione (7) (189 mg, 1.33 mmol) in THF (20 mL). After 
stirring for 2 h (-78 oC), a saturated solution of NH4Cl (50 mL, aqueous) was added and the 
mixture was extracted with ether (3 x 70 mL). The combined organic layers were dried 
(MgSO4), filtered, and the solvents were removed under reduced pressure. The crude product 
was purified by chromatography (hexanes/EtOAc, 8:2) to give 137 (170 mg, 0.628 mmol, 
47%) as a yellow oil. 1H NMR (600 MHz) δ 7.36-7.27 (5H), 7.01 (d, J=16.2 Hz, 1H), 6.18 (d, 
J=16.2 Hz, 1H), 4.22 (s, 3H), 3.98 (s, 3H);27 13C NMR (150 MHz) δ 180.8, 164.8, 143.0, 
135.7, 135.5, 129.0, 128.7, 126.4, 106.5, 88.3, 84.9, 79.0, 60.2, 58.6; IR (ATR) 3365, 2958, 
2180, 1772, 1627, 1351, 1046, 957, 868, 746, 685 cm-1; HRMS (ESI) calcd for C16H15O4 
(M+H+) 271.0970, found: 271.0966. 
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137                                 138 
4,5-Dimethoxy-[(E)-2-(1-iodo-3-phenyl-2-propen-1-ylidene)]-4-cyclopentene-1,3-dione 
(138). Treatment of 137 (55 mg, 0.20 mmol) with NIS (50mg, 0.22mmol) in benzene 
(0.75mL) as described for 71 (80 oC, 3 h) gave after chromatography (hexanes/EtOAc, 9:1) 
138 (30 mg, 0.075 mmol, 37%) as a yellow oil. 1H NMR (600 MHz) δ 8.38 (d, J=14.4 Hz, 
1H), 7.65 (d, J=7.8 Hz, 2H), 7.41-7.36 (m, 4H), 4.29 (s, 3H), 4.26 (s, 3H); 13C NMR (150 
MHz) δ 184.1, 184.0, 151.3, 150.8, 148.4,135.5,130.2,129.0,128.7,126.8,126.4,115.4, 60.1, 
60.1; IR (ATR) 2929, 1674, 1632, 1468, 1332, 1093, 1041, 760, 695 cm-1; HRMS (ESI) calcd 
for C16H14IO4 (M+H+) 396.9937; found: 396.9934. 
 
 
137                                 139 
4,5-Dimethoxy-2-[(E)-3-phenyl-2-propen-1-ylidene]-4-cyclopente-1,3-dione (139).  
Treatment of 137 (55 mg, 0.20 mmol) in benzene (0.75 mL) as described for 69 (140 oC, 3 h) 
gave after chromatography (hexanes/EtOAc, 85:15) 139 (30 mg, 0.11 mmol, 54%) as a 
yellow solid. Mp 114-119 oC; 1H NMR (600 MHz) δ 8.11 (dd, J=15.6 and 11.4 Hz, 1H), 7.58 
(d, J=7.8 Hz, 2H), 7.39-7.35 (3H), 7.13 (d, J=12.0 Hz, 1H), 7.09 (d, J=15.6 Hz, 1H), 4.28 (s, 
3H), 4.27 (s, 3H); 13C NMR (150 MHz) δ 186.0, 185.8, 151.8, 150.3, 147.0, 136.1, 135.8, 
130.0, 128.9, 128.0, 124.5, 123.2, 59.9, 59.9; IR (ATR) 2962, 1669, 1632, 1608, 1468, 1435, 
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1322, 1102, 1060, 999, 788, 760 cm-1; HRMS (ESI) calcd for C16H15O4 (M+H+): 271.0970; 
Found: 271.0967. 
 
 
138                                 107 
4,5-Dimethoxy-[(E)-2-(1-methoxy-3-phenyl-2-propen-1-ylidene)]-4-cyclopentene-1,3-dione 
(methyl linderone). Treatment of 138 (28 mg, 0.072 mmol) with K2CO3 (10 mg, 0.073 mmol) 
in MeOH (5 mL) at 60oC for 3 days gave after solvent removal and chromatography 
(hexanes/EtOAc, 9:1) methyl linderone (19 mg, 0.064 mmol, 89%) as a yellow oil. 1H NMR 
and 13C NMR data were in complete accordance with literature values.15 
 
 
138                                 140 
4,5-Dimethoxy-2-[(E)-1-(N,N-dimethylamino)-3-phenyl-2-propen-1-ylidene]-4-cyclopente-
1,3-dione (140). Treatment of 138 (10 mg, 0.0263 mmol) with p-toluenesulfonic acid (0.2 mg, 
0.001 mmol) in a mixture of DMF (1.8 mL) and H2O (0.2 mL) at 100 oC. Water (5 mL) was 
added and the mixture was extracted with EtOAc (3 x 50 mL). The combined organic phases 
were dried (MgSO4) and filtered. The solvent was removed under reduced pressure. 
Purification by chromatography (hexanes/EtOAc, 85:15) gave 140 (8 mg, 0.025 mmol, 95%) 
as a yellow oil. 1H NMR (600 MHz) δ 7.52 (dd, J=7.8 and 1.8 Hz, 2H), 7.39-7.33 (m, 3H), 
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7.04 (d, J=16.2 Hz, 1H), 6.75 (d, J=16.2 Hz, 1H), 4.05 (s, 6H), 3.21 (s, 6H); 13C NMR (150 
MHz) δ 187.5, 160.5, 145.0, 142.6, 139.3, 135.2, 129.9, 128.8, 128.0, 120.9, 96.5, 59.8, 44.0; 
IR (ATR) 2929, 1646, 1543, 1482, 1407, 1313, 1004, 765 cm-1; HRMS (ESI) calcd for 
C18H19NNaO4 (M+Na+) 336.1212; found: 336.1210. 
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4.3 Supporting information Chapter 3: Wacker-type oxidation of aryl-substituted 
alkenes 
 
I
NO2 NO2  
                       230 
2-Nitro-1-(1-propen-1-yl)benzene (230).167 To a solution of Pd(dba)2 (870 mg, 1.51 mmol) 
and PPh3 (1.60 g, 6.08 mmol) in toluene (80 mL) under N2 atmosphere was added 
tributyl-1-propen-1-yltin168 (12.62 g, 38.12 mmol) and 1-iodo-2-nitrobenzene (7.55 g, 30.3 
mmol). The mixture was heated at reflux for 48 h. The solvent was removed under reduced 
pressure and Et2O (200 mL) was added. The solution was washed with NH4OH 
(10%-aqueous, 6 x 100 mL), H2O (3 x 100 mL), brine (100 mL). The organic phase was dried 
(MgSO4), filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by chromatography (hexanes/EtOAc, 99:1) to give 230 (3.02 g, 18.5 mmol, 49%) 
as a pale yellow oil. 
 
 
231 
3-Nitro-1-(1-propen-1-yl)benzene (231).169 Treatment of 1-bromo-3-nitrobenzene (716 mg, 
3.55 mmol) with tributyl-1-propen-1-yltin (1.40 g, 4.22 mmol) a solution of Pd(dba)2 (105 mg, 
0.183 mmol) and PPh3 (183mg, 0.699 mmol) in toluene (50 mL), as described for 1, gave 
after work up and chromatography (hexanes/EtOAc, 98:2) 231 (339 mg, 2.08 mmol, 49%) as 
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a pale yellow oil. 
 
 
                           232 
4-Nitro-1-(1-propen-1-yl)benzene (232).170 Treatment of 1-bromo-4-nitrobenzene (713 mg, 
3.53 mmol) with tributyl 1-propen-1-yltin (1.40 g, 4.23 mmol) a solution of Pd(dba)2 (107 mg, 
0.186 mmol) and PPh3 (183mg, 0.698 mmol) in toluene (50 mL), as described for 230, gave 
after work up and chromatography (hexanes/EtOAc, 99:1) 232 (396 mg, 2.43 mmol, 57%) as 
a pale yellow oil. 
 
 
233 
4-Fluoro-2-nitro-1-(1-propen-1-yl)benzene (233).Treatment of 4-fluoro-2-nitro-iodobenzene 
(967 mg, 3.62 mmol) with tributyl 1-propen-1-yltin (1.45 g, 4.38 mmol) a solution of 
Pd(dba)2 (106 mg, 0.185 mmol) and PPh3 (194 mg, 0.740 mmol) in toluene (50 mL), as 
described for 230, gave after work up and chromatography (hexanes/EtOAc, 98:2) 233 (579 
mg, 3.20 mmol, 73%) as a pale yellow oil. Spectral data from a 1.9:1 mixture of E/Z-233. 
E-233: 1H NMR (600 MHz) δ 7.61 (dd, J=8.4, 2.4 Hz, 1H), 7.57 (dd, J=8.4, 5.4 Hz, 1H), 
7.26 (dt, J=8.4, 2.4 Hz, 1H), 6.81 (d, J=15.6 Hz, 1H), 6.19 (dq, J=15.6, 7.2 Hz, 1H), 1.93 (dd, 
J=7.2, 1.8 Hz, 3H); 13C NMR δ (150 MHz) 160.7 (d, JCF=248.7 Hz), 147.4, 131.6, 130.0 (d, 
JCF=8.1 Hz), 129.7 (d, JCF=3.8 Hz), 125.2, 120.4 (d, JCF=21.3 Hz), 111.6 (d, JCF=26.1 Hz), 
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18.7. Z-233: 1H NMR δ (600 MHz) 7.74 (dd, J=8.4, 2.4 Hz, 1H), 7.37 (dd, J=8.4, 5.4 Hz, 1H), 
7.31 (dt, J=8.4, 2.4 Hz, 1H), 6.66 (d, J=11.4 Hz, 1H), 5.94 (dq, J=11.4, 7.2 Hz, 1H), 1.71 (dd, 
J=7.2, 1.8 Hz, 3H); 13C NMR (150 MHz) δ 160.7 (d, JCF=249.3 Hz), 148.7, 133.4 (d, JCF=7.5 
Hz), 129.2, 128.7 (d, JCF=4.4 Hz), 125.1, 120.0 (d, JCF=20.7 Hz), 112.0 (d, JCF=26.1 Hz), 
14.2. IR (ATR) 2918, 1527, 1490, 1343, 1240, 1131, 944, 874, 816, 789, 753, 676 cm-1; 
HRMS (ESI) calcd for C9H9FNO2 (M+H+) 182.0617; found 182.0612. 
 
 
234 
2,4-Dinitro-1-(1-propen-1-yl)benzene (234). Treatment of 1-bromo-2,4-dinitronitrobenzene 
(865 mg, 3.50 mmol) with tributyl 1-propen-1-yltin (1.40 g, 4.24 mmol) a solution of 
Pd(dba)2 (101 mg, 0.175mmol) and PPh3 (186 mg, 0.711mmol) in toluene (50 mL), as 
described for 230, gave after work up and chromatography (hexanes/EtOAc, 9:1) 234 (453 
mg, 2.18 mmol, 51%) as a pale orange-brown oil. Spectral data from a 1:1.8 mixture of 
E/Z-234. E-234: 1H NMR (600 MHz) δ 8.74 (d, J=2.4 Hz, 1H), 8.36 (dd, J=9.0, 2.4 Hz, 1H), 
7.79 (d, J=9.0 Hz, 1H), 6.91 (dd, J=15.6, 1.8 Hz, 1H), 6.51 (dq, J=15.6, 6.6 Hz, 1H), 2.02 (dd, 
J=6.6, 1.8Hz, 3H). Z-234: 1H NMR (600 MHz) δ 8.86 (d, J=2.4Hz, 1H), 8.42 (dd, J=8.4, 2.4 
Hz, 1H), 7.62 (d, J=8.4 Hz, 1H), 6.76 (dd, J=12.0, 1.8 Hz, 1H), 6.13 (dq, J=12.0, 7.2Hz, 1H), 
1.79 (dd, J=7.2, 1.8Hz, 6H). IR (ATR) 2918, 1596, 1522, 1446, 1340, 959, 915, 834, 767, 
736, 716, 698 cm-1; HRMS (ESI) calcd for C9H9N2O4 (M+H+) 209.0562; found 209.0557. 
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                            235 
4-Carbomethoxy-2-nitro-1-(1-propen-1-yl)benzene (235). 1-Bromo-4-carbomethoxy-2- 
nitrobenzene (865 mg, 3.50 mmol) was treated with Pd(dba)2 (84mg, 0.15 mmol), PPh3 (154 
mg, 0.587mmol), and tributyl 1-propen-1-yltin (1.17 g, 3.52mmol) in toluene (50 mL) as 
described for 230. Work up and purification by chromatography (hexanes/EtOAc, 95:5) gave 
235 (364 mg, 1.64 mmol, 56%) as a pale yellow oil. Spectral data from a 1:1.2 mixture of 
E/Z-235. E-235: 1H NMR (270 MHz) δ 8.50 (d, J=1.6 Hz, 1H), 8.15 (dd, J=7.9, 1.6 Hz, 1H), 
7.66 (d, J=8.3 Hz, 1H), 6.87 (dd, J=15.4, 1.8 Hz, 1H), 6.41 (dq, J=15.4, 6.7 Hz, 1H), 3.95 (s, 
3H), 1.98 (dd, J=6.7, 1.8 Hz, 3H). Z-235: 1H NMR (270 MHz) δ 8.63 (d, J=1.6 Hz, 1H), 
8.21(dd, J=8.1, 1.6 Hz, 1H), 7.48 (d, J=8.1 Hz, 1H), 6.73 (dd, J=11.5, 1.8 Hz, 1H), 6.03 (dq, 
J=11.5, 7.1 Hz, 1H), 3.97 (s, 3H), 1.76 (dd, J=7.1, 1.8Hz, 3H). HRMS (ESI) calcd for 
C11H12NO4 (M+H+) 222.0766; found 222.0761. 
 
I
MeOMeO NO2 NO2  
                            236 
4-Methoxy-2-nitro-1-(1-propen-1-yl)benzene (236). 4-Methoxy-2-nitro-1-iodobenzene (884 
mg, 3.17 mmol) was treated with Pd(dba)2 (91 mg, 0.16 mmol), PPh3 (166 mg, 0.634 mmol), 
and tributyl 1-propen-1-yltin (1.27 g, 3.80 mmol) in toluene (50 mL) as described for 230.  
Work up and purification by chromatography (hexanes/EtOAc, 95:5) gave 236 (195 mg, 
1.01mmol, 32%) as a pale yellow oil. Spectral data from a 1.7:1 mixture of E/Z-236. E-236: 
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1H NMR (270 MHz) δ 7.48 (d, J=8.7 Hz, 1H), 7.38 (d, J=2.6 Hz, 1H), 7.08 (dd, J=8.1, 2.8 
Hz, 1H), 6.78 (dd, J=15.7, 1.8 Hz, 1H), 6.13 (dq, J=15.4, 6.5 Hz, 1H), 3.85 (s, 3H), 1.91 (dd, 
J=6.5, 1.8 Hz, 3H); 13C NMR (67.5 MHz) δ 158.5, 147.9, 129,7, 129.3, 126.0, 125.7, 120.0, 
108.4, 55.8, 18.7. Z-236: 1H NMR (270 MHz) δ 7.52 (d, J=2.6 Hz, 1H), 7.28 (d, J=8.7 Hz, 
1H), 7.12 (overlapping E-isomer, 1H), 6.64 (dd, J=11.3, 1.8 Hz, 1H), 5.88 (dq, J=11.5, 7.1 Hz, 
1H), 3.88 (s, 3H), 1.71 (dd, J=7.1, 1.8 Hz, 3H); 13C NMR (67.5 MHz) δ 158.6, 148.8, 132.7, 
128.1, 125.7, 125.0, 119.4, 108.9, 55.8, 14.3. IR (ATR) 2915, 2841, 1619, 1522, 1346, 1286, 
1253, 1033, 961, 839, 814, 784, 679 cm-1; HRMS (ESI) calcd for C10H12NO3 (M+H+) 
194.0817; found 194.0812. 
 
  
                            237 
5-Methoxy-2-nitro-1-(1-propen-1-yl)-benzene (237). 5-Methoxy-2-nitro-1-iodobenzene (283 
mg, 1.01 mmol) was treated with Pd(dba)2 (29.8 mg, 0.052 mmol), PPh3 (57.6 mg, 0.22 
mmol), and tributyl 1-propen-1-yltin (411 mg, 1.24 mmol) in toluene (50 mL) as described 
for 230.  Work up and purification by chromatography (hexanes/EtOAc, 8:2) affording 237 
(89.7 mg, 0.464 mmol, 37%) as a pale yellow oil. Spectral data from a 1.8:1 mixture of 
E/Z-237. E-237: 1H NMR (600 MHz) δ 7.99 (d, J=9.6 Hz, 1H), 6.99 (dd, J=15.6, 1.2 Hz, 1H), 
6.96 (d, J=2.4 Hz, 1H), 6.19 (dq, J=15.6, 6.6 Hz, 1H), 3.89 (s, 3H), 1.94 (dd, J=6.6, 1.2Hz, 
3H). Z-237: 1H NMR (600 MHz) δ 8.11 (d, J=9.6 Hz, 1H), 6.86 (dd, J=9.0, 2.4 Hz, 1H), 6.77 
(dd, J=12, 1.8 Hz, 1H), 5.91 (dq, J=12, 7.2 Hz, 1H), 3.89 (s, 3H), 1.74 (dd, J=7.2, 1.8 Hz, 
3H). 6.82-6.80 (m, 2H) could not be assigned to the specific proton for the two isomers. IR 
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(ATR) 2917, 2845, 1620, 1524, 1351, 1285, 1255, 1034, 962, 837, 813, 783, 678 cm-1; 
HRMS (ESI) calcd for C10H11NNaO3 (M+H+) 216.0631; found 216.0630.  
 
 
                        243 
2-Bromo-1-(1-propen-1-yl)-benzene (243).171 2-Bromo-1-iodobenzene (1.02g, 3.10 mmol) 
was treated with Pd(dba)2 (72.2 mg, 0.126 mmol), PPh3 (132 mg, 0.504 mmol), and tributyl 
1-propen-1-yltin (728 mg, 2.57 mmol) in toluene (50 mL) as described for 230. Work up and 
purification by chromatography (hexanes/EtOAc, 8:2) gave 243 (203 mg, 1.03 mmol, 40%) 
as a pale yellow oil. 
 
 
230                      245          246           247         248 
Typical oxidation procedure using Condition A: 1-(2-Nitrophenyl)-2-propanone (245),172 
1-(1,1-dimethoxymethyl)-2-nitrobenzene (246),173 2-nitrobenzaldehyde (247),174 and 
1-(2-nitrophenyl)-1,2-propandione (248).175 To a suspension of PdCl2 (15.5 mg, 0.087mmol) 
and CuCl (69 mg, 0.70 mmol) in a solution of MeOH (1 mL) and H2O (200 μL) was added 
230 (100 mg, 0.614mmol) dissolved in MeOH (1 mL). The reaction flask was attached to a 
balloon filled with oxygen and the mixture was stirred at 50 oC for 20 h. The resulting 
mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvents were removed under reduced 
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pressure. The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give in 
order of elution 246 (4.9 mg, 0.025 mmol, 4%), an inseparable mixture of 247 and 248 (1:1 
ratio, 13.9 mg; 6.10 mg, 0.0404 mmol, 6.4% 247; 7.80 mg, 0.0404 mol, 6.4% 248) and 245 
(79.9 mg, 0.45 mmol, 73%) all as a pale yellow oils.  
 
 
230                        245            247 
Typical oxidation procedure using Condition B: 1-(2-Nitrophenyl)-2-propanone (245) 
and 2-nitrobenzaldehyde (247). To a suspension of PdCl2 (10.2 mg, 0.058) in H2O2 
(50%-aqueous, 300 μL, 6.40 mmol) was added 230 (99.2 mg, 0.608 mmol). After 48 h at 50 
oC, the resulting mixture worked up and purified as described using Conditions A to give after 
chromatography (hexanes/EtOAc, 8:2) in order of elution 247 (7.4 mg, 0.049mmol, 8%) and 
245 (20.1 mg, 0.11 mmol, 18%) both as pale yellow oils. 
 
 
230                        245            246           247 
Typical oxidation procedure using Condition C: 1-(2-Nitrophenyl)-2-propanone (245), 
1-(1,1-dimethoxymethyl)-2-nitrobenzene (246), and 2-nitrobenzaldehyde (247). To a 
suspension of PdCl2 (14.2 mg, 0.080 mmol) and 2,6-di-tert-butyl-p-cresol (15.0 mg, 0.068 
mmol) in a solution of MeOH (1 mL), H2O (200 μL) and H2O2 (50%-aqueous, 300 μL, 6.40 
mmol) was added to 230 (106 mg, 0.648 mmol) dissolved in MeOH (1 mL). The reaction 
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mixture was stirred at 50 oC for 48 h. The resulting mixture worked up and purified as 
described using Conditions A to give in order of elution after chromatography 
(hexanes/EtOAc, 8:2) 246 (2.3 mg, 0.012 mmol, 2%), 247 (20.8 mg, 0.138 mmol, 21%), and 
245 (83.4 mg, 0.466 mmol, 72%) all as pale yellow oils.  
 
 
230                        245 
Typical oxidation procedure using Condition D: 1-(2-Nitrophenyl)-2-propanone (245). To 
a suspension of PdCl2 (5.8 mg, 0.033 mmol) and 2,6-di-tert-butyl-p-cresol (6.3 mg, 0.029 
mmol) in a solution of MeOH (500 μL), H2O (100 μL) and t-butyl hydrogenperoxide (TBHP, 
90%-aqueous, 267 μL, 2.49 mmol) was added 230 (31.0 mg, 0.190 mmol) dissolved in 
MeOH (500 μL). The reaction mixture was stirred at 50 oC for 48 h. The mixture was diluted 
with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic phases 
were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. The 
crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 245 (31.3 mg, 
0.175 mmol, 92%) as a pale yellow oil. 
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231                       249            250          251 
1-(1,1-Dimethoxymethyl)-3-nitrobenzene (249),176 3-nitrobenzaldehyde (250),177 and 
1-(3-nitrophenyl)-1,2-propandione (251).178 A solution of 231 (116 mg, 0.709 mmol) in 
MeOH (1 mL) was added to a suspension of PdCl2 (12.5 mg, 0.0705mmol) and CuCl (69.0 
mg, 0.70 mmol) in a solution of MeOH (1 mL) and H2O (200 μL) under an atmosphere of 
oxygen, as described for 230 in Condition A (50 oC, 20 h). Extraction and purification by 
chromatography (hexanes/EtOAc, 8:2) gave in order of elution 249 (41.4 mg, 0.210 mmol, 
30%) as a colorless oil and an inseparable mixture of 250 and 251 (1:1 ratio, 17.2 mg; 7.55 
mg, 0.050 mmol, 7% 250; 9.66 mg, 0.050 mmol, 7% 251) as a yellow solid. Analytical data 
for 251: 1H NMR (600 MHz) δ 8.89 (t, J=2.4 Hz, 1H), 8.48 (dt, J=7.2, 2.4 Hz, 1H), 8.40 (td, 
J=8.4, 1.8 Hz, 1H), 7.71 (t, J=8.4 Hz, 1H), 2.58 (s, 3H); 13C NMR (150 MHz) 198.5, 187.7, 
148.4, 135.7, 133.3, 130.0, 128.4, 125.3, 26.0; IR (ATR) 1704, 1615, 1533, 1352, 1170, 1093, 
818, 711, 677 cm-1. 
 
  
231                        252 
1-(3-Nitrophenyl)-2-propanone (252).179 To a suspension of PdCl2 (5.6 mg, 0.032 mmol) and 
2,6-di-tert-butyl-p-cresol (6.1 mg, 0.028 mmol) in a solution of MeOH (500 μL), H2O (100 
μL) and TBHP (90%-aqueous, 267 μL, 2.49 mmol) was added 231 (40.6 mg, 0.249mmol) 
116 
 
dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 48 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 252 (15.3 
mg, 0.140 mmol, 34%) as a pale yellow oil. 
 
 
232                         253              254             255 
1-(1,1-Dimethoxymethyl)-4-nitrobenzene (253),180 4-nitrobenzaldehyde (254),177 and 
1-(4-nitrophenyl)-1,2-propandione (255).181 A solution of 232182 (57.0 mg, 0.349 mmol) in 
MeOH (500 μL) was added to a suspension of PdCl2 (6.3 mg, 0.036 mmol) and CuCl (35.2 
mg, 0.36 mmol) in a solution of MeOH (500 μL) and H2O (100 μL) under an atmosphere O2, 
as described for 230 in Condition A (50 oC, 20 h). Extraction and purification by 
chromatography (hexanes/EtOAc, 95:5) gave in order of elution, 253 (21.8 mg, 0.11 mmol, 
32%) as a colorless oil and an inseparable mixture of 254 and 255 (1:1 ratio, 11.7 mg; 5.1 mg, 
0.034 mmol, 10% 254; 6.6 mg, 0.034 mmol, 10% 255) as a yellow solid. 
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232                         253              254             255 
1-(1,1-Dimethoxymethyl)-4-nitrobenzene (253), 4-nitrobenzaldehyde (254), and 
1-(4-nitrophenyl)-1,2-propandione (255). To a suspension of PdCl2 (7.5 mg, 0.042 mmol) 
and 2,6-di-tert-butyl-p-cresol (7.9 mg, 0.036 mmol) in a solution of MeOH (500 μL), H2O 
(100 μL) and H2O2 (50%-aqueous,150 μL, 3.20 mmol) was added 232 (56.6 mg, 0.347mmol) 
dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 48 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give in order of 
elution 253 (23.0 mg, 0.117mmol, 34%) as a colorless oil and an inseparable mixture of 254 
and 255 (1:1 ratio, 8.7 mg; 3.8 mg, 0.025 mmol, 7% 254; 4.9 mg, 0.025 mmol, 7% 255 ) as a 
yellow solid. 
 
 
232                          256               253 
1-(1,1-Dimethoxymethyl)-4-nitrobenzene (253) and 1-(4-nitrophenyl)-2-propanone 
(256).183 To a suspension of PdCl2 (6.6 mg, 0.037mmol) and 2,6-di-tert-butyl-p-cresol (6.1 
mg, 0.028 mmol) in a solution of MeOH (500 μL), H2O (100 μL) and TBHP (90%-aqueous, 
267 mL, 2.49 mmol) was added 232 (40.6 mg, 0.249mmol) dissolved in MeOH (500 μL). 
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The reaction mixture was stirred at 50 oC for 72 h. The mixture was diluted with H2O (50 mL) 
and extracted with EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 95:5) to give in order of elution 253 (0.9 mg, 
0.0046 mmol, 2%) as a colorless oiland 256 (24.7 mg, 0.138 mmol, 55%) as a pale yellow 
oil. 
 
 
233                    257           258           259         260 
1-(4-Fluoro-2-nitrophenyl)-2-propanone (257), 4-fluoro-1-(1,1-dimethoxymethyl)- 
2-nitrobenzene (258), 4-fluoro-2-nitrobenzaldehyde(259), and 1-(4-fluoro-2- 
nitrophenyl)-1,2-propanedione (260). A solution of 233 (65.2 mg, 0.36 mmol) in MeOH 
(500 μL) was added to a suspension of PdCl2 (6.5 mg, 0.037 mmol) and CuCl (34.8 mg, 
0.352 mmol) in a solution of MeOH (500 μL) and H2O (100 μL) under an atmosphere of 
oxygen, as described for 230 in Condition A (50 oC, 20 h). Extraction and purification by 
chromatography (hexanes/EtOAc, 9:1) gave in order of elution, 258 (2.2 mg, 0.010mmol, 3%) 
as a colorless oil, an inseparable mixture of 259 and 260 (1:1 ratio, 6.8 mg; 3.0 mg, 0.018 
mmol, 5% 259; 3.8 mg, 0.018 mmol, 5% 260) as a pale yellow oil, and 257 (39.2 mg, 0.199 
mmol, 55%) as a pale yellow oil. Spectral data for 257: 1H NMR (600 MHz) δ 7.86 (dd, 
J=8.4, 2.4 Hz, 1H), 7.32 (dt, J=9.0, 3.0 Hz, 1H), 7.57 (dd, J=9, 5.4 Hz, 1H), 4.10 (s, 2H), 
2.33 (s, 3H); 13C NMR (150 MHz) δ 203.2, 162.2, 160.5, 134.8 (d, JCF=8.0 Hz), 126.3 (d, 
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JCF=4.7 Hz), 120.8 (d, JCF=20.6 Hz), 112.9 (d, JCF=26.3 Hz), 47.9, 29.9. IR (ATR) 1720, 
1532, 1499, 1360, 1237, 1163, 944, 878, 807 cm-1. Spectral data for 258: 1H NMR (600 MHz) 
δ 7.80 (dd, J=9.0, 5.4 Hz, 1H), 7.56 (dd, J=8.4, 2.4 Hz, 1H), 7.31 (td, J=7.8, 2.4 Hz, 1H), 
5.88 (s, 1H), 3.40 (s, 6H); 13C NMR (150 MHz) δ 161.9 (d, JC,F=251.3 Hz), 149.4, 130.1 (d, 
JC,F=8.1 Hz), 129.0, 119.5 (d, JC,F=20.6 Hz), 112.1 (d, JC,F=26.4 Hz), 99.6, 54.6; IR (ATR) 
2961, 1736, 1540, 1364, 1262, 1233, 1105, 1058, 877, 806 cm-1; HRMS (ESI) calcd for 
C9H11FO4 (M+H+) 216.0672; found 216.0667. Spectral data for diketone 260 from the 
mixture with 259 (1.26:1 ratio): 1H NMR (600 MHz) δ 7.88 (dd, J=7.8, 1.8 Hz, 1H), 7.63 (dd, 
J=8.4, 5.4 Hz, 1H), 7.53-7.48 (m, 1H), 2.56 (s, 3H); Spectral data for mixture of 259 and 260: 
13C NMR (150 MHz) δ 195.9, 188.5, 186.5, 165.6, 164.7, 163.9, 163.0, 132.3, 132.2, 132.2, 
132.2, 128.2, 128.2, 127.5, 127.5, 122.1, 122.0, 121.4, 121.2, 112.6, 112.4, 112.0, 111.8, 24.2; 
IR (ATR) 3099, 1701, 1610, 1535, 1347, 1219, 1231, 1167, 882, 826, 809 cm-1. 259: HRMS 
(ESI) calcd for C7H4FNNaO3 (M+H+) 192.0073; found 192.0069. 260: HRMS (ESI) calcd for 
C9H7FNO4 (M+H+) 212.0359; found 212.0354.  
 
 
233                        257             258 
1-(4-Fluoro-2-nitrophenyl)-2-propanone (257) and 4-fluoro-1-(1,1-dimethoxymethyl)-2- 
nitrobenzene (258). Compound 233 (47.6 mg, 0.263 mmol) dissolved in MeOH (500 μL) 
was added to a suspension of PdCl2 (7.8 mg, 0.044 mmol), 2,6-di-tert-butyl-p-cresol (7.8 mg, 
0.035 mmol), and H2O2 (50%-aqueous, 150 μL, 3.20 mmol) in MeOH (500 μL) and H2O 
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(100 μL). After 48 h at 50 oC, the mixture was worked up and purified as described in 
Condition C to give after chromatography (hexanes/EtOAc, 9:1), in order of elution, 258 (9.4 
mg, 0.044 mmol, 17%) and 257 (18.3 mg, 0.093 mmol, 35%) both as a yellow oils. 
 
 
233                        257 
1-(4-Fluoro-2-nitrophenyl)-2-propanone (257). Compound 233 (45.8 mg, 0.253 mmol) 
dissolved in MeOH (500 μL) was added to a suspension of PdCl2 (5.8 mg, 0.033 mmol), 
2,6-di-tert-butyl-p-cresol (5.7 mg, 0.026 mmol) and TBHP (90%-aqueous, 267 μL, 2.49 
mmol) in a solution of MeOH (500 μL) and H2O (100 μL).  After 48 h at 50 oC, the mixture 
was worked up and purified as described in Conditions D to give after chromatography 
(hexanes/EtOAc, 9:1) 257 (26.7 mg, 0.135mmol, 54%) as a pale yellow oil. 
 
 
234                        261              262              263 
Methyl 2,4-dinitrobenozate (261),184 2,4-dinitrobenzaldehyde (262),1861-(2,4-dinitrophenyl)- 
1,2-propanedione (263). A solution of 234 (68.7 mg, 0.330 mmol) in MeOH (500 μL) was 
added to a suspension of PdCl2 (7.0 mg, 0.039mmol) and CuCl (35.4mg, 0.358mmol) in a 
solution of MeOH (500 μL) and H2O (100 μL) under an atmosphere of oxygen, as described 
for 230 in Condition A (50 oC, 20 h). Extraction and purification by chromatography 
(hexanes/EtOAc, 95:5) gave in order of elution 263 (23.5 mg, 0.096mmol, 29%), 261 (9.6 mg, 
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0.042mmol, 13%), and 262 (25.3 mg, 0.129 mmol, 39%) all as pale yellow oils. Spectral data 
for 263: 1H NMR (600 MHz) δ 9.02 (dd, J=2.4, 1H), 8.65 (dd, J=8.4, 2.4 Hz, 1H), 7.79 (dd, 
J=8.4 Hz, 1H), 2.60 (s, 1H); 13C NMR (150 MHz) δ 195.3, 187.4, 149.5, 147.6, 137.9, 131.4,  
129.1, 119.4, 24.0; IR (ATR) 1717, 1601, 1536, 1345, 1170, 903, 835, 736, 721 cm-1. 
 
 
234                          264 
1-(2,4-Dinitrophenyl)-2-propanone (264).185 To a suspension of PdCl2 (7.8 mg, 0.044 mmol) 
and 2,6-di-tert-butyl-p-cresol (7.5 mg, 0.034 mmol) in a solution of MeOH (500 μL), H2O 
(100 μL) and H2O2 (50%-aqueous, 150 μL, 3.20 mmol) was added 234 (40.9 mg, 0.196mmol) 
dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 48 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 95:5) to give 264 (13.5 
mg, 0.060 mmol, 31%) as a yellow oil. 
 
 
235                       265              266              267 
1-(4-Carbomethoxy-2-nitrophenyl)-2-propanone (265),186  4-carbomethoxy-2- 
nitrobenzaldehyde (266),187 and 1-(4-carbomethoxy-2-nitrophenyl)-1,2-propanedione (267). 
A solution of 235 (68.2 mg, 0.308 mmol) in MeOH (500 μL) was added to a suspension of 
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PdCl2 (6.5 mg, 0.037 mmol) and CuCl (30.3mg, 0.306 mmol) in a solution of MeOH (500 μL) 
and H2O (100 μL) under an atmosphere of oxygen, as described 230 in Condition A (50 oC, 
20 h). Extraction and purification by chromatography (hexanes/EtOAc, 95:5) gave in order of 
elutionan inseparable mixture of 266 and 267 (1.1:1 ratio, 26.9 mg; 12.9 mg, 0.0615 mmol, 
20 % 266; 14.0  mg, 0.0559 mmol, 18% 267) and 265 (21.5mg, 0.0906 mmol, 29%) both as 
pale yellow oils. 
 
 
235                        265              266              267 
1-(4-Carbomethoxy-2-nitrophenyl)-2-propanone (265), 4-carbomethoxy-2- 
nitrobenzaldehyde (266), and 1-(4-carbomethoxy-2-nitrophenyl)-1,2-propanedione (267). 
To a suspension of PdCl2 (5.0 mg, 0.028 mmol) and 2,6-di-tert-butyl-p-cresol (5.8 mg, 0.026 
mmol) in a solution of MeOH (500 μL), H2O (100 μL) and H2O2 (50%-aqueous, 150 μL, 3.20 
mmol) was added 235 (55.5 mg, 0.251 mmol) dissolved in MeOH (500 μL). The reaction 
mixture was stirred at 50 oC for 48 h. The mixture was diluted with H2O (50 mL) and 
extracted with EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 95:5) to give in order of elutionan inseparable 
mixture of 266 and 267 (1.1:1 ratio, 5.2 mg; 2.7 mg, 0.012 mmol, 5% 266; 2.7 mg, 0.011 
mmol, 4% 267) and 265 (22.3mg, 0.094mmol, 37%) all as pale yellow oils. 
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235                        265              266              267 
1-(4-Carbomethoxy-2-nitrophenyl)-2-propanone (265), 4-carbomethoxy-2- 
nitrobenzaldehyde (266) and 1-(4-carbomethoxy-2-nitrophenyl)-1,2-propanedione (267). 
To a suspension of PdCl2 (5.8 mg, 0.033 mmol) and 2,6-di-tert-butyl-p-cresol (5.5 mg, 0.025 
mmol) in a solution of MeOH (500 μL), H2O (100 μL) and TBHP (90%-aqueous, 267 μL, 
2.49 mmol) was added 235 (55.3 mg, 0.250mmol) dissolved in MeOH (500 μL). The reaction 
mixture was stirred at 50 oC for 48 h. The mixture was diluted with H2O (50 mL) and 
extracted with EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 9:1) to give in order of elutionan inseparable 
mixture of 266 and 267 (1.3:1 ratio, 3.4 mg; 1.8 mg, 0.0084 mmol, 4% 266; 1.63 mg, 0.0065 
mmol, 3% 267) and 265 (12.5 mg, 0.0527 mmol, 21%) as pale yellow oils. Partial spectral 
data of 267 from the mixture:1H NMR (600 MHz) δ 8.81 (d, J=1.6 Hz, 1H), ~8.4 
(overlapping with 266), 6.96 (d, J=3.0 Hz, 1H), 4.01 (s, 3H), 2.58 (s, 3H).  
 
 
236                             268 
1-(4-Methoxy-2-nitrophenyl)-2-propanone (268).188 A solution of 236 (41.1 mg, 0.213mmol) 
in MeOH (500 μL) was added to a suspension of PdCl2 (4.1 mg, 0.023 mmol) and CuCl (22.6 
mg, 0.2283mmol) in a solution of MeOH (500 μL) and H2O (100 μL) under O2, as described 
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for 230 in Condition A (50 oC, 20h). Extraction and purification by chromatography 
(hexanes/EtOAc, 95:5) gave 268 (23.7 mg, 0.113 mmol, 53%) as a pale yellow oil. 
 
 
236                             268 
1-(4-Methoxy-2-nitrophenyl)-2-propanone (268). To a suspension of PdCl2 (5.6 mg, 0.032 
mmol) and 2,6-di-tert-butyl-p-cresol (5.5 mg, 0.025 mmol) in a solution of MeOH (500 μL), 
H2O (100 μL) and TBHP (90%-aqueous, 267 μL, 2.49 mmol) was added 236 (40.3 mg, 0.209 
mmol) dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 48 h. The 
mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvents were removed under reduced 
pressure. The crude product was purified by chromatography (hexanes/EtOAc, 9:1) to give 
268 (23.8 mg, 0.114 mmol, 55%) as a pale yellow oil. 
 
 
237                          269             270             271 
1-(5-Methoxy-2-nitrophenyl)-2-propanone (269), 5-methoxy-2-nitro-benzaldehyde (270),189 
and 1-(5-methoxy-2-nitrophenyl)-1,2-propanedione (271). A solution of 237 (65.0 mg, 
0.336 mmol) in MeOH (500 μL) was added to a suspension of PdCl2 (6.2 mg, 0.035 mmol) 
and CuCl (34.9 mg, 0.352 mmol) in a solution of MeOH (500 μL) and H2O (100 μL) under 
O2, as described for 230 in Condition A (50 oC, 20 h). Extraction and purification by 
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chromatography (hexanes/EtOAc, 95:5) gave in order of elutionan inseparable mixture of 270 
and 271 (1.3:1 ratio, 11.5 mg; 5.9 mg, 0.033 mmol, 10% 270; 5.6 mg, 0.0251 mmol, 7% 271) 
and 269 (28.7 mg, 0.137 mmol, 41%) both as pale yellow oils. Spectral data for 269: 1H 
NMR (600 MHz) δ 8.19 (d, J=9.0 Hz, 1H), 6.89 (dd, J=9.6, 3.0 Hz, 1H), 6.44 (d, J=2.4 Hz, 
1H), 4.09 (s, 2H), 3.88 (s, 3H), 2.33 (s, 3H); 13C NMR (150 MHz) δ 203.7, 163.4, 141.4, 
133.5, 128.1, 118.7, 112.9, 55.9, 49.2, 30.0; IR (ATR) 1721, 1581, 1509, 1335, 1292, 1261, 
1162, 1085, 843 cm-1. Spectral data for 271 from the mixture of 270/271: 1H NMR (600 MHz) 
δ 8.17 (d, J=9.0 Hz, 1H), 7.10 (dd, J=9.0, 3.0 Hz, 1H), 6.96 (d, J=3.0 Hz, 1H), 3.94 (s, 3H), 
2.57 (s, 3H); 13C NMR (100 MHz) δ196.0, 189.6, 164.7, 135.6, 126.6, 116.7, 114.6, 56.4, 
24.2; IR (ATR) 2945, 1706, 1582, 1513, 1485, 1333, 1290, 1239, 1190, 1026, 933, 849, 743 
cm-1; HRMS (ESI) calcd for C10H9NNaO5(M+Na+) 246.0378; found 246.0374.  
 
 
237                          269             270             271 
1-(5-Methoxy-2-nitrophenyl)-2-propanone (269), 5-methoxy-2-nitro-benzaldehyde (270), 
and 1-(5-methoxy-2-nitrophenyl)-1,2-propanedione (271). To a suspension of PdCl2 (5.7 
mg, 0.032 mmol) and 2,6-di-tert-butyl-p-cresol (5.6 mg, 0.025 mmol) in a solution of MeOH 
(500 μL), H2O (100 μL) and H2O2 (50%-aqueous, 150 μL, 3.20mmol) was added 237 (20.1 
mg, 0.104 mmol) dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 
48 h. The mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The 
combined organic phases were dried (MgSO4), filtered, and the solvents were removed under 
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reduced pressure. The crude product was purified by chromatography (hexanes/EtOAc, 95:5) 
to give in order of elutionan inseparable mixture of 270 and 271 (1:1 ratio, 5.0 mg；2.3 mg, 
0.012 mmol, 12% 270; 2.8 mg, 0.012 mmol, 12% 271) and 269 (7.8 mg, 0.037 mmol, 36%) 
both as pale yellow oils. 
 
 
238                             272                273     
1-(2,4,5-Trimethoxyphenyl)-2-propanone (272)190 and 1-(2,4,5-trimethoxyphenyl)-1- 
propanone (273).191 To a suspension of PdCl2 (24.2 mg, 0.136 mmol) and CuCl (140 mg, 
1.41 mmol) in a solution of MeOH (2 mL) and H2O (400 μL) was added 238 (292mg, 1.40 
mmol) dissolved in MeOH (2 mL). The reaction flask was attached to a balloon filled with 
oxygen and the mixture was stirred at 50 oC for 20 h. The mixture was diluted with H2O (50 
mL) and extracted with EtOAc (4 x 50 mL). The combined organic phases were dried 
(MgSO4), filtered, and the solvents were removed under reduced pressure. The crude product 
was purified by chromatography (hexanes/EtOAc, 8:2) to give in order of elution 273 (62 mg, 
0.276 mmol, 20%) and 272 (21.7 mg, 0.097 mmol, 7%) both as pale yellow oils. 
 
 
240                            274               246 
1-(2-Nitrophenyl)-2-pentanone (274)192 and 1-(1,1-dimethoxymethyl)-2-nitrobenzene (246). 
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To a suspension of PdCl2 (12.0 mg, 0.068 mmol) and CuCl (61.4 mg, 0.620 mmol) in a 
solution of MeOH (1 mL) and H2O (200 μL) was added 1-(2-nitrophenyl)-1-pentene (240)163 
(113 mg, 0.589mmol) dissolved in MeOH (1 mL). The reaction flask was attached to a 
balloon filled with oxygen and the mixture was stirred at 50 oC for 72 h. The mixture was 
diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give in order of 
elution 246 (10.7 mg, 0.054mmol, 9%) and 274 (71.6 mg, 0.45 mmol, 58%) as pale yellow 
oils. 
 
240                            274              246             247 
1-(2-Nitrophenyl)-2-pentanone (274), 1-(1,1-dimethoxymethyl)-2-nitrobenzene (246), and 
2-nitrobenzaldehyde (247). To a suspension of PdCl2 (13.0 mg, 0.073 mmol) and H2O2 
(50%-aqueous, 300 μL, 6.40 mmol) in a solution of MeOH (1 mL) and H2O (200 μL) was 
added 240 (117 mg, 0.610 mmol) dissolved in MeOH (1 mL). The reaction mixture was 
stirred at 50 oC for 72 h. The mixture was diluted with H2O (50 mL) and extracted with 
EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), filtered, and the 
solvents were removed under reduced pressure. The crude product was purified by 
chromatography (hexanes/EtOAc, 8:2) to give in order of elution 246 (15.9 mg, 0.081mmol, 
13%), 247 (3.2 mg, 0.021mmol, 4%), and 274 (36.7 mg, 0.177mmol, 29%) as pale yellow 
oils.  
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240                            274               246 
1-(2-Nitrophenyl)-2-pentanone (274) and 1-(dimethoxymethyl)-2-nitrobenzene (246). To a 
suspension of PdCl2 (6.7 mg, 0.038 mmol) and 2,6-di-tert-butyl-p-cresol (5.4 mg, 0.025 
mmol) in a solution of MeOH (500 μL), H2O (100 μL) and H2O2 (aqueous-50%, 150 μL, 3.20 
mmol) was added 240 (48.3 mg, 0.252 mmol) dissolved in MeOH (500 μL). The reaction 
mixture was stirred at 50 oC for 96 h. The mixture was diluted with H2O (50 mL) and 
extracted with EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 8:2) to give in order of elution 246 (5.9 mg, 
0.030mmol, 12%) as a pale yellow oiland 274 (26.4 mg, 0.127 mmol, 50%) as a pale yellow 
oil.  
 
 
240                           274 
1-(2-Nitrophenyl)-2-pentanone (274). To a suspension of PdCl2 (6.3 mg, 0.0355 mmol) and 
2,6-di-tert-butyl-p-cresol (6.3 mg, 0.0295 mmol) in a solution of MeOH (500 μL), H2O (100 
μL) and TBHP (90%-aqueous, 267 μL, 2.49 mmol) was added 240 (47.3 mg, 0.247mmol) 
dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 72 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
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The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 274 (32.8 
mg, 0.158 mmol, 64%) as a pale yellow oil.  
 
NO2 NO2
O
NO2
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241                         275             276                277 
3-Methyl-1-(2-nitrophenyl)-2-butanone (275),193 1-(2-nitrophenyl)-3-methoxy-3-methyl-1- 
butene (276), 4-(2-nitrophenyl)-3-methoxy-2-methyl-1-butene (277). To a suspension of 
PdCl2 (11.4 mg, 0.064 mmol) and CuCl (62.1 mg, 0.627 mmol) in a solution of MeOH (1 mL) 
and H2O (200 μL) was added 1-(2-nitrophenyl)-3-methyl-1-butene (241)194 (116 mg, 0.334 
mmol) dissolved in MeOH (1 mL). The reaction flask was attached to a balloon filled with 
oxygen and the mixture was stirred at 50 oC for 72 h. The mixture was diluted with H2O (50 
mL) and extracted with EtOAc (4 x 50 mL). The combined organic phases were dried 
(MgSO4), filtered, and the solvents were removed under reduced pressure. The crude product 
was dissolved in 5 mL of Sat. NaHSO4 to remove the aldehyde and extracted with 5 mL of 
ether. The product was then purified by chromatography (hexanes/EtOAc, 95:5) to give in 
order of elution starting material (51.7 mg, 0.27 mmol, 45%), 277(17.7 mg, 0.080 mmol, 
13%), 276 (15.1 mg, 0.068 mmol, 11%), and 275 (21.5 mg, 0.10 mmol, 17%) as pale yellow 
oils. Spectral data for 277: 1H NMR (600 MHz) δ 7.88 (dd, J=8.4, 1.2 Hz, 1H), 7.50 (td, 
J=7.8, 1.2 Hz, 1H), 7.38 (dd, J=7.2,1.2 Hz, 1H), 7.36 (td, J=7.8,1.8 Hz, 1H), 4.93 (pent, 
J=1.2 Hz, 1H), 4.89 (pent, J=0.7 Hz, 1H), 3.76 (dd, J=8.5, 4.5 Hz, 1H), 3.15 (dd, J=13.8, 
8.4Hz, 1H), 3.12 (s, 3H), 3.08 (dd, J=13.8, 4.2Hz, 1H), 1.74 (t, J=1.2 Hz,3H); 13C NMR (150 
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MHz) δ 149.8, 143.7, 133.8, 133.3, 132.4, 127.3, 124.4, 113.8, 85.1, 56.3, 37.7, 16.8; IR 
(ATR) 2934, 1578, 1524, 1449, 1348, 1096, 905, 861, 785, 739, 668 cm-1; HRMS (ESI) calcd 
for C12H15NNaO3 (M+Na+)244.0944; found 244.0944. 
 
 
241                          275             247  
3-Methyl-1-(2-nitrophenyl)-2-butanone (275) and 2-nitrobenzaldehyde (247). To a 
suspension of PdCl2 (13.1 mg, 0.074 mmol) and H2O2 (50%-aqueous, 300 μL, 6.40 mmol) in 
a solution of MeOH (1 mL) and H2O (200 μL) was added 241 (117 mg, 0.611 mmol) 
dissolved in MeOH (1 mL). The reaction mixture was stirred at 50 oC for 72 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give in order of 
elution starting material (21.8 mg, 0.11 mmol, 19%),  and inseparable mixture of 275 and 
247 (2.2:1 ratio, 31.1 mg；23.3 mg, 0.112 mmol, 18% 275; 7.7 mg, 0.0512 mmol, 8% 247) as 
pale yellow oils. 
 
 
241                          275              246            247 
3-Methyl-1-(2-nitrophenyl)-2-butanone (275), 1-(1,1-dimethoxymethyl)-2-nitrobenzene 
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(246), and 2-nitrobenzaldehyde (247). To a suspension of PdCl2 (5.7 mg, 0.032 mmol) and 
2,6-di-tert-butyl-p-cresol (5.8 mg, 0.026 mmol) in a solution of MeOH (500 μL), H2O (100 
μL) and H2O2 (50%-aqueous, 150 μL, 3.20 mmol) was added 241 (47.1 mg, 0.246 mmol) 
dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 96 h. The mixture 
was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined organic 
phases were dried (MgSO4), filtered, and the solvents were removed under reduced pressure. 
The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give in order of 
elution starting material (16.9 mg, 0.088 mmol, 36%), 246 (4.5 mg, 0.023mmol, 9%) and an 
inseparable mixture of 275 and 247 (4.2:1 ratio, 14.9 mg；12.7 mg, 0.613 mmol, 25% 275; 
2.2 mg, 0.0146 mmol, 6% 247) as yellow oils.  
 
 
241                          275 
3-Methyl-1-(2-nitrophenyl)-2-butanone (275). To a suspension of PdCl2 (5.4 mg, 0.030 
mmol) and 2,6-di-tert-butyl-p-cresol (5.6 mg, 0.025 mmol) in a solution of MeOH (500 μL), 
H2O (100 μL) and TBHP (90%-aqueous, 267 μL, 2.49 mmol) was added 241 (47.8 mg, 0.250 
mmol) dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 96 h. The 
mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvents were removed under reduced 
pressure. The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 
275 (9.0 mg, 0.043mmol, 17%) as a pale yellow oil.  
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242                            278 
2-(2-Nitrophenyl)-1-phenyl-ethanone (278).172 To a suspension of PdCl2 (14.5 mg, 0.0818 
mmol) and CuCl (70.7 mg, 0.714 mmol) in a solution of MeOH (1 mL) and H2O (200 μL) 
was added 2-nitro-1-(2-phenylethenyl)benzene (242)195 (152 mg, 0.675 mmol) dissolved in 
MeOH (1 mL). The reaction flask was attached to a balloon filled with oxygen and the 
mixture was stirred at 50 oC for 48 h. The mixture was diluted with H2O (50 mL) and 
extracted with EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and the solvents were removed under reduced pressure. The crude product was 
purified by chromatography (hexanes/EtOAc, 95:5) to give 278 (23.4 mg, 0.097 mmol, 14%) 
as a light brown oil. 
 
 
242                            278 
2-(2-Nitrophenyl)-1-phenyl-ethanone (278). To a suspension of PdCl2 (14.4 mg, 0.0812 
mmol) and 2,6-di-tert-butyl-p-cresol (17.8 mg, 0.0808 mmol) in a solution of MeOH (1 mL), 
H2O (200 μL) and H2O2 (50%-aqueous, 300 μL, 6.40 mmol) was added 242 (15.0 mg, 0.067 
mmol) dissolved in MeOH (1 mL). The reaction mixture was stirred at 50 oC for 68 h. The 
mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvents were removed under reduced 
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pressure. The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 
278 (8.2 mg, 0.034 mmol, 51%) as a light brown oil. 
 
 
242                           278 
2-(2-Nitrophenyl)-1-phenyl-ethanone (278). To a suspension of PdCl2 (5.5 mg, 0.031 mmol) 
and 2,6-di-tert-butyl-p-cresol (5.8 mg, 0.026 mmol) in a solution of MeOH (500 μL), H2O 
(100 μL) and TBHP (90%-aqueous, 267 μL, 2.49 mmol) was added 242 (49.1 mg, 0.218 
mmol) dissolved in MeOH (500 μL). The reaction mixture was stirred at 50 oC for 72 h. The 
mixture was diluted with H2O (50 mL) and extracted with EtOAc (4 x 50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvents were removed under reduced 
pressure. The crude product was purified by chromatography (hexanes/EtOAc, 8:2) to give 
278 (38.9 mg, 0.161mmol, 74%) as a pale brown oil. 
 
 
242                           278 
2-(2-Nitrophenyl)-1-phenyl-ethanone (278). To a suspension of PdCl2 (6.6 mg, 0.037 mmol) 
in a solution of MeOH (500 μL), H2O (100 μL) and TBHP (90%-aqueous, 267μL, 2.49 mmol) 
was added 242 (50.5 mg, 0.224mmol) dissolved in MeOH (500 μL). The reaction mixture 
was stirred at 50 oC for 72 h. The mixture was diluted with H2O (50 mL) and extracted with 
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EtOAc (4 x 50 mL). The combined organic phases were dried (MgSO4), filtered, and the 
solvents were removed under reduced pressure. The crude product was purified by 
chromatography (hexanes/EtOAc, 8:2) to give 278 (14.6 mg, 0.060 mmol, 27%) as a light 
brown oil. 
 
 
243                    279          280              281         282 
1-(2-Bromophenyl)-2-propanone (279),196 1-bromo-2-(1,1-dimethoxymethyl)benzene 
(280),197 and 2-bromobenzaldehyde (281), 1-(2-bromophenyl)-1,2-propanedione (282). A 
solution of 243 (133 mg, 0.672 mmol) in MeOH (1 mL) was added to a suspension of PdCl2 
(12.9 mg, 0.073 mmol) and CuCl (69.8 mg, 0.71 mmol) in a solution of MeOH (1 mL) and 
H2O (200 μL) under an atmosphere of oxygen, as described for 230 in Condition A (50 oC, 20 
h). Extraction and purification by chromatography (hexanes/EtOAc, 98:2) gave in order of 
elution, an inseparable mixture of 280 and 281 (7:1 ratio, 13.1 mg; 11.7 mg, 0.051 mmol, 8% 
280; 1.34 mg, 0.0073 mmol, 1% 281), 282 (9 mg, 0.040 mmol, <6%), and 279 (64.5 mg, 0.30 
mmol, 45%) as pale yellow oils. Spectral data for impure 1-(2-bromophenyl)-1,2-propane 
dione 282: 1H NMR (600 MHz) δ 7.61 (dd, J=7.2, 1.8 Hz, 1H), 7.57 (dd, J=7.2, 2.4 Hz, 1H), 
7.45 (td, J=7.2, 1.8 Hz, 1H), 7.41 (td, J=7.2, 1.8 Hz, 1H), 2.59 (s, 3H); 13C NMR (100 MHz) 
197.9, 193.4, 136.3, 133.6, 133.1, 131.4, 127.7, 121.0, 25.1; IR (ATR) 2970, 1715, 1688, 
1587, 1434, 1356, 1172, 1053, 1027, 903, 802, 738 cm-1; HRMS (ESI) calcd for C9H8BrO2 
(M+H+) 226.9708; found 226.9702.  
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244                       283            284 
1-Phenyl-2-propanone (283)198 and 1-phenyl-1-propanone (284). A solution of 
1-propen-1-yl-benzene (244)199 (95.3 mg, 0.806 mmol) in MeOH (1 mL) was added to a 
suspension of PdCl2 (14.3 mg, 0.081 mmol) and CuCl (79.8 mg, 0.81 mmol) in a solution of 
MeOH (1 mL) and H2O (200 μL) under an atmosphere of oxygen, as described for 230 in 
Condition A (50 oC, 20 h). Extraction and purification by chromatography (hexanes/EtOAc, 
9:1) gave in order of elution, 284 (16.0 mg, 0.099 mmol, 12%) and 283 (44.2 mg, 0.27 mmol, 
34%) as colorless oils. 
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1H and 13C for Chapter 1 
 
Figure 17: 1H NMR of 2,3-bis(1-methylethoxy)-5-trimethylsilyl-2,5-cyclohexadiene- 
1,4-dione (70) 
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Figure 18: 13C NMR of 2,3-bis(1-methylethoxy)-5-trimethylsilyl-2,5-cyclohexadiene- 
1,4-dione (70) 
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Figure 19: 1H NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)- 
4-cyclopentene-1,3-dione (71) 
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Figure 20: 13C NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)- 
4-cyclopentene-1,3-dione (71) 
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Figure 21: 1H NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (72) 
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Figure 22: 13C NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (72) 
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Figure 23: 1H NMR of 2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (74) 
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Figure 24: 13C NMR of 2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (74) 
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Figure 25: 1H NMR of 2-(iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (75) 
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Figure 26: 13C NMR of 2-(iodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (75) 
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Figure 27: 1H NMR of 2-(bromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (76) 
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Figure 28: 13C NMR of 2-(bromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (76) 
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Figure 29: 1H NMR of 5-chloro-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (77) 
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Figure 30: 13C NMR of 5-chloro-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (77) 
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Figure 31: 1H NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-iodoethynyl)-2- 
cyclobutene-1-one (78) 
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Figure 32: 13C NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-iodoethynyl)-2- 
cyclobutene-1-one (78) 
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Figure 33: 1H NMR of 5-iodo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (79) 
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Figure 34: 13C NMR of 5-iodo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (79) 
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Figure 35: 1H NMR of 2-(diiodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (80) 
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Figure 36: 13C NMR of 2-(diiodomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (80) 
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Figure 37: 1H NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-bromoethynyl)-2- 
cyclobutene-1-one (81) 
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Figure 38: 13C NMR of 4-hydroxy-2,3-bis(1-methylethoxy)-4-(2-bromoethynyl)-2- 
cyclobutene-1-one (81) 
171 
 
 
Figure 39: 1H NMR of 5-bromo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (82) 
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Figure 40: 13C NMR of 5-bromo-2,3-bis(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (82) 
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Figure 41: 1H NMR of 2-(1-bromo-1-iodomethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (83) 
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Figure 42: 13C NMR of 2-(1-bromo-1-iodomethylene)-4,5-bis(1-methylethoxy)-4- 
cyclopentene-1,3-dione (83) 
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Figure 43: 1H NMR of 2-(dibromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (84) 
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Figure 44: 13C NMR of 2-(dibromomethylene)-4,5-bis(1-methylethoxy)-4-cyclopentene- 
1,3-dione (84) 
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Figure 45: 1H NMR of 4-hydroxy-2-methyl-3-(1-methylethoxy)-4-(2-trimethylsilylethynyl)- 
2-cyclobutene-1-one (89) 
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Figure 46: 13C NMR of 4-hydroxy-2-methyl-3-(1-methylethoxy)-4-(2-trimethylsilylethynyl)- 
2-cyclobutene-1-one (89) 
179 
 
 
Figure 47: 1H NMR of 2-trimethylsilylmethylene-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (90) and 5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (91) 
180 
 
 
Figure 48: 13C NMR of 2-trimethylsilylmethylene-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (90) and 5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (91) 
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Figure 49: 1H NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (92) 
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Figure 50: 13C NMR of 2-(1-iodo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5-methyl- 
4-cyclopentene-1,3-dione (92) 
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Figure 51: 1H NMR of 6-iodo-5-trimethylsilyl-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (93) 
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Figure 52: 13C NMR of 6-iodo-5-trimethylsilyl-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (93) 
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Figure 53: 1H NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5- 
methyl-4-cyclopentene-1,3-dione (94) 
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Figure 54: 13C NMR of 2-(1-bromo-1-trimethylsilylmethylene)-4-(1-methylethoxy)-5- 
methyl-4-cyclopentene-1,3-dione (94) 
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Figure 55: 1H NMR of 6-bromo-5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (95) 
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Figure 56: 13C NMR of 6-bromo-5-trimethylsily-3-methyl-2-(1-methylethoxy)-2,5- 
cyclohexadiene-1,4-dione (95) 
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Figure 57: 1H NMR of 3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (97) 
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Figure 58: 13C NMR of 3-methyl-2-(1-methylethoxy)-2,5-cyclohexadiene-1,4-dione (97) 
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Figure 59: 1H NMR of 2-(1-iodomethylene)-4-methyl-5-(1-methylethoxy)-4-cyclopentene- 
1,3-dione (98) 
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Figure 60: 13C NMR of 2-(1-iodomethylene)-4-methyl-5-(1-methylethoxy)-4-cyclopentene- 
1,3-dione (98) 
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Figure 61: 1H NMR of 2-(1-bromomethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene- 
1,3-dione (99) 
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Figure 62: 13C NMR of 2-(1-bromomethylene)-4-(1-methylethoxy)-5-methyl-4- 
cyclopentene-1,3-dione (99) 
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Figure 63: 1H NMR of 2-(diiodomethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene- 
1,3-dione (101) 
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Figure 64: 13C NMR of 2-(diiodomethylene)-4-(1-methylethoxy)-5-methyl-4-cyclopentene- 
1,3-dione (101) 
 Figure 65: 1H NMR of ethyl 2-(3,4-d
iodo
imethoxy-
ethanoate (
2,5-dioxo-3
104) 
-cyclopenten-1-ylene)
197 
-2- 
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Figure 66: 13C NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
iodoethanoate (104) 
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Figure 67: 1H NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
bromoethanoate (105) 
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Figure 68: 13C NMR of ethyl 2-(3,4-dimethoxy-2,5-dioxo-3-cyclopenten-1-ylene)-2- 
bromoethanoate (105) 
201 
 
1H and 13C for Chapter 2 
 
Figure 69: 1H NMR of 2,3-dimethoxy-4-hydroxy-4-[(E)-4-phenyl-3-buten-1-yn-1-yl]-2- 
cyclobuten-1-one (137) 
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Figure 70: 13C NMR of 2,3-dimethoxy-4-hydroxy-4-[(E)-4-phenyl-3-buten-1-yn-1-yl]-2- 
cyclobuten-1-one (137) 
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Figure 71: 1H NMR of 4,5-dimethoxy-[(E)-2-(1-iodo-3-phenyl-2-propen-1-ylidene)]-4- 
cyclopentene-1,3-dione (138) 
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Figure 72: 13C NMR of 4,5-dimethoxy-[(E)-2-(1-iodo-3-phenyl-2-propen-1-ylidene)]-4- 
cyclopentene-1,3-dione (138) 
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Figure 73: 1H NMR of 4,5-dimethoxy-2-[(E)-3-phenyl-2-propen-1-ylidene]-4- 
cyclopente-1,3-dione (139) 
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Figure 74: 13C NMR of 4,5-dimethoxy-2-[(E)-3-phenyl-2-propen-1-ylidene]-4- 
cyclopente-1,3-dione (139) 
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Figure 75: 1H NMR of 4,5-dimethoxy-2-[(E)-1-(N,N-dimethylamino)-3-phenyl-2-propen-1- 
ylidene]-4-cyclopente-1,3-dione (140) 
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1H and 13C for Chapter 3 
 
Figure 76: 1H NMR of 4-fluoro-2-nitro-1-(1-propen-1-yl)benzene (233) 
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Figure 77: 13C NMR of 4-fluoro-2-nitro-1-(1-propen-1-yl)benzene (233) 
 
210 
 
 
Figure 78: 1H NMR of 2,4-dinitro-1-(1-propen-1-yl)benzene (234) 
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Figure 79: 1H NMR of 4-carbomethoxy-2-nitro-1-(1-propen-1-yl)benzene (235) 
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Figure 80: 1H NMR of 4-methoxy-2-nitro-1-(1-propen-1-yl)benzene (236) 
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Figure 81: 13C NMR of 4-methoxy-2-nitro-1-(1-propen-1-yl)benzene (236) 
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Figure 82: 1H NMR of 5-methoxy-2-nitro-1-(1-propen-1-yl)-benzene (8) 
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Figure 83: 1H NMR of 3-nitrobenzaldehyde (250) and  
1-(3-nitrophenyl)-1,2-propandione (251) 
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Figure 84:13C NMR of 3-nitrobenzaldehyde (250) and  
1-(3-nitrophenyl)-1,2-propandione (251) 
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Figure 85: 1H NMR of 1-(4-fluoro-2-nitrophenyl)-2-propanone (257) 
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Figure 86: 13C NMR of 1-(4-fluoro-2-nitrophenyl)-2-propanone (257) 
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Figure 87: 1H NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-Nitrobenzene (258) 
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Figure 88: 13C NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-Nitrobenzene (258) 
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Figure 89: 1H NMR of 4-fluoro-2-nitrobenzaldehyde (259) and  
1-(4-fluoro-2-nitrophenyl)-1,2-propanedione (260) 
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Figure 90: 13C NMR of 4-fluoro-2-nitrobenzaldehyde (259) and  
1-(4-fluoro-2-nitrophenyl)-1,2-propanedione (260) 
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Figure 91: 1H NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-Nitrobenzene (263) 
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Figure 92: 13C NMR of 4-fluoro-1-(1,1-dimethoxymethyl)-2-nitrobenzene (263) 
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Figure 93: 1H NMR of 4-carbomethoxy-2-nitrobenzaldehyde (266) and 
1-(4-carbomethoxy-2-nitrophenyl)-1,2-propanedione (267) 
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Figure 94: 1H NMR of 1-(5-methoxy-2-nitrophenyl)-2-propanone (269) 
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Figure 95: 13C NMR of 1-(5-methoxy-2-nitrophenyl)-2-propanone (269) 
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Figure 96: 1H NMR of 5-methoxy-2-nitro-benzaldehyde (270) and 
1-(5-methoxy-2-nitrophenyl)-1,2-propanedione (271) 
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Figure 97: 13C NMR of 5-methoxy-2-nitro-benzaldehyde (270) and 
1-(5-methoxy-2-nitrophenyl)-1,2-propanedione (271) 
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Figure 98: 1H NMR of 4-(2-nitrophenyl)-3-methoxy-2-methyl-1-butene (277) 
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Figure 99: 13C NMR of 4-(2-nitrophenyl)-3-methoxy-2-methyl-1-butene (277) 
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Figure 100: 1H NMR of 1-(2-bromophenyl)-1,2-propanedione (282) 
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Figure 101: 13C NMR of 1-(2-bromophenyl)-1,2-propanedione (282) 
